Provinces;Employee strata;Cohorts;ERTEs;Demographic Concepts;Periodo;Total
National Total;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
National Total;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.203.242
National Total;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
National Total;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.137.295
National Total;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.089.513
National Total;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
National Total;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
National Total;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
National Total;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
National Total;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
National Total;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
National Total;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
National Total;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
National Total;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,52
National Total;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;90,55
National Total;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
National Total;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
National Total;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
National Total;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
National Total;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
National Total;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;415.649
National Total;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
National Total;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;380.220
National Total;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;355.749
National Total;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
National Total;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
National Total;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
National Total;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
National Total;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
National Total;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
National Total;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
National Total;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,48
National Total;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;85,59
National Total;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
National Total;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
National Total;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
National Total;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
National Total;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
National Total;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;787.593
National Total;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
National Total;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;757.075
National Total;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;733.764
National Total;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
National Total;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
National Total;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
National Total;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,13
National Total;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;93,17
National Total;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
National Total;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
National Total;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
National Total;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
National Total;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
National Total;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.212.050
National Total;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
National Total;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.151.809
National Total;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
National Total;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
National Total;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
National Total;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
National Total;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
National Total;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
National Total;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
National Total;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
National Total;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
National Total;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,03
National Total;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
National Total;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
National Total;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
National Total;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
National Total;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
National Total;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
National Total;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
National Total;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;391.560
National Total;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;360.182
National Total;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
National Total;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
National Total;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
National Total;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
National Total;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
National Total;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
National Total;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
National Total;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
National Total;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,99
National Total;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
National Total;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
National Total;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
National Total;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
National Total;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
National Total;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
National Total;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
National Total;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;820.490
National Total;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;791.627
National Total;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
National Total;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
National Total;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
National Total;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
National Total;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,48
National Total;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
National Total;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
National Total;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
National Total;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
National Total;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
National Total;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
National Total;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
National Total;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
National Total;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
National Total;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
National Total;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
National Total;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
National Total;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
National Total;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
National Total;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
National Total;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
National Total;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
National Total;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
National Total;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
National Total;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
National Total;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
National Total;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
National Total;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
National Total;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
National Total;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
National Total;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
National Total;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
National Total;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
National Total;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
National Total;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
National Total;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
National Total;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
National Total;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
National Total;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
National Total;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
National Total;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
National Total;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
National Total;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
National Total;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
National Total;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
National Total;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
National Total;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
National Total;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
National Total;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
National Total;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
National Total;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
National Total;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
National Total;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
National Total;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
National Total;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
National Total;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
National Total;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
National Total;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
National Total;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
National Total;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
National Total;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
National Total;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
National Total;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
National Total;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
National Total;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
National Total;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
National Total;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
National Total;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
National Total;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
National Total;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
National Total;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
National Total;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
National Total;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
National Total;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
National Total;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
National Total;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
National Total;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
National Total;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
National Total;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
National Total;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
National Total;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
National Total;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
National Total;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
National Total;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
National Total;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
National Total;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
National Total;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
National Total;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
National Total;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
National Total;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
National Total;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
National Total;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
National Total;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
National Total;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
National Total;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
National Total;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
National Total;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
National Total;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
National Total;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
National Total;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
National Total;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
National Total;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
National Total;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
National Total;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
National Total;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
National Total;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
National Total;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
National Total;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
National Total;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;872.833
National Total;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
National Total;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;811.530
National Total;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;769.027
National Total;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
National Total;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
National Total;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
National Total;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
National Total;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;92,98
National Total;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;88,11
National Total;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
National Total;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
National Total;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
National Total;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;336.725
National Total;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
National Total;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;303.033
National Total;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;280.689
National Total;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
National Total;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
National Total;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
National Total;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;89,99
National Total;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;83,36
National Total;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
National Total;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
National Total;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
National Total;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;536.108
National Total;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
National Total;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;508.497
National Total;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;488.338
National Total;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
National Total;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
National Total;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
National Total;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;94,85
National Total;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;91,09
National Total;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
National Total;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
National Total;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
National Total;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;873.745
National Total;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
National Total;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;819.190
National Total;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
National Total;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
National Total;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
National Total;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
National Total;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
National Total;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,76
National Total;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
National Total;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
National Total;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
National Total;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
National Total;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
National Total;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;317.455
National Total;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;288.532
National Total;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
National Total;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
National Total;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
National Total;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
National Total;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,89
National Total;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
National Total;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
National Total;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
National Total;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
National Total;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
National Total;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;556.290
National Total;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;530.658
National Total;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
National Total;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
National Total;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
National Total;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
National Total;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,39
National Total;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
National Total;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
National Total;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
National Total;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
National Total;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
National Total;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
National Total;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
National Total;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
National Total;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
National Total;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
National Total;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
National Total;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
National Total;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
National Total;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
National Total;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
National Total;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
National Total;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
National Total;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
National Total;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
National Total;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
National Total;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
National Total;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
National Total;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
National Total;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
National Total;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
National Total;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
National Total;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
National Total;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
National Total;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
National Total;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
National Total;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
National Total;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
National Total;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
National Total;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
National Total;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
National Total;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
National Total;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
National Total;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
National Total;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
National Total;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
National Total;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
National Total;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
National Total;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
National Total;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
National Total;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
National Total;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
National Total;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
National Total;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
National Total;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
National Total;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
National Total;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
National Total;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
National Total;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
National Total;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
National Total;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
National Total;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
National Total;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
National Total;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
National Total;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
National Total;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
National Total;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
National Total;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
National Total;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
National Total;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
National Total;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
National Total;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
National Total;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
National Total;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
National Total;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
National Total;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
National Total;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
National Total;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
National Total;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
National Total;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
National Total;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;132.687
National Total;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
National Total;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;130.164
National Total;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;127.242
National Total;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
National Total;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
National Total;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
National Total;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
National Total;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,1
National Total;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;95,9
National Total;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
National Total;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
National Total;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
National Total;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;37.746
National Total;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
National Total;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;36.723
National Total;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;35.530
National Total;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
National Total;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
National Total;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
National Total;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,29
National Total;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;94,13
National Total;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
National Total;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
National Total;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
National Total;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;94.941
National Total;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
National Total;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;93.441
National Total;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;91.712
National Total;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
National Total;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
National Total;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
National Total;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,42
National Total;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,6
National Total;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
National Total;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
National Total;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
National Total;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;134.899
National Total;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
National Total;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;132.032
National Total;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
National Total;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
National Total;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
National Total;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
National Total;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
National Total;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,87
National Total;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
National Total;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
National Total;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
National Total;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
National Total;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
National Total;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;35.580
National Total;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;34.502
National Total;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
National Total;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
National Total;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
National Total;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
National Total;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;96,97
National Total;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
National Total;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
National Total;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
National Total;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
National Total;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
National Total;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;99.319
National Total;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;97.530
National Total;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
National Total;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
National Total;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
National Total;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
National Total;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,2
National Total;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
National Total;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
National Total;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
National Total;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
National Total;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
National Total;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
National Total;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
National Total;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
National Total;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
National Total;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
National Total;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
National Total;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
National Total;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
National Total;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
National Total;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
National Total;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
National Total;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
National Total;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
National Total;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
National Total;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
National Total;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
National Total;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
National Total;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
National Total;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
National Total;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
National Total;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
National Total;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
National Total;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
National Total;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
National Total;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
National Total;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
National Total;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
National Total;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
National Total;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
National Total;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
National Total;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
National Total;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
National Total;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
National Total;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
National Total;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
National Total;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
National Total;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
National Total;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
National Total;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
National Total;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
National Total;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
National Total;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
National Total;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
National Total;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
National Total;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
National Total;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
National Total;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
National Total;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
National Total;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
National Total;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
National Total;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
National Total;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
National Total;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
National Total;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
National Total;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
National Total;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
National Total;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
National Total;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
National Total;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
National Total;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
National Total;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
National Total;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
National Total;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
National Total;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
National Total;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
National Total;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
National Total;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
National Total;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
National Total;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
National Total;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;181.653
National Total;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
National Total;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;179.602
National Total;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;177.299
National Total;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
National Total;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
National Total;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
National Total;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
National Total;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,87
National Total;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,6
National Total;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
National Total;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
National Total;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
National Total;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;38.755
National Total;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
National Total;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;38.062
National Total;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;37.148
National Total;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
National Total;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
National Total;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
National Total;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,21
National Total;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;95,85
National Total;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
National Total;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
National Total;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
National Total;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;142.898
National Total;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
National Total;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;141.540
National Total;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;140.151
National Total;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
National Total;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
National Total;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
National Total;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,05
National Total;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,08
National Total;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
National Total;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
National Total;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
National Total;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;186.426
National Total;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
National Total;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;183.810
National Total;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
National Total;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
National Total;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
National Total;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
National Total;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
National Total;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,6
National Total;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
National Total;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
National Total;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
National Total;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
National Total;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
National Total;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;36.263
National Total;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;35.054
National Total;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
National Total;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
National Total;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
National Total;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
National Total;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;96,67
National Total;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
National Total;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
National Total;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
National Total;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
National Total;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
National Total;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;150.163
National Total;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;148.756
National Total;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
National Total;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
National Total;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
National Total;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
National Total;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,06
National Total;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
National Total;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
National Total;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
National Total;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
National Total;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
National Total;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
National Total;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
National Total;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
National Total;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
National Total;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
National Total;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
National Total;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
National Total;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
National Total;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
National Total;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
National Total;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
National Total;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
National Total;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
National Total;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
National Total;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
National Total;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
National Total;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
National Total;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
National Total;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
National Total;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
National Total;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
National Total;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
National Total;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
National Total;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
National Total;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
National Total;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
National Total;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
National Total;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
National Total;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
National Total;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
National Total;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
National Total;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
National Total;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
National Total;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
National Total;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
National Total;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
National Total;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
National Total;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
National Total;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
National Total;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
National Total;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
National Total;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
National Total;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
National Total;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
National Total;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
National Total;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
National Total;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
National Total;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
National Total;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
National Total;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
National Total;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
National Total;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
National Total;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
National Total;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
National Total;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
National Total;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
National Total;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
National Total;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
National Total;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
National Total;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
National Total;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
National Total;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
National Total;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
National Total;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
National Total;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
National Total;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
National Total;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
National Total;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
National Total;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
National Total;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
National Total;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;10.201
National Total;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
National Total;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;10.148
National Total;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;10.114
National Total;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
National Total;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
National Total;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
National Total;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
National Total;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
National Total;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
National Total;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
National Total;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
National Total;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,48
National Total;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;99,15
National Total;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
National Total;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
National Total;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
National Total;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
National Total;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
National Total;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1.535
National Total;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
National Total;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1.520
National Total;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.509
National Total;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
National Total;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
National Total;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
National Total;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
National Total;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
National Total;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
National Total;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
National Total;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;99,02
National Total;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;98,31
National Total;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
National Total;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
National Total;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
National Total;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
National Total;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
National Total;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;8.666
National Total;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
National Total;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;8.628
National Total;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;8.605
National Total;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
National Total;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
National Total;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
National Total;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,56
National Total;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;99,3
National Total;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
National Total;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
National Total;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
National Total;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
National Total;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
National Total;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;10.864
National Total;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
National Total;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;10.707
National Total;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
National Total;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
National Total;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
National Total;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
National Total;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
National Total;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
National Total;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
National Total;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
National Total;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
National Total;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,55
National Total;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
National Total;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
National Total;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
National Total;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
National Total;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
National Total;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
National Total;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
National Total;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1.497
National Total;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.363
National Total;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
National Total;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
National Total;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
National Total;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
National Total;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
National Total;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
National Total;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
National Total;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
National Total;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,05
National Total;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
National Total;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
National Total;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
National Total;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
National Total;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
National Total;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
National Total;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
National Total;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;9.367
National Total;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;9.344
National Total;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
National Total;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
National Total;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
National Total;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
National Total;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,75
National Total;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
National Total;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
National Total;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
National Total;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
National Total;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
National Total;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
National Total;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
National Total;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
National Total;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
National Total;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
National Total;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
National Total;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
National Total;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
National Total;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
National Total;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
National Total;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
National Total;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
National Total;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
National Total;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
National Total;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
National Total;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
National Total;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
National Total;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
National Total;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
National Total;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
National Total;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
National Total;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
National Total;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
National Total;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
National Total;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
National Total;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
National Total;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
National Total;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
National Total;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
National Total;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
National Total;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
National Total;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
National Total;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
National Total;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
National Total;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
National Total;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
National Total;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
National Total;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
National Total;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
National Total;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
National Total;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
National Total;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
National Total;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
National Total;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
National Total;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
National Total;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
National Total;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
National Total;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
National Total;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
National Total;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
National Total;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
National Total;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
National Total;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
National Total;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
National Total;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
National Total;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
National Total;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
National Total;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
National Total;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
National Total;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
National Total;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
National Total;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
National Total;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
National Total;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
National Total;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
National Total;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
National Total;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
National Total;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
National Total;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
National Total;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
National Total;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
National Total;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
National Total;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
National Total;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
National Total;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
National Total;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
National Total;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
National Total;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
National Total;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
National Total;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
National Total;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
National Total;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
National Total;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
National Total;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
National Total;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
National Total;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
National Total;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
National Total;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
National Total;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
National Total;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
National Total;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
National Total;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
National Total;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
National Total;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
National Total;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
National Total;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
National Total;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
National Total;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
National Total;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;5.868
National Total;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
National Total;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;5.851
National Total;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;5.831
National Total;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
National Total;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
National Total;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
National Total;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
National Total;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,71
National Total;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;99,37
National Total;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
National Total;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
National Total;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
National Total;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;888
National Total;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
National Total;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;882
National Total;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;873
National Total;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
National Total;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
National Total;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
National Total;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;99,32
National Total;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;98,31
National Total;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
National Total;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
National Total;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
National Total;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;4.980
National Total;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
National Total;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;4.969
National Total;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;4.958
National Total;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
National Total;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
National Total;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
National Total;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,78
National Total;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;99,56
National Total;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
National Total;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
National Total;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
National Total;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;6.116
National Total;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
National Total;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;6.070
National Total;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
National Total;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
National Total;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
National Total;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
National Total;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
National Total;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;99,25
National Total;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
National Total;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
National Total;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
National Total;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
National Total;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
National Total;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;765
National Total;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;731
National Total;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
National Total;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
National Total;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
National Total;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
National Total;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;95,56
National Total;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
National Total;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
National Total;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
National Total;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
National Total;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
National Total;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;5.351
National Total;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;5.339
National Total;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
National Total;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
National Total;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
National Total;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
National Total;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,78
National Total;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
National Total;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
National Total;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
National Total;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
National Total;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
National Total;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
National Total;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
National Total;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
National Total;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
National Total;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
National Total;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
National Total;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
National Total;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
National Total;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
National Total;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
National Total;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
National Total;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
National Total;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
National Total;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
National Total;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
National Total;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
National Total;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
National Total;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
National Total;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
National Total;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
National Total;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
National Total;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
National Total;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
National Total;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
National Total;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
National Total;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
National Total;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
National Total;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
National Total;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
National Total;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
National Total;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
National Total;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
National Total;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
National Total;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
National Total;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
National Total;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
National Total;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
National Total;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
National Total;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
National Total;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
National Total;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
National Total;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
National Total;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
National Total;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
National Total;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
National Total;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
National Total;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
National Total;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
National Total;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
National Total;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
National Total;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
National Total;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
National Total;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
National Total;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
National Total;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
National Total;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
National Total;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
National Total;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
National Total;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
National Total;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
National Total;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
National Total;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
National Total;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
National Total;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
National Total;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
National Total;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
National Total;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
National Total;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
National Total;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
National Total;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
National Total;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
National Total;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
National Total;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
National Total;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
National Total;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
National Total;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
National Total;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
National Total;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
National Total;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;9.230
02 Albacete;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
02 Albacete;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;8.737
02 Albacete;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;8.328
02 Albacete;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
02 Albacete;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
02 Albacete;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,66
02 Albacete;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;90,23
02 Albacete;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;2.768
02 Albacete;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
02 Albacete;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;2.536
02 Albacete;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;2.337
02 Albacete;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
02 Albacete;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
02 Albacete;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,62
02 Albacete;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;84,43
02 Albacete;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;6.462
02 Albacete;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
02 Albacete;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;6.201
02 Albacete;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;5.991
02 Albacete;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
02 Albacete;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
02 Albacete;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,96
02 Albacete;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;92,71
02 Albacete;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;9.279
02 Albacete;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;8.757
02 Albacete;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
02 Albacete;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
02 Albacete;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
02 Albacete;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
02 Albacete;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,37
02 Albacete;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
02 Albacete;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;2.620
02 Albacete;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;2.360
02 Albacete;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
02 Albacete;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
02 Albacete;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
02 Albacete;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
02 Albacete;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,08
02 Albacete;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
02 Albacete;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;6.659
02 Albacete;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;6.397
02 Albacete;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
02 Albacete;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
02 Albacete;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
02 Albacete;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
02 Albacete;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,07
02 Albacete;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
02 Albacete;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
02 Albacete;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
02 Albacete;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
02 Albacete;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
02 Albacete;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
02 Albacete;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
02 Albacete;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
02 Albacete;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
02 Albacete;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
02 Albacete;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
02 Albacete;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
02 Albacete;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
02 Albacete;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
02 Albacete;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
02 Albacete;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
02 Albacete;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
02 Albacete;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
02 Albacete;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
02 Albacete;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
02 Albacete;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
02 Albacete;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
02 Albacete;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
02 Albacete;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
02 Albacete;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
02 Albacete;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
02 Albacete;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
02 Albacete;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
02 Albacete;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
02 Albacete;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
02 Albacete;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
02 Albacete;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;6.731
02 Albacete;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;6.270
02 Albacete;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;5.924
02 Albacete;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
02 Albacete;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,15
02 Albacete;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;88,01
02 Albacete;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;2.282
02 Albacete;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;2.060
02 Albacete;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.885
02 Albacete;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
02 Albacete;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;90,27
02 Albacete;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;82,6
02 Albacete;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;4.449
02 Albacete;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;4.210
02 Albacete;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;4.039
02 Albacete;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
02 Albacete;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;94,63
02 Albacete;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;90,78
02 Albacete;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;6.765
02 Albacete;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;6.324
02 Albacete;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
02 Albacete;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,48
02 Albacete;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;2.161
02 Albacete;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.935
02 Albacete;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
02 Albacete;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;89,54
02 Albacete;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;4.604
02 Albacete;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;4.389
02 Albacete;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
02 Albacete;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,33
02 Albacete;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.076
02 Albacete;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.057
02 Albacete;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.020
02 Albacete;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
02 Albacete;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,23
02 Albacete;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;94,8
02 Albacete;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;246
02 Albacete;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;239
02 Albacete;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;225
02 Albacete;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
02 Albacete;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,15
02 Albacete;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;91,46
02 Albacete;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;830
02 Albacete;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;818
02 Albacete;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;795
02 Albacete;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
02 Albacete;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,55
02 Albacete;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;95,78
02 Albacete;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.050
02 Albacete;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.015
02 Albacete;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
02 Albacete;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;96,67
02 Albacete;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;219
02 Albacete;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;213
02 Albacete;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
02 Albacete;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;97,26
02 Albacete;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;831
02 Albacete;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;802
02 Albacete;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
02 Albacete;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,51
02 Albacete;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.356
02 Albacete;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.343
02 Albacete;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.318
02 Albacete;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
02 Albacete;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,04
02 Albacete;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,2
02 Albacete;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;229
02 Albacete;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;226
02 Albacete;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;216
02 Albacete;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
02 Albacete;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,69
02 Albacete;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;94,32
02 Albacete;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.127
02 Albacete;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.117
02 Albacete;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.102
02 Albacete;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
02 Albacete;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,11
02 Albacete;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,78
02 Albacete;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.389
02 Albacete;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.349
02 Albacete;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
02 Albacete;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,12
02 Albacete;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;227
02 Albacete;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;205
02 Albacete;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
02 Albacete;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,31
02 Albacete;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.162
02 Albacete;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.144
02 Albacete;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
02 Albacete;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,45
02 Albacete;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;43
02 Albacete;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;43
02 Albacete;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;42
02 Albacete;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
02 Albacete;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
02 Albacete;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,67
02 Albacete;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
02 Albacete;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
02 Albacete;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
02 Albacete;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;5
02 Albacete;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;5
02 Albacete;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;5
02 Albacete;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
02 Albacete;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
02 Albacete;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
02 Albacete;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
02 Albacete;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
02 Albacete;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
02 Albacete;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;38
02 Albacete;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;38
02 Albacete;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;37
02 Albacete;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
02 Albacete;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
02 Albacete;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,37
02 Albacete;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
02 Albacete;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
02 Albacete;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
02 Albacete;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;53
02 Albacete;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;47
02 Albacete;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
02 Albacete;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;88,68
02 Albacete;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
02 Albacete;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
02 Albacete;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
02 Albacete;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
02 Albacete;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;9
02 Albacete;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;3
02 Albacete;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
02 Albacete;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;33,33
02 Albacete;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
02 Albacete;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
02 Albacete;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
02 Albacete;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
02 Albacete;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;44
02 Albacete;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;44
02 Albacete;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
02 Albacete;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
02 Albacete;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
02 Albacete;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
02 Albacete;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
02 Albacete;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
02 Albacete;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
02 Albacete;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
02 Albacete;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
02 Albacete;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
02 Albacete;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
02 Albacete;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
02 Albacete;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
02 Albacete;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
02 Albacete;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
02 Albacete;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
02 Albacete;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
02 Albacete;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
02 Albacete;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
02 Albacete;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
02 Albacete;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
02 Albacete;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
02 Albacete;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
02 Albacete;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
02 Albacete;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
02 Albacete;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
02 Albacete;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
02 Albacete;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
02 Albacete;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
02 Albacete;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
02 Albacete;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;24
02 Albacete;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;24
02 Albacete;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;24
02 Albacete;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
02 Albacete;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
02 Albacete;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
02 Albacete;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;6
02 Albacete;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;6
02 Albacete;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;6
02 Albacete;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
02 Albacete;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
02 Albacete;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
02 Albacete;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;18
02 Albacete;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;18
02 Albacete;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;18
02 Albacete;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
02 Albacete;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
02 Albacete;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
02 Albacete;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;22
02 Albacete;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;22
02 Albacete;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
02 Albacete;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
02 Albacete;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;4
02 Albacete;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;4
02 Albacete;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
02 Albacete;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
02 Albacete;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;18
02 Albacete;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;18
02 Albacete;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
02 Albacete;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
02 Albacete;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
02 Albacete;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
02 Albacete;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
02 Albacete;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
02 Albacete;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
02 Albacete;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
02 Albacete;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;54.337
03 Alicante/Alacant;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;51.115
03 Alicante/Alacant;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;48.911
03 Alicante/Alacant;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,07
03 Alicante/Alacant;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;90,01
03 Alicante/Alacant;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;20.560
03 Alicante/Alacant;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;18.707
03 Alicante/Alacant;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;17.553
03 Alicante/Alacant;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;90,99
03 Alicante/Alacant;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;85,37
03 Alicante/Alacant;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;33.777
03 Alicante/Alacant;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;32.408
03 Alicante/Alacant;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;31.358
03 Alicante/Alacant;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,95
03 Alicante/Alacant;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;92,84
03 Alicante/Alacant;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;55.041
03 Alicante/Alacant;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;52.218
03 Alicante/Alacant;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,87
03 Alicante/Alacant;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;19.396
03 Alicante/Alacant;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;17.886
03 Alicante/Alacant;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;92,21
03 Alicante/Alacant;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;35.645
03 Alicante/Alacant;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;34.332
03 Alicante/Alacant;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,32
03 Alicante/Alacant;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;40.443
03 Alicante/Alacant;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;37.417
03 Alicante/Alacant;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;35.442
03 Alicante/Alacant;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;92,52
03 Alicante/Alacant;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;87,63
03 Alicante/Alacant;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;16.933
03 Alicante/Alacant;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;15.167
03 Alicante/Alacant;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;14.101
03 Alicante/Alacant;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;89,57
03 Alicante/Alacant;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;83,28
03 Alicante/Alacant;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;23.510
03 Alicante/Alacant;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;22.250
03 Alicante/Alacant;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;21.341
03 Alicante/Alacant;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;94,64
03 Alicante/Alacant;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;90,77
03 Alicante/Alacant;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;40.698
03 Alicante/Alacant;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;38.094
03 Alicante/Alacant;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,6
03 Alicante/Alacant;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;15.974
03 Alicante/Alacant;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;14.552
03 Alicante/Alacant;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,1
03 Alicante/Alacant;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;24.724
03 Alicante/Alacant;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;23.542
03 Alicante/Alacant;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,22
03 Alicante/Alacant;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;5.885
03 Alicante/Alacant;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;5.769
03 Alicante/Alacant;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;5.639
03 Alicante/Alacant;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,03
03 Alicante/Alacant;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;95,82
03 Alicante/Alacant;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1.893
03 Alicante/Alacant;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1.840
03 Alicante/Alacant;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.789
03 Alicante/Alacant;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,2
03 Alicante/Alacant;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;94,51
03 Alicante/Alacant;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;3.992
03 Alicante/Alacant;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;3.929
03 Alicante/Alacant;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;3.850
03 Alicante/Alacant;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,42
03 Alicante/Alacant;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,44
03 Alicante/Alacant;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;5.984
03 Alicante/Alacant;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;5.864
03 Alicante/Alacant;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,99
03 Alicante/Alacant;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1.743
03 Alicante/Alacant;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.695
03 Alicante/Alacant;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;97,25
03 Alicante/Alacant;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;4.241
03 Alicante/Alacant;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;4.169
03 Alicante/Alacant;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,3
03 Alicante/Alacant;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;7.624
03 Alicante/Alacant;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;7.545
03 Alicante/Alacant;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;7.447
03 Alicante/Alacant;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,96
03 Alicante/Alacant;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,68
03 Alicante/Alacant;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1.669
03 Alicante/Alacant;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1.635
03 Alicante/Alacant;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.598
03 Alicante/Alacant;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,96
03 Alicante/Alacant;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;95,75
03 Alicante/Alacant;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;5.955
03 Alicante/Alacant;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;5.910
03 Alicante/Alacant;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;5.849
03 Alicante/Alacant;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,24
03 Alicante/Alacant;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,22
03 Alicante/Alacant;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;7.916
03 Alicante/Alacant;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;7.818
03 Alicante/Alacant;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,76
03 Alicante/Alacant;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1.607
03 Alicante/Alacant;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.567
03 Alicante/Alacant;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;97,51
03 Alicante/Alacant;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;6.309
03 Alicante/Alacant;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;6.251
03 Alicante/Alacant;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,08
03 Alicante/Alacant;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;264
03 Alicante/Alacant;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;263
03 Alicante/Alacant;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;263
03 Alicante/Alacant;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,62
03 Alicante/Alacant;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;99,62
03 Alicante/Alacant;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;45
03 Alicante/Alacant;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;45
03 Alicante/Alacant;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;45
03 Alicante/Alacant;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
03 Alicante/Alacant;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
03 Alicante/Alacant;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;219
03 Alicante/Alacant;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;218
03 Alicante/Alacant;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;218
03 Alicante/Alacant;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,54
03 Alicante/Alacant;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;99,54
03 Alicante/Alacant;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;310
03 Alicante/Alacant;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;309
03 Alicante/Alacant;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;99,68
03 Alicante/Alacant;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;55
03 Alicante/Alacant;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;55
03 Alicante/Alacant;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
03 Alicante/Alacant;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;255
03 Alicante/Alacant;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;254
03 Alicante/Alacant;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,61
03 Alicante/Alacant;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;121
03 Alicante/Alacant;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;121
03 Alicante/Alacant;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;120
03 Alicante/Alacant;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
03 Alicante/Alacant;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;99,17
03 Alicante/Alacant;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;20
03 Alicante/Alacant;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;20
03 Alicante/Alacant;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;20
03 Alicante/Alacant;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
03 Alicante/Alacant;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
03 Alicante/Alacant;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;101
03 Alicante/Alacant;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;101
03 Alicante/Alacant;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;100
03 Alicante/Alacant;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
03 Alicante/Alacant;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
03 Alicante/Alacant;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;99,01
03 Alicante/Alacant;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;133
03 Alicante/Alacant;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;133
03 Alicante/Alacant;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
03 Alicante/Alacant;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;17
03 Alicante/Alacant;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;17
03 Alicante/Alacant;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
03 Alicante/Alacant;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;116
03 Alicante/Alacant;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;116
03 Alicante/Alacant;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
03 Alicante/Alacant;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
03 Alicante/Alacant;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;16.714
04 Almería;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
04 Almería;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;15.747
04 Almería;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;14.968
04 Almería;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
04 Almería;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
04 Almería;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
04 Almería;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,21
04 Almería;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;89,55
04 Almería;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
04 Almería;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
04 Almería;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
04 Almería;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;5.846
04 Almería;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
04 Almería;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;5.346
04 Almería;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;4.942
04 Almería;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
04 Almería;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
04 Almería;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
04 Almería;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,45
04 Almería;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;84,54
04 Almería;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
04 Almería;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
04 Almería;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
04 Almería;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;10.868
04 Almería;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
04 Almería;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;10.401
04 Almería;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;10.026
04 Almería;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
04 Almería;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
04 Almería;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
04 Almería;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,7
04 Almería;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;92,25
04 Almería;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
04 Almería;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
04 Almería;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
04 Almería;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;16.997
04 Almería;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;16.032
04 Almería;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
04 Almería;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
04 Almería;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
04 Almería;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
04 Almería;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,32
04 Almería;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
04 Almería;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
04 Almería;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
04 Almería;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
04 Almería;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
04 Almería;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;5.559
04 Almería;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;5.061
04 Almería;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
04 Almería;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
04 Almería;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
04 Almería;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
04 Almería;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,04
04 Almería;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
04 Almería;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
04 Almería;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
04 Almería;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
04 Almería;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
04 Almería;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;11.438
04 Almería;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;10.971
04 Almería;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
04 Almería;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
04 Almería;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
04 Almería;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
04 Almería;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,92
04 Almería;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
04 Almería;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
04 Almería;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
04 Almería;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
04 Almería;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
04 Almería;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
04 Almería;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
04 Almería;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
04 Almería;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
04 Almería;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
04 Almería;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
04 Almería;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
04 Almería;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
04 Almería;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
04 Almería;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
04 Almería;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
04 Almería;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
04 Almería;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
04 Almería;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
04 Almería;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
04 Almería;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
04 Almería;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
04 Almería;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
04 Almería;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
04 Almería;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
04 Almería;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
04 Almería;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
04 Almería;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
04 Almería;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
04 Almería;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
04 Almería;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
04 Almería;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
04 Almería;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
04 Almería;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
04 Almería;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
04 Almería;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
04 Almería;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
04 Almería;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
04 Almería;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
04 Almería;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
04 Almería;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
04 Almería;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
04 Almería;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
04 Almería;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
04 Almería;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
04 Almería;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
04 Almería;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
04 Almería;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
04 Almería;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
04 Almería;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
04 Almería;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
04 Almería;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
04 Almería;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
04 Almería;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
04 Almería;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
04 Almería;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
04 Almería;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
04 Almería;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
04 Almería;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
04 Almería;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
04 Almería;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
04 Almería;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
04 Almería;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
04 Almería;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
04 Almería;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
04 Almería;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;12.630
04 Almería;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
04 Almería;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;11.720
04 Almería;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;11.014
04 Almería;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
04 Almería;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
04 Almería;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;92,79
04 Almería;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;87,21
04 Almería;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;4.851
04 Almería;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
04 Almería;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;4.370
04 Almería;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;3.992
04 Almería;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
04 Almería;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
04 Almería;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;90,08
04 Almería;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;82,29
04 Almería;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;7.779
04 Almería;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
04 Almería;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;7.350
04 Almería;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;7.022
04 Almería;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
04 Almería;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
04 Almería;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;94,49
04 Almería;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;90,27
04 Almería;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;12.737
04 Almería;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;11.845
04 Almería;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
04 Almería;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
04 Almería;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
04 Almería;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
04 Almería;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93
04 Almería;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;4.602
04 Almería;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;4.128
04 Almería;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
04 Almería;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
04 Almería;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
04 Almería;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
04 Almería;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;89,7
04 Almería;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;8.135
04 Almería;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;7.717
04 Almería;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
04 Almería;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
04 Almería;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
04 Almería;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
04 Almería;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;94,86
04 Almería;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
04 Almería;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
04 Almería;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
04 Almería;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
04 Almería;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
04 Almería;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
04 Almería;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
04 Almería;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
04 Almería;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
04 Almería;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
04 Almería;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
04 Almería;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
04 Almería;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
04 Almería;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
04 Almería;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
04 Almería;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
04 Almería;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
04 Almería;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
04 Almería;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
04 Almería;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
04 Almería;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
04 Almería;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
04 Almería;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
04 Almería;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
04 Almería;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.783
04 Almería;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
04 Almería;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.749
04 Almería;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.706
04 Almería;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
04 Almería;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
04 Almería;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,09
04 Almería;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;95,68
04 Almería;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;534
04 Almería;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
04 Almería;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;520
04 Almería;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;505
04 Almería;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
04 Almería;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
04 Almería;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,38
04 Almería;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;94,57
04 Almería;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.249
04 Almería;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
04 Almería;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.229
04 Almería;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.201
04 Almería;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
04 Almería;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
04 Almería;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,4
04 Almería;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,16
04 Almería;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.846
04 Almería;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.804
04 Almería;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
04 Almería;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
04 Almería;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
04 Almería;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
04 Almería;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,72
04 Almería;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;512
04 Almería;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;499
04 Almería;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
04 Almería;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
04 Almería;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
04 Almería;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
04 Almería;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;97,46
04 Almería;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.334
04 Almería;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.305
04 Almería;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
04 Almería;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
04 Almería;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
04 Almería;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
04 Almería;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;97,83
04 Almería;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
04 Almería;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
04 Almería;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
04 Almería;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
04 Almería;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
04 Almería;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
04 Almería;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
04 Almería;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
04 Almería;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
04 Almería;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
04 Almería;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
04 Almería;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
04 Almería;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
04 Almería;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
04 Almería;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
04 Almería;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
04 Almería;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
04 Almería;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
04 Almería;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
04 Almería;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
04 Almería;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
04 Almería;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
04 Almería;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
04 Almería;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
04 Almería;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;2.123
04 Almería;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
04 Almería;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;2.101
04 Almería;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;2.075
04 Almería;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
04 Almería;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
04 Almería;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,96
04 Almería;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,74
04 Almería;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;437
04 Almería;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
04 Almería;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;432
04 Almería;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;423
04 Almería;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
04 Almería;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
04 Almería;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,86
04 Almería;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;96,8
04 Almería;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.686
04 Almería;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
04 Almería;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.669
04 Almería;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.652
04 Almería;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
04 Almería;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
04 Almería;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,99
04 Almería;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,98
04 Almería;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;2.231
04 Almería;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;2.204
04 Almería;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
04 Almería;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
04 Almería;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
04 Almería;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
04 Almería;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,79
04 Almería;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;424
04 Almería;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;414
04 Almería;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
04 Almería;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
04 Almería;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
04 Almería;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
04 Almería;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;97,64
04 Almería;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.807
04 Almería;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.790
04 Almería;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
04 Almería;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
04 Almería;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
04 Almería;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
04 Almería;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,06
04 Almería;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
04 Almería;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
04 Almería;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
04 Almería;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
04 Almería;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
04 Almería;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
04 Almería;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
04 Almería;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
04 Almería;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
04 Almería;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
04 Almería;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
04 Almería;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
04 Almería;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
04 Almería;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
04 Almería;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
04 Almería;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
04 Almería;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
04 Almería;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
04 Almería;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
04 Almería;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
04 Almería;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
04 Almería;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
04 Almería;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
04 Almería;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
04 Almería;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;96
04 Almería;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
04 Almería;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;95
04 Almería;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;94
04 Almería;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
04 Almería;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
04 Almería;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
04 Almería;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,96
04 Almería;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,92
04 Almería;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
04 Almería;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
04 Almería;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
04 Almería;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;11
04 Almería;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
04 Almería;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;11
04 Almería;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;11
04 Almería;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
04 Almería;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
04 Almería;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
04 Almería;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
04 Almería;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
04 Almería;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
04 Almería;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
04 Almería;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
04 Almería;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;85
04 Almería;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
04 Almería;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;84
04 Almería;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;83
04 Almería;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
04 Almería;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
04 Almería;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
04 Almería;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,82
04 Almería;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,65
04 Almería;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
04 Almería;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
04 Almería;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
04 Almería;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;103
04 Almería;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;102
04 Almería;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
04 Almería;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
04 Almería;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
04 Almería;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
04 Almería;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;99,03
04 Almería;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
04 Almería;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
04 Almería;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
04 Almería;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
04 Almería;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
04 Almería;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;11
04 Almería;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;11
04 Almería;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
04 Almería;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
04 Almería;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
04 Almería;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
04 Almería;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
04 Almería;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
04 Almería;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
04 Almería;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
04 Almería;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
04 Almería;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
04 Almería;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;92
04 Almería;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;91
04 Almería;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
04 Almería;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
04 Almería;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
04 Almería;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
04 Almería;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,91
04 Almería;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
04 Almería;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
04 Almería;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
04 Almería;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
04 Almería;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
04 Almería;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
04 Almería;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
04 Almería;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
04 Almería;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
04 Almería;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
04 Almería;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
04 Almería;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
04 Almería;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
04 Almería;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
04 Almería;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
04 Almería;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
04 Almería;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
04 Almería;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
04 Almería;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
04 Almería;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
04 Almería;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
04 Almería;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
04 Almería;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
04 Almería;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
04 Almería;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
04 Almería;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
04 Almería;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
04 Almería;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
04 Almería;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
04 Almería;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
04 Almería;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
04 Almería;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
04 Almería;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
04 Almería;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
04 Almería;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
04 Almería;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
04 Almería;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
04 Almería;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
04 Almería;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
04 Almería;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
04 Almería;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
04 Almería;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
04 Almería;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
04 Almería;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
04 Almería;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
04 Almería;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
04 Almería;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
04 Almería;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
04 Almería;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
04 Almería;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
04 Almería;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
04 Almería;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
04 Almería;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
04 Almería;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
04 Almería;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
04 Almería;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
04 Almería;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
04 Almería;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
04 Almería;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
04 Almería;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
04 Almería;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
04 Almería;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
04 Almería;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
04 Almería;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
04 Almería;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
04 Almería;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;82
04 Almería;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
04 Almería;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;82
04 Almería;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;79
04 Almería;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
04 Almería;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
04 Almería;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
04 Almería;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,34
04 Almería;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;13
04 Almería;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
04 Almería;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;13
04 Almería;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;11
04 Almería;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
04 Almería;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
04 Almería;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
04 Almería;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;84,62
04 Almería;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;69
04 Almería;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
04 Almería;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;69
04 Almería;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;68
04 Almería;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
04 Almería;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
04 Almería;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
04 Almería;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,55
04 Almería;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;80
04 Almería;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;77
04 Almería;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
04 Almería;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
04 Almería;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
04 Almería;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
04 Almería;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;96,25
04 Almería;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;10
04 Almería;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;9
04 Almería;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
04 Almería;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
04 Almería;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
04 Almería;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
04 Almería;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90
04 Almería;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;70
04 Almería;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;68
04 Almería;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
04 Almería;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
04 Almería;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
04 Almería;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
04 Almería;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;97,14
04 Almería;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
04 Almería;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
04 Almería;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
04 Almería;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
04 Almería;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
04 Almería;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
04 Almería;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
04 Almería;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
04 Almería;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
04 Almería;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
04 Almería;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
04 Almería;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
04 Almería;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
04 Almería;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
04 Almería;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
04 Almería;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
04 Almería;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
04 Almería;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
04 Almería;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
04 Almería;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
04 Almería;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
04 Almería;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
04 Almería;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
04 Almería;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
04 Almería;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
04 Almería;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
04 Almería;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
04 Almería;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
04 Almería;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
04 Almería;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
04 Almería;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
04 Almería;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
04 Almería;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
04 Almería;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
04 Almería;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
04 Almería;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
04 Almería;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;7.542
01 Araba/Álava;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
01 Araba/Álava;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;7.160
01 Araba/Álava;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;6.834
01 Araba/Álava;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
01 Araba/Álava;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
01 Araba/Álava;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,94
01 Araba/Álava;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;90,61
01 Araba/Álava;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;2.211
01 Araba/Álava;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
01 Araba/Álava;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;2.038
01 Araba/Álava;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.882
01 Araba/Álava;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
01 Araba/Álava;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
01 Araba/Álava;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;92,18
01 Araba/Álava;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;85,12
01 Araba/Álava;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;5.331
01 Araba/Álava;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
01 Araba/Álava;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;5.122
01 Araba/Álava;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;4.952
01 Araba/Álava;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
01 Araba/Álava;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
01 Araba/Álava;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,08
01 Araba/Álava;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;92,89
01 Araba/Álava;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;7.505
01 Araba/Álava;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;7.115
01 Araba/Álava;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
01 Araba/Álava;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
01 Araba/Álava;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
01 Araba/Álava;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
01 Araba/Álava;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,8
01 Araba/Álava;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;2.059
01 Araba/Álava;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.876
01 Araba/Álava;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
01 Araba/Álava;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
01 Araba/Álava;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
01 Araba/Álava;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
01 Araba/Álava;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,11
01 Araba/Álava;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;5.446
01 Araba/Álava;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;5.239
01 Araba/Álava;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
01 Araba/Álava;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
01 Araba/Álava;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
01 Araba/Álava;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
01 Araba/Álava;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,2
01 Araba/Álava;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
01 Araba/Álava;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
01 Araba/Álava;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
01 Araba/Álava;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
01 Araba/Álava;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
01 Araba/Álava;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
01 Araba/Álava;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
01 Araba/Álava;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
01 Araba/Álava;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
01 Araba/Álava;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
01 Araba/Álava;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
01 Araba/Álava;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
01 Araba/Álava;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
01 Araba/Álava;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
01 Araba/Álava;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
01 Araba/Álava;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
01 Araba/Álava;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
01 Araba/Álava;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
01 Araba/Álava;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
01 Araba/Álava;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
01 Araba/Álava;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
01 Araba/Álava;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
01 Araba/Álava;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
01 Araba/Álava;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
01 Araba/Álava;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;5.059
01 Araba/Álava;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;4.703
01 Araba/Álava;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;4.421
01 Araba/Álava;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
01 Araba/Álava;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;92,96
01 Araba/Álava;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;87,39
01 Araba/Álava;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1.767
01 Araba/Álava;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1.599
01 Araba/Álava;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.456
01 Araba/Álava;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
01 Araba/Álava;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;90,49
01 Araba/Álava;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;82,4
01 Araba/Álava;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;3.292
01 Araba/Álava;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;3.104
01 Araba/Álava;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;2.965
01 Araba/Álava;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
01 Araba/Álava;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;94,29
01 Araba/Álava;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;90,07
01 Araba/Álava;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;5.029
01 Araba/Álava;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;4.677
01 Araba/Álava;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
01 Araba/Álava;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93
01 Araba/Álava;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1.657
01 Araba/Álava;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.484
01 Araba/Álava;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
01 Araba/Álava;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;89,56
01 Araba/Álava;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;3.372
01 Araba/Álava;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;3.193
01 Araba/Álava;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
01 Araba/Álava;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;94,69
01 Araba/Álava;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;883
01 Araba/Álava;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;869
01 Araba/Álava;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;842
01 Araba/Álava;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
01 Araba/Álava;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,41
01 Araba/Álava;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;95,36
01 Araba/Álava;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;191
01 Araba/Álava;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;186
01 Araba/Álava;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;177
01 Araba/Álava;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
01 Araba/Álava;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,38
01 Araba/Álava;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;92,67
01 Araba/Álava;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;692
01 Araba/Álava;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;683
01 Araba/Álava;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;665
01 Araba/Álava;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
01 Araba/Álava;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,7
01 Araba/Álava;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,1
01 Araba/Álava;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;885
01 Araba/Álava;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;862
01 Araba/Álava;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
01 Araba/Álava;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,4
01 Araba/Álava;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;185
01 Araba/Álava;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;180
01 Araba/Álava;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
01 Araba/Álava;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;97,3
01 Araba/Álava;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;700
01 Araba/Álava;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;682
01 Araba/Álava;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
01 Araba/Álava;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;97,43
01 Araba/Álava;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.471
01 Araba/Álava;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.459
01 Araba/Álava;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.442
01 Araba/Álava;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
01 Araba/Álava;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,18
01 Araba/Álava;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;98,03
01 Araba/Álava;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;244
01 Araba/Álava;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;244
01 Araba/Álava;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;240
01 Araba/Álava;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
01 Araba/Álava;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
01 Araba/Álava;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;98,36
01 Araba/Álava;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.227
01 Araba/Álava;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.215
01 Araba/Álava;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.202
01 Araba/Álava;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
01 Araba/Álava;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,02
01 Araba/Álava;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,96
01 Araba/Álava;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.459
01 Araba/Álava;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.444
01 Araba/Álava;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
01 Araba/Álava;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,97
01 Araba/Álava;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;208
01 Araba/Álava;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;203
01 Araba/Álava;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
01 Araba/Álava;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;97,6
01 Araba/Álava;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.251
01 Araba/Álava;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.241
01 Araba/Álava;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
01 Araba/Álava;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,2
01 Araba/Álava;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;103
01 Araba/Álava;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;103
01 Araba/Álava;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;103
01 Araba/Álava;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
01 Araba/Álava;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
01 Araba/Álava;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
01 Araba/Álava;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;7
01 Araba/Álava;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;7
01 Araba/Álava;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;7
01 Araba/Álava;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
01 Araba/Álava;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
01 Araba/Álava;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
01 Araba/Álava;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;96
01 Araba/Álava;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;96
01 Araba/Álava;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;96
01 Araba/Álava;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
01 Araba/Álava;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
01 Araba/Álava;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
01 Araba/Álava;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;102
01 Araba/Álava;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;102
01 Araba/Álava;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
01 Araba/Álava;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
01 Araba/Álava;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;8
01 Araba/Álava;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;8
01 Araba/Álava;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
01 Araba/Álava;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
01 Araba/Álava;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;94
01 Araba/Álava;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;94
01 Araba/Álava;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
01 Araba/Álava;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
01 Araba/Álava;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;26
01 Araba/Álava;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;26
01 Araba/Álava;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;26
01 Araba/Álava;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
01 Araba/Álava;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
01 Araba/Álava;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
01 Araba/Álava;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;2
01 Araba/Álava;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;2
01 Araba/Álava;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;2
01 Araba/Álava;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
01 Araba/Álava;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
01 Araba/Álava;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
01 Araba/Álava;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;24
01 Araba/Álava;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;24
01 Araba/Álava;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;24
01 Araba/Álava;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
01 Araba/Álava;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
01 Araba/Álava;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
01 Araba/Álava;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;30
01 Araba/Álava;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;30
01 Araba/Álava;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
01 Araba/Álava;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
01 Araba/Álava;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1
01 Araba/Álava;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1
01 Araba/Álava;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
01 Araba/Álava;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
01 Araba/Álava;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;29
01 Araba/Álava;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;29
01 Araba/Álava;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
01 Araba/Álava;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
01 Araba/Álava;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;23.630
33 Asturias;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
33 Asturias;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;22.492
33 Asturias;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;21.514
33 Asturias;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
33 Asturias;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
33 Asturias;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;95,18
33 Asturias;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;91,05
33 Asturias;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;7.139
33 Asturias;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
33 Asturias;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;6.584
33 Asturias;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;6.151
33 Asturias;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
33 Asturias;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
33 Asturias;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;92,23
33 Asturias;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;86,16
33 Asturias;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;16.491
33 Asturias;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
33 Asturias;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;15.908
33 Asturias;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;15.363
33 Asturias;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
33 Asturias;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
33 Asturias;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,46
33 Asturias;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;93,16
33 Asturias;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;23.854
33 Asturias;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;22.648
33 Asturias;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
33 Asturias;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
33 Asturias;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
33 Asturias;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
33 Asturias;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,94
33 Asturias;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
33 Asturias;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;6.745
33 Asturias;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;6.176
33 Asturias;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
33 Asturias;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
33 Asturias;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
33 Asturias;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
33 Asturias;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,56
33 Asturias;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
33 Asturias;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;17.109
33 Asturias;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;16.472
33 Asturias;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
33 Asturias;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
33 Asturias;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
33 Asturias;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
33 Asturias;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,28
33 Asturias;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
33 Asturias;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
33 Asturias;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
33 Asturias;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
33 Asturias;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
33 Asturias;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
33 Asturias;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
33 Asturias;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
33 Asturias;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
33 Asturias;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
33 Asturias;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
33 Asturias;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
33 Asturias;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
33 Asturias;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
33 Asturias;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
33 Asturias;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
33 Asturias;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
33 Asturias;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
33 Asturias;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
33 Asturias;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
33 Asturias;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
33 Asturias;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
33 Asturias;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
33 Asturias;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
33 Asturias;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
33 Asturias;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
33 Asturias;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
33 Asturias;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
33 Asturias;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
33 Asturias;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
33 Asturias;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
33 Asturias;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;17.741
33 Asturias;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;16.697
33 Asturias;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;15.835
33 Asturias;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
33 Asturias;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,12
33 Asturias;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;89,26
33 Asturias;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;5.971
33 Asturias;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;5.453
33 Asturias;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;5.068
33 Asturias;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
33 Asturias;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,32
33 Asturias;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;84,88
33 Asturias;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;11.770
33 Asturias;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;11.244
33 Asturias;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;10.767
33 Asturias;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
33 Asturias;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,53
33 Asturias;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;91,48
33 Asturias;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;17.784
33 Asturias;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;16.733
33 Asturias;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
33 Asturias;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,09
33 Asturias;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;5.616
33 Asturias;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;5.126
33 Asturias;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
33 Asturias;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,27
33 Asturias;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;12.168
33 Asturias;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;11.607
33 Asturias;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
33 Asturias;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,39
33 Asturias;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;2.443
33 Asturias;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;2.386
33 Asturias;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;2.316
33 Asturias;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
33 Asturias;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;97,67
33 Asturias;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;94,8
33 Asturias;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;592
33 Asturias;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;566
33 Asturias;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;536
33 Asturias;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
33 Asturias;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;95,61
33 Asturias;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;90,54
33 Asturias;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.851
33 Asturias;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.820
33 Asturias;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.780
33 Asturias;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
33 Asturias;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,33
33 Asturias;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,16
33 Asturias;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;2.525
33 Asturias;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;2.464
33 Asturias;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
33 Asturias;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,58
33 Asturias;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;578
33 Asturias;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;560
33 Asturias;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
33 Asturias;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;96,89
33 Asturias;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.947
33 Asturias;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.904
33 Asturias;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
33 Asturias;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;97,79
33 Asturias;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;3.214
33 Asturias;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;3.177
33 Asturias;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;3.131
33 Asturias;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
33 Asturias;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,85
33 Asturias;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,42
33 Asturias;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;546
33 Asturias;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;535
33 Asturias;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;517
33 Asturias;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
33 Asturias;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,99
33 Asturias;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;94,69
33 Asturias;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;2.668
33 Asturias;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;2.642
33 Asturias;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;2.614
33 Asturias;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
33 Asturias;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,03
33 Asturias;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,98
33 Asturias;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;3.297
33 Asturias;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;3.211
33 Asturias;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
33 Asturias;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,39
33 Asturias;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;522
33 Asturias;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;469
33 Asturias;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
33 Asturias;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;89,85
33 Asturias;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;2.775
33 Asturias;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;2.742
33 Asturias;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
33 Asturias;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,81
33 Asturias;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;157
33 Asturias;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;157
33 Asturias;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;157
33 Asturias;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
33 Asturias;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
33 Asturias;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
33 Asturias;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
33 Asturias;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
33 Asturias;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
33 Asturias;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;21
33 Asturias;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;21
33 Asturias;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;21
33 Asturias;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
33 Asturias;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
33 Asturias;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
33 Asturias;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
33 Asturias;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
33 Asturias;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
33 Asturias;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;136
33 Asturias;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;136
33 Asturias;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;136
33 Asturias;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
33 Asturias;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
33 Asturias;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
33 Asturias;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
33 Asturias;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
33 Asturias;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
33 Asturias;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;168
33 Asturias;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;163
33 Asturias;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
33 Asturias;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,02
33 Asturias;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
33 Asturias;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
33 Asturias;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
33 Asturias;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
33 Asturias;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;18
33 Asturias;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;13
33 Asturias;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
33 Asturias;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;72,22
33 Asturias;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
33 Asturias;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
33 Asturias;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
33 Asturias;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
33 Asturias;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;150
33 Asturias;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;150
33 Asturias;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
33 Asturias;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
33 Asturias;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
33 Asturias;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
33 Asturias;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
33 Asturias;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
33 Asturias;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
33 Asturias;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
33 Asturias;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
33 Asturias;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
33 Asturias;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
33 Asturias;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
33 Asturias;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
33 Asturias;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
33 Asturias;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
33 Asturias;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
33 Asturias;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
33 Asturias;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
33 Asturias;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
33 Asturias;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
33 Asturias;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
33 Asturias;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
33 Asturias;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
33 Asturias;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
33 Asturias;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
33 Asturias;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
33 Asturias;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
33 Asturias;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
33 Asturias;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
33 Asturias;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
33 Asturias;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;75
33 Asturias;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;75
33 Asturias;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;75
33 Asturias;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
33 Asturias;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
33 Asturias;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
33 Asturias;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;9
33 Asturias;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;9
33 Asturias;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;9
33 Asturias;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
33 Asturias;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
33 Asturias;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
33 Asturias;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;66
33 Asturias;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;66
33 Asturias;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;66
33 Asturias;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
33 Asturias;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
33 Asturias;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
33 Asturias;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;80
33 Asturias;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;77
33 Asturias;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
33 Asturias;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;96,25
33 Asturias;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;11
33 Asturias;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;8
33 Asturias;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
33 Asturias;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;72,73
33 Asturias;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;69
33 Asturias;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;69
33 Asturias;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
33 Asturias;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
33 Asturias;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
33 Asturias;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
33 Asturias;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
33 Asturias;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
33 Asturias;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
33 Asturias;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
33 Asturias;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;3.786
05 Ávila;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
05 Ávila;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;3.602
05 Ávila;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;3.455
05 Ávila;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
05 Ávila;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
05 Ávila;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;95,14
05 Ávila;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;91,26
05 Ávila;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1.099
05 Ávila;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
05 Ávila;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1.009
05 Ávila;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;944
05 Ávila;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
05 Ávila;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
05 Ávila;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,81
05 Ávila;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;85,9
05 Ávila;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;2.687
05 Ávila;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
05 Ávila;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;2.593
05 Ávila;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;2.511
05 Ávila;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
05 Ávila;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
05 Ávila;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,5
05 Ávila;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;93,45
05 Ávila;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;3.805
05 Ávila;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;3.601
05 Ávila;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
05 Ávila;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
05 Ávila;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
05 Ávila;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
05 Ávila;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,64
05 Ávila;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
05 Ávila;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1.035
05 Ávila;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;935
05 Ávila;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
05 Ávila;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
05 Ávila;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
05 Ávila;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
05 Ávila;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,34
05 Ávila;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
05 Ávila;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;2.770
05 Ávila;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;2.666
05 Ávila;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
05 Ávila;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
05 Ávila;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
05 Ávila;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
05 Ávila;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,25
05 Ávila;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
05 Ávila;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
05 Ávila;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
05 Ávila;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
05 Ávila;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
05 Ávila;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
05 Ávila;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
05 Ávila;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
05 Ávila;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
05 Ávila;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
05 Ávila;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
05 Ávila;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
05 Ávila;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
05 Ávila;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
05 Ávila;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
05 Ávila;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
05 Ávila;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
05 Ávila;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
05 Ávila;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
05 Ávila;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
05 Ávila;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
05 Ávila;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
05 Ávila;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
05 Ávila;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
05 Ávila;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
05 Ávila;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
05 Ávila;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
05 Ávila;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
05 Ávila;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
05 Ávila;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
05 Ávila;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
05 Ávila;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;2.977
05 Ávila;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;2.804
05 Ávila;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;2.663
05 Ávila;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
05 Ávila;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,19
05 Ávila;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;89,45
05 Ávila;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;936
05 Ávila;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;848
05 Ávila;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;787
05 Ávila;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
05 Ávila;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;90,6
05 Ávila;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;84,08
05 Ávila;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;2.041
05 Ávila;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.956
05 Ávila;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.876
05 Ávila;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
05 Ávila;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,84
05 Ávila;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;91,92
05 Ávila;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;2.976
05 Ávila;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;2.792
05 Ávila;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
05 Ávila;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,82
05 Ávila;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;883
05 Ávila;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;799
05 Ávila;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
05 Ávila;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,49
05 Ávila;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;2.093
05 Ávila;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.993
05 Ávila;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
05 Ávila;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,22
05 Ávila;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;391
05 Ávila;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;384
05 Ávila;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;379
05 Ávila;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
05 Ávila;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,21
05 Ávila;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,93
05 Ávila;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;91
05 Ávila;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;89
05 Ávila;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;85
05 Ávila;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
05 Ávila;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,8
05 Ávila;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;93,41
05 Ávila;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;300
05 Ávila;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;295
05 Ávila;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;294
05 Ávila;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
05 Ávila;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,33
05 Ávila;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98
05 Ávila;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;399
05 Ávila;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;390
05 Ávila;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
05 Ávila;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,74
05 Ávila;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;82
05 Ávila;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;77
05 Ávila;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
05 Ávila;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;93,9
05 Ávila;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;317
05 Ávila;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;313
05 Ávila;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
05 Ávila;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,74
05 Ávila;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;406
05 Ávila;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;402
05 Ávila;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;401
05 Ávila;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
05 Ávila;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,01
05 Ávila;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;98,77
05 Ávila;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;70
05 Ávila;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;70
05 Ávila;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;70
05 Ávila;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
05 Ávila;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
05 Ávila;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
05 Ávila;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;336
05 Ávila;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;332
05 Ávila;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;331
05 Ávila;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
05 Ávila;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,81
05 Ávila;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,51
05 Ávila;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;417
05 Ávila;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;407
05 Ávila;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
05 Ávila;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,6
05 Ávila;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;66
05 Ávila;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;56
05 Ávila;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
05 Ávila;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;84,85
05 Ávila;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;351
05 Ávila;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;351
05 Ávila;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
05 Ávila;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
05 Ávila;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;8
05 Ávila;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;8
05 Ávila;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;8
05 Ávila;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
05 Ávila;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
05 Ávila;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
05 Ávila;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
05 Ávila;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
05 Ávila;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
05 Ávila;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1
05 Ávila;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1
05 Ávila;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1
05 Ávila;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
05 Ávila;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
05 Ávila;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
05 Ávila;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
05 Ávila;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
05 Ávila;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
05 Ávila;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;7
05 Ávila;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;7
05 Ávila;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;7
05 Ávila;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
05 Ávila;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
05 Ávila;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
05 Ávila;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
05 Ávila;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
05 Ávila;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
05 Ávila;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;9
05 Ávila;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;8
05 Ávila;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
05 Ávila;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;88,89
05 Ávila;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
05 Ávila;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
05 Ávila;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
05 Ávila;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
05 Ávila;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;3
05 Ávila;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;2
05 Ávila;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
05 Ávila;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;66,67
05 Ávila;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
05 Ávila;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
05 Ávila;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
05 Ávila;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
05 Ávila;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;6
05 Ávila;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;6
05 Ávila;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
05 Ávila;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
05 Ávila;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
05 Ávila;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
05 Ávila;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
05 Ávila;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
05 Ávila;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
05 Ávila;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
05 Ávila;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
05 Ávila;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
05 Ávila;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
05 Ávila;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
05 Ávila;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
05 Ávila;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
05 Ávila;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
05 Ávila;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
05 Ávila;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
05 Ávila;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
05 Ávila;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
05 Ávila;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
05 Ávila;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
05 Ávila;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
05 Ávila;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
05 Ávila;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
05 Ávila;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
05 Ávila;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
05 Ávila;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
05 Ávila;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
05 Ávila;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
05 Ávila;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
05 Ávila;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;4
05 Ávila;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;4
05 Ávila;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;4
05 Ávila;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
05 Ávila;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
05 Ávila;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
05 Ávila;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1
05 Ávila;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1
05 Ávila;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1
05 Ávila;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
05 Ávila;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
05 Ávila;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
05 Ávila;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;3
05 Ávila;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;3
05 Ávila;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;3
05 Ávila;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
05 Ávila;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
05 Ávila;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
05 Ávila;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;4
05 Ávila;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;4
05 Ávila;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
05 Ávila;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
05 Ávila;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1
05 Ávila;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1
05 Ávila;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
05 Ávila;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
05 Ávila;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;3
05 Ávila;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;3
05 Ávila;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
05 Ávila;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
05 Ávila;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
05 Ávila;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
05 Ávila;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
05 Ávila;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
05 Ávila;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
05 Ávila;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
05 Ávila;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;14.860
06 Badajoz;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
06 Badajoz;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;13.933
06 Badajoz;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;13.345
06 Badajoz;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
06 Badajoz;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
06 Badajoz;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,76
06 Badajoz;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;89,8
06 Badajoz;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;4.917
06 Badajoz;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
06 Badajoz;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;4.455
06 Badajoz;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;4.143
06 Badajoz;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
06 Badajoz;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
06 Badajoz;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;90,6
06 Badajoz;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;84,26
06 Badajoz;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;9.943
06 Badajoz;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
06 Badajoz;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;9.478
06 Badajoz;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;9.202
06 Badajoz;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
06 Badajoz;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
06 Badajoz;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,32
06 Badajoz;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;92,55
06 Badajoz;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;14.793
06 Badajoz;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;14.007
06 Badajoz;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
06 Badajoz;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
06 Badajoz;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
06 Badajoz;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
06 Badajoz;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,69
06 Badajoz;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;4.551
06 Badajoz;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;4.120
06 Badajoz;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
06 Badajoz;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
06 Badajoz;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
06 Badajoz;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
06 Badajoz;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,53
06 Badajoz;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;10.242
06 Badajoz;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;9.887
06 Badajoz;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
06 Badajoz;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
06 Badajoz;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
06 Badajoz;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
06 Badajoz;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,53
06 Badajoz;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
06 Badajoz;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
06 Badajoz;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
06 Badajoz;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
06 Badajoz;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
06 Badajoz;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
06 Badajoz;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
06 Badajoz;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
06 Badajoz;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
06 Badajoz;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
06 Badajoz;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
06 Badajoz;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
06 Badajoz;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
06 Badajoz;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
06 Badajoz;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
06 Badajoz;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
06 Badajoz;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
06 Badajoz;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
06 Badajoz;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
06 Badajoz;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
06 Badajoz;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
06 Badajoz;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
06 Badajoz;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
06 Badajoz;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
06 Badajoz;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;11.411
06 Badajoz;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;10.551
06 Badajoz;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;10.012
06 Badajoz;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
06 Badajoz;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;92,46
06 Badajoz;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;87,74
06 Badajoz;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;4.124
06 Badajoz;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;3.691
06 Badajoz;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;3.405
06 Badajoz;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
06 Badajoz;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;89,5
06 Badajoz;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;82,57
06 Badajoz;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;7.287
06 Badajoz;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;6.860
06 Badajoz;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;6.607
06 Badajoz;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
06 Badajoz;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;94,14
06 Badajoz;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;90,67
06 Badajoz;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;11.304
06 Badajoz;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;10.609
06 Badajoz;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
06 Badajoz;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,85
06 Badajoz;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;3.805
06 Badajoz;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;3.443
06 Badajoz;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
06 Badajoz;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,49
06 Badajoz;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;7.499
06 Badajoz;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;7.166
06 Badajoz;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
06 Badajoz;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,56
06 Badajoz;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.538
06 Badajoz;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.496
06 Badajoz;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.466
06 Badajoz;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
06 Badajoz;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;97,27
06 Badajoz;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;95,32
06 Badajoz;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;395
06 Badajoz;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;378
06 Badajoz;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;363
06 Badajoz;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
06 Badajoz;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;95,7
06 Badajoz;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;91,9
06 Badajoz;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.143
06 Badajoz;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.118
06 Badajoz;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.103
06 Badajoz;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
06 Badajoz;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;97,81
06 Badajoz;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,5
06 Badajoz;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.522
06 Badajoz;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.479
06 Badajoz;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
06 Badajoz;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,17
06 Badajoz;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;355
06 Badajoz;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;326
06 Badajoz;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
06 Badajoz;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,83
06 Badajoz;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.167
06 Badajoz;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.153
06 Badajoz;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
06 Badajoz;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,8
06 Badajoz;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.792
06 Badajoz;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.767
06 Badajoz;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.748
06 Badajoz;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
06 Badajoz;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,6
06 Badajoz;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,54
06 Badajoz;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;383
06 Badajoz;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;371
06 Badajoz;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;360
06 Badajoz;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
06 Badajoz;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;96,87
06 Badajoz;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;93,99
06 Badajoz;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.409
06 Badajoz;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.396
06 Badajoz;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.388
06 Badajoz;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
06 Badajoz;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,08
06 Badajoz;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,51
06 Badajoz;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.842
06 Badajoz;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.798
06 Badajoz;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
06 Badajoz;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,61
06 Badajoz;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;373
06 Badajoz;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;337
06 Badajoz;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
06 Badajoz;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,35
06 Badajoz;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.469
06 Badajoz;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.461
06 Badajoz;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
06 Badajoz;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,46
06 Badajoz;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;90
06 Badajoz;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;90
06 Badajoz;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;90
06 Badajoz;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
06 Badajoz;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
06 Badajoz;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
06 Badajoz;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;12
06 Badajoz;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;12
06 Badajoz;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;12
06 Badajoz;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
06 Badajoz;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
06 Badajoz;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
06 Badajoz;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;78
06 Badajoz;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;78
06 Badajoz;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;78
06 Badajoz;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
06 Badajoz;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
06 Badajoz;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
06 Badajoz;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;97
06 Badajoz;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;93
06 Badajoz;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
06 Badajoz;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,88
06 Badajoz;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;16
06 Badajoz;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;12
06 Badajoz;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
06 Badajoz;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;75
06 Badajoz;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;81
06 Badajoz;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;81
06 Badajoz;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
06 Badajoz;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
06 Badajoz;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;29
06 Badajoz;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;29
06 Badajoz;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;29
06 Badajoz;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
06 Badajoz;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
06 Badajoz;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
06 Badajoz;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;3
06 Badajoz;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;3
06 Badajoz;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;3
06 Badajoz;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
06 Badajoz;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
06 Badajoz;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
06 Badajoz;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;26
06 Badajoz;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;26
06 Badajoz;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;26
06 Badajoz;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
06 Badajoz;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
06 Badajoz;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
06 Badajoz;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;28
06 Badajoz;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;28
06 Badajoz;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
06 Badajoz;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
06 Badajoz;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;2
06 Badajoz;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;2
06 Badajoz;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
06 Badajoz;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
06 Badajoz;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;26
06 Badajoz;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;26
06 Badajoz;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
06 Badajoz;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
06 Badajoz;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
06 Badajoz;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
06 Badajoz;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
06 Badajoz;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
06 Badajoz;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
06 Badajoz;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
06 Badajoz;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;35.779
07 Balears, Illes;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
07 Balears, Illes;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;33.425
07 Balears, Illes;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;32.111
07 Balears, Illes;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
07 Balears, Illes;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
07 Balears, Illes;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,42
07 Balears, Illes;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;89,75
07 Balears, Illes;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;13.175
07 Balears, Illes;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
07 Balears, Illes;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;11.886
07 Balears, Illes;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;11.173
07 Balears, Illes;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
07 Balears, Illes;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
07 Balears, Illes;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;90,22
07 Balears, Illes;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;84,8
07 Balears, Illes;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;22.604
07 Balears, Illes;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
07 Balears, Illes;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;21.539
07 Balears, Illes;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;20.938
07 Balears, Illes;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
07 Balears, Illes;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
07 Balears, Illes;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,29
07 Balears, Illes;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;92,63
07 Balears, Illes;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;38.300
07 Balears, Illes;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;36.583
07 Balears, Illes;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
07 Balears, Illes;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
07 Balears, Illes;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
07 Balears, Illes;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
07 Balears, Illes;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,52
07 Balears, Illes;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;13.478
07 Balears, Illes;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;12.542
07 Balears, Illes;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
07 Balears, Illes;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
07 Balears, Illes;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
07 Balears, Illes;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
07 Balears, Illes;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;93,06
07 Balears, Illes;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;24.822
07 Balears, Illes;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;24.041
07 Balears, Illes;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
07 Balears, Illes;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
07 Balears, Illes;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
07 Balears, Illes;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
07 Balears, Illes;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,85
07 Balears, Illes;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
07 Balears, Illes;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
07 Balears, Illes;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
07 Balears, Illes;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
07 Balears, Illes;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
07 Balears, Illes;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
07 Balears, Illes;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
07 Balears, Illes;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
07 Balears, Illes;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
07 Balears, Illes;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
07 Balears, Illes;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
07 Balears, Illes;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
07 Balears, Illes;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
07 Balears, Illes;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
07 Balears, Illes;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
07 Balears, Illes;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
07 Balears, Illes;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
07 Balears, Illes;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
07 Balears, Illes;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
07 Balears, Illes;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
07 Balears, Illes;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
07 Balears, Illes;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
07 Balears, Illes;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
07 Balears, Illes;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
07 Balears, Illes;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;26.618
07 Balears, Illes;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;24.433
07 Balears, Illes;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;23.240
07 Balears, Illes;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
07 Balears, Illes;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;91,79
07 Balears, Illes;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;87,31
07 Balears, Illes;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;10.930
07 Balears, Illes;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;9.714
07 Balears, Illes;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;9.057
07 Balears, Illes;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
07 Balears, Illes;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;88,87
07 Balears, Illes;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;82,86
07 Balears, Illes;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;15.688
07 Balears, Illes;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;14.719
07 Balears, Illes;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;14.183
07 Balears, Illes;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
07 Balears, Illes;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;93,82
07 Balears, Illes;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;90,41
07 Balears, Illes;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;27.620
07 Balears, Illes;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;26.033
07 Balears, Illes;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
07 Balears, Illes;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,25
07 Balears, Illes;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;10.948
07 Balears, Illes;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;10.068
07 Balears, Illes;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
07 Balears, Illes;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,96
07 Balears, Illes;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;16.672
07 Balears, Illes;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;15.965
07 Balears, Illes;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
07 Balears, Illes;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,76
07 Balears, Illes;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;3.949
07 Balears, Illes;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;3.855
07 Balears, Illes;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;3.794
07 Balears, Illes;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
07 Balears, Illes;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;97,62
07 Balears, Illes;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,07
07 Balears, Illes;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1.159
07 Balears, Illes;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1.117
07 Balears, Illes;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.086
07 Balears, Illes;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
07 Balears, Illes;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;96,38
07 Balears, Illes;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;93,7
07 Balears, Illes;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;2.790
07 Balears, Illes;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;2.738
07 Balears, Illes;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;2.708
07 Balears, Illes;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
07 Balears, Illes;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,14
07 Balears, Illes;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,06
07 Balears, Illes;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;4.399
07 Balears, Illes;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;4.328
07 Balears, Illes;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
07 Balears, Illes;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,39
07 Balears, Illes;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1.272
07 Balears, Illes;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.239
07 Balears, Illes;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
07 Balears, Illes;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;97,41
07 Balears, Illes;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;3.127
07 Balears, Illes;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;3.089
07 Balears, Illes;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
07 Balears, Illes;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,78
07 Balears, Illes;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;4.898
07 Balears, Illes;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;4.823
07 Balears, Illes;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;4.763
07 Balears, Illes;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
07 Balears, Illes;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,47
07 Balears, Illes;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,24
07 Balears, Illes;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1.045
07 Balears, Illes;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1.014
07 Balears, Illes;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;989
07 Balears, Illes;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
07 Balears, Illes;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,03
07 Balears, Illes;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;94,64
07 Balears, Illes;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;3.853
07 Balears, Illes;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;3.809
07 Balears, Illes;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;3.774
07 Balears, Illes;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
07 Balears, Illes;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,86
07 Balears, Illes;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,95
07 Balears, Illes;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;5.860
07 Balears, Illes;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;5.801
07 Balears, Illes;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
07 Balears, Illes;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,99
07 Balears, Illes;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1.209
07 Balears, Illes;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.186
07 Balears, Illes;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
07 Balears, Illes;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;98,1
07 Balears, Illes;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;4.651
07 Balears, Illes;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;4.615
07 Balears, Illes;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
07 Balears, Illes;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,23
07 Balears, Illes;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;212
07 Balears, Illes;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;212
07 Balears, Illes;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;212
07 Balears, Illes;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
07 Balears, Illes;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
07 Balears, Illes;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
07 Balears, Illes;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;27
07 Balears, Illes;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;27
07 Balears, Illes;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;27
07 Balears, Illes;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
07 Balears, Illes;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
07 Balears, Illes;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
07 Balears, Illes;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;185
07 Balears, Illes;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;185
07 Balears, Illes;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;185
07 Balears, Illes;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
07 Balears, Illes;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
07 Balears, Illes;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
07 Balears, Illes;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;290
07 Balears, Illes;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;290
07 Balears, Illes;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
07 Balears, Illes;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
07 Balears, Illes;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;36
07 Balears, Illes;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;36
07 Balears, Illes;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
07 Balears, Illes;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
07 Balears, Illes;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;254
07 Balears, Illes;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;254
07 Balears, Illes;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
07 Balears, Illes;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
07 Balears, Illes;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;102
07 Balears, Illes;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;102
07 Balears, Illes;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;102
07 Balears, Illes;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
07 Balears, Illes;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
07 Balears, Illes;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
07 Balears, Illes;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;14
07 Balears, Illes;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;14
07 Balears, Illes;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;14
07 Balears, Illes;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
07 Balears, Illes;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
07 Balears, Illes;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
07 Balears, Illes;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;88
07 Balears, Illes;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;88
07 Balears, Illes;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;88
07 Balears, Illes;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
07 Balears, Illes;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
07 Balears, Illes;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
07 Balears, Illes;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;131
07 Balears, Illes;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;131
07 Balears, Illes;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
07 Balears, Illes;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
07 Balears, Illes;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;13
07 Balears, Illes;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;13
07 Balears, Illes;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
07 Balears, Illes;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
07 Balears, Illes;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;118
07 Balears, Illes;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;118
07 Balears, Illes;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
07 Balears, Illes;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
07 Balears, Illes;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;159.684
08 Barcelona;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
08 Barcelona;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;151.116
08 Barcelona;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;145.526
08 Barcelona;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
08 Barcelona;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
08 Barcelona;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,63
08 Barcelona;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;91,13
08 Barcelona;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;56.874
08 Barcelona;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
08 Barcelona;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;52.067
08 Barcelona;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;49.041
08 Barcelona;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
08 Barcelona;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
08 Barcelona;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,55
08 Barcelona;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;86,23
08 Barcelona;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;102.810
08 Barcelona;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
08 Barcelona;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;99.049
08 Barcelona;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;96.485
08 Barcelona;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
08 Barcelona;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
08 Barcelona;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,34
08 Barcelona;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;93,85
08 Barcelona;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;159.669
08 Barcelona;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;152.822
08 Barcelona;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
08 Barcelona;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
08 Barcelona;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
08 Barcelona;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
08 Barcelona;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,71
08 Barcelona;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;53.368
08 Barcelona;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;49.608
08 Barcelona;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
08 Barcelona;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
08 Barcelona;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
08 Barcelona;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
08 Barcelona;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;92,95
08 Barcelona;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;106.301
08 Barcelona;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;103.214
08 Barcelona;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
08 Barcelona;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
08 Barcelona;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
08 Barcelona;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
08 Barcelona;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;97,1
08 Barcelona;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
08 Barcelona;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
08 Barcelona;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
08 Barcelona;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
08 Barcelona;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
08 Barcelona;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
08 Barcelona;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
08 Barcelona;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
08 Barcelona;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
08 Barcelona;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
08 Barcelona;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
08 Barcelona;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
08 Barcelona;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
08 Barcelona;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
08 Barcelona;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
08 Barcelona;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
08 Barcelona;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
08 Barcelona;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
08 Barcelona;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
08 Barcelona;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
08 Barcelona;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
08 Barcelona;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
08 Barcelona;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
08 Barcelona;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
08 Barcelona;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;112.571
08 Barcelona;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;104.584
08 Barcelona;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;99.602
08 Barcelona;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
08 Barcelona;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;92,9
08 Barcelona;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;88,48
08 Barcelona;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;45.858
08 Barcelona;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;41.266
08 Barcelona;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;38.488
08 Barcelona;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
08 Barcelona;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;89,99
08 Barcelona;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;83,93
08 Barcelona;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;66.713
08 Barcelona;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;63.318
08 Barcelona;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;61.114
08 Barcelona;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
08 Barcelona;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;94,91
08 Barcelona;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;91,61
08 Barcelona;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;112.174
08 Barcelona;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;105.889
08 Barcelona;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
08 Barcelona;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,4
08 Barcelona;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;43.333
08 Barcelona;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;39.781
08 Barcelona;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
08 Barcelona;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,8
08 Barcelona;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;68.841
08 Barcelona;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;66.108
08 Barcelona;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
08 Barcelona;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,03
08 Barcelona;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;17.415
08 Barcelona;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;17.131
08 Barcelona;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;16.801
08 Barcelona;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
08 Barcelona;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,37
08 Barcelona;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,47
08 Barcelona;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;4.967
08 Barcelona;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;4.860
08 Barcelona;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;4.729
08 Barcelona;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
08 Barcelona;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,85
08 Barcelona;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;95,21
08 Barcelona;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;12.448
08 Barcelona;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;12.271
08 Barcelona;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;12.072
08 Barcelona;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
08 Barcelona;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,58
08 Barcelona;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,98
08 Barcelona;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;17.421
08 Barcelona;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;17.111
08 Barcelona;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
08 Barcelona;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,22
08 Barcelona;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;4.568
08 Barcelona;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;4.460
08 Barcelona;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
08 Barcelona;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;97,64
08 Barcelona;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;12.853
08 Barcelona;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;12.651
08 Barcelona;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
08 Barcelona;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,43
08 Barcelona;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;26.734
08 Barcelona;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;26.446
08 Barcelona;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;26.175
08 Barcelona;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
08 Barcelona;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,92
08 Barcelona;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,91
08 Barcelona;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;5.622
08 Barcelona;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;5.515
08 Barcelona;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;5.402
08 Barcelona;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
08 Barcelona;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,1
08 Barcelona;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;96,09
08 Barcelona;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;21.112
08 Barcelona;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;20.931
08 Barcelona;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;20.773
08 Barcelona;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
08 Barcelona;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,14
08 Barcelona;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,39
08 Barcelona;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;27.030
08 Barcelona;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;26.784
08 Barcelona;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
08 Barcelona;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;99,09
08 Barcelona;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;5.097
08 Barcelona;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;5.002
08 Barcelona;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
08 Barcelona;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;98,14
08 Barcelona;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;21.933
08 Barcelona;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;21.782
08 Barcelona;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
08 Barcelona;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,31
08 Barcelona;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.908
08 Barcelona;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.901
08 Barcelona;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.895
08 Barcelona;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
08 Barcelona;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,63
08 Barcelona;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;99,32
08 Barcelona;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;285
08 Barcelona;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;284
08 Barcelona;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;281
08 Barcelona;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
08 Barcelona;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;99,65
08 Barcelona;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;98,6
08 Barcelona;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.623
08 Barcelona;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.617
08 Barcelona;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.614
08 Barcelona;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
08 Barcelona;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,63
08 Barcelona;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;99,45
08 Barcelona;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.960
08 Barcelona;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.955
08 Barcelona;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
08 Barcelona;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;99,74
08 Barcelona;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;250
08 Barcelona;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;246
08 Barcelona;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
08 Barcelona;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;98,4
08 Barcelona;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.710
08 Barcelona;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.709
08 Barcelona;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
08 Barcelona;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,94
08 Barcelona;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.056
08 Barcelona;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.054
08 Barcelona;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.053
08 Barcelona;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
08 Barcelona;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,81
08 Barcelona;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;99,72
08 Barcelona;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;142
08 Barcelona;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;142
08 Barcelona;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;141
08 Barcelona;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
08 Barcelona;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
08 Barcelona;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;99,3
08 Barcelona;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;914
08 Barcelona;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;912
08 Barcelona;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;912
08 Barcelona;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
08 Barcelona;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,78
08 Barcelona;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;99,78
08 Barcelona;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.084
08 Barcelona;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.083
08 Barcelona;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
08 Barcelona;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;99,91
08 Barcelona;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;120
08 Barcelona;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;119
08 Barcelona;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
08 Barcelona;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;99,17
08 Barcelona;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;964
08 Barcelona;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;964
08 Barcelona;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
08 Barcelona;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
08 Barcelona;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
08 Barcelona;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
08 Barcelona;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
08 Barcelona;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
08 Barcelona;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
08 Barcelona;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
08 Barcelona;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;26.357
48 Bizkaia;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
48 Bizkaia;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;25.050
48 Bizkaia;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;24.022
48 Bizkaia;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
48 Bizkaia;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
48 Bizkaia;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;95,04
48 Bizkaia;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;91,14
48 Bizkaia;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;8.381
48 Bizkaia;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
48 Bizkaia;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;7.672
48 Bizkaia;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;7.191
48 Bizkaia;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
48 Bizkaia;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
48 Bizkaia;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,54
48 Bizkaia;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;85,8
48 Bizkaia;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;17.976
48 Bizkaia;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
48 Bizkaia;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;17.378
48 Bizkaia;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;16.831
48 Bizkaia;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
48 Bizkaia;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
48 Bizkaia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,67
48 Bizkaia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;93,63
48 Bizkaia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;26.257
48 Bizkaia;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;25.042
48 Bizkaia;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
48 Bizkaia;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
48 Bizkaia;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
48 Bizkaia;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
48 Bizkaia;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,37
48 Bizkaia;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;7.701
48 Bizkaia;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;7.122
48 Bizkaia;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
48 Bizkaia;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
48 Bizkaia;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
48 Bizkaia;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
48 Bizkaia;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;92,48
48 Bizkaia;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;18.556
48 Bizkaia;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;17.920
48 Bizkaia;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
48 Bizkaia;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
48 Bizkaia;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
48 Bizkaia;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
48 Bizkaia;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,57
48 Bizkaia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
48 Bizkaia;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
48 Bizkaia;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
48 Bizkaia;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
48 Bizkaia;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
48 Bizkaia;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
48 Bizkaia;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
48 Bizkaia;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
48 Bizkaia;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
48 Bizkaia;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
48 Bizkaia;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
48 Bizkaia;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
48 Bizkaia;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
48 Bizkaia;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
48 Bizkaia;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
48 Bizkaia;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
48 Bizkaia;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
48 Bizkaia;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
48 Bizkaia;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
48 Bizkaia;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
48 Bizkaia;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
48 Bizkaia;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
48 Bizkaia;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
48 Bizkaia;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
48 Bizkaia;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;18.407
48 Bizkaia;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;17.200
48 Bizkaia;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;16.296
48 Bizkaia;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
48 Bizkaia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,44
48 Bizkaia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;88,53
48 Bizkaia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;6.712
48 Bizkaia;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;6.043
48 Bizkaia;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;5.605
48 Bizkaia;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
48 Bizkaia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;90,03
48 Bizkaia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;83,51
48 Bizkaia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;11.695
48 Bizkaia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;11.157
48 Bizkaia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;10.691
48 Bizkaia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
48 Bizkaia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,4
48 Bizkaia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;91,42
48 Bizkaia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;18.267
48 Bizkaia;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;17.171
48 Bizkaia;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
48 Bizkaia;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94
48 Bizkaia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;6.254
48 Bizkaia;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;5.711
48 Bizkaia;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
48 Bizkaia;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,32
48 Bizkaia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;12.013
48 Bizkaia;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;11.460
48 Bizkaia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
48 Bizkaia;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,4
48 Bizkaia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;2.976
48 Bizkaia;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;2.935
48 Bizkaia;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;2.864
48 Bizkaia;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
48 Bizkaia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,62
48 Bizkaia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,24
48 Bizkaia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;802
48 Bizkaia;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;784
48 Bizkaia;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;757
48 Bizkaia;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
48 Bizkaia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,76
48 Bizkaia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;94,39
48 Bizkaia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;2.174
48 Bizkaia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;2.151
48 Bizkaia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;2.107
48 Bizkaia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
48 Bizkaia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,94
48 Bizkaia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,92
48 Bizkaia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;2.996
48 Bizkaia;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;2.930
48 Bizkaia;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
48 Bizkaia;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,8
48 Bizkaia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;690
48 Bizkaia;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;669
48 Bizkaia;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
48 Bizkaia;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;96,96
48 Bizkaia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;2.306
48 Bizkaia;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;2.261
48 Bizkaia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
48 Bizkaia;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,05
48 Bizkaia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;4.529
48 Bizkaia;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;4.472
48 Bizkaia;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;4.421
48 Bizkaia;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
48 Bizkaia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,74
48 Bizkaia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,62
48 Bizkaia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;807
48 Bizkaia;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;786
48 Bizkaia;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;770
48 Bizkaia;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
48 Bizkaia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,4
48 Bizkaia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;95,42
48 Bizkaia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;3.722
48 Bizkaia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;3.686
48 Bizkaia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;3.651
48 Bizkaia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
48 Bizkaia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,03
48 Bizkaia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,09
48 Bizkaia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;4.546
48 Bizkaia;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;4.495
48 Bizkaia;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
48 Bizkaia;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,88
48 Bizkaia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;706
48 Bizkaia;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;691
48 Bizkaia;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
48 Bizkaia;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;97,88
48 Bizkaia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;3.840
48 Bizkaia;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;3.804
48 Bizkaia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
48 Bizkaia;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,06
48 Bizkaia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;275
48 Bizkaia;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;273
48 Bizkaia;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;272
48 Bizkaia;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
48 Bizkaia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,27
48 Bizkaia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;98,91
48 Bizkaia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;39
48 Bizkaia;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;38
48 Bizkaia;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;38
48 Bizkaia;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
48 Bizkaia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,44
48 Bizkaia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;97,44
48 Bizkaia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;236
48 Bizkaia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;235
48 Bizkaia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;234
48 Bizkaia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
48 Bizkaia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,58
48 Bizkaia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;99,15
48 Bizkaia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;276
48 Bizkaia;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;275
48 Bizkaia;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
48 Bizkaia;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;99,64
48 Bizkaia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;33
48 Bizkaia;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;33
48 Bizkaia;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
48 Bizkaia;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
48 Bizkaia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;243
48 Bizkaia;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;242
48 Bizkaia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
48 Bizkaia;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,59
48 Bizkaia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;170
48 Bizkaia;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;170
48 Bizkaia;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;169
48 Bizkaia;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
48 Bizkaia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
48 Bizkaia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;99,41
48 Bizkaia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;21
48 Bizkaia;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;21
48 Bizkaia;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;21
48 Bizkaia;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
48 Bizkaia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
48 Bizkaia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
48 Bizkaia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;149
48 Bizkaia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;149
48 Bizkaia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;148
48 Bizkaia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
48 Bizkaia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
48 Bizkaia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;99,33
48 Bizkaia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;172
48 Bizkaia;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;171
48 Bizkaia;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
48 Bizkaia;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;99,42
48 Bizkaia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;18
48 Bizkaia;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;18
48 Bizkaia;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
48 Bizkaia;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
48 Bizkaia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;154
48 Bizkaia;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;153
48 Bizkaia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
48 Bizkaia;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,35
48 Bizkaia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;8.400
09 Burgos;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
09 Burgos;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;8.003
09 Burgos;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;7.716
09 Burgos;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
09 Burgos;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
09 Burgos;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;95,27
09 Burgos;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;91,86
09 Burgos;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;2.233
09 Burgos;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
09 Burgos;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;2.039
09 Burgos;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.917
09 Burgos;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
09 Burgos;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
09 Burgos;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,31
09 Burgos;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;85,85
09 Burgos;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;6.167
09 Burgos;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
09 Burgos;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;5.964
09 Burgos;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;5.799
09 Burgos;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
09 Burgos;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
09 Burgos;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,71
09 Burgos;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;94,03
09 Burgos;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;8.419
09 Burgos;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;8.048
09 Burgos;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
09 Burgos;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
09 Burgos;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
09 Burgos;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
09 Burgos;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,59
09 Burgos;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
09 Burgos;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;2.126
09 Burgos;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.944
09 Burgos;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
09 Burgos;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
09 Burgos;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
09 Burgos;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
09 Burgos;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,44
09 Burgos;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
09 Burgos;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;6.293
09 Burgos;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;6.104
09 Burgos;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
09 Burgos;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
09 Burgos;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
09 Burgos;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
09 Burgos;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;97
09 Burgos;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
09 Burgos;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
09 Burgos;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
09 Burgos;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
09 Burgos;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
09 Burgos;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
09 Burgos;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
09 Burgos;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
09 Burgos;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
09 Burgos;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
09 Burgos;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
09 Burgos;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
09 Burgos;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
09 Burgos;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
09 Burgos;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
09 Burgos;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
09 Burgos;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
09 Burgos;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
09 Burgos;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
09 Burgos;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
09 Burgos;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
09 Burgos;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
09 Burgos;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
09 Burgos;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
09 Burgos;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
09 Burgos;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
09 Burgos;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
09 Burgos;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
09 Burgos;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
09 Burgos;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
09 Burgos;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
09 Burgos;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;6.015
09 Burgos;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;5.647
09 Burgos;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;5.393
09 Burgos;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
09 Burgos;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,88
09 Burgos;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;89,66
09 Burgos;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1.832
09 Burgos;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1.649
09 Burgos;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.535
09 Burgos;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
09 Burgos;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;90,01
09 Burgos;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;83,79
09 Burgos;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;4.183
09 Burgos;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;3.998
09 Burgos;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;3.858
09 Burgos;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
09 Burgos;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,58
09 Burgos;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;92,23
09 Burgos;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;6.019
09 Burgos;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;5.687
09 Burgos;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
09 Burgos;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,48
09 Burgos;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1.757
09 Burgos;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.589
09 Burgos;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
09 Burgos;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,44
09 Burgos;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;4.262
09 Burgos;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;4.098
09 Burgos;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
09 Burgos;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,15
09 Burgos;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;952
09 Burgos;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;936
09 Burgos;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;916
09 Burgos;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
09 Burgos;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,32
09 Burgos;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,22
09 Burgos;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;196
09 Burgos;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;187
09 Burgos;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;183
09 Burgos;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
09 Burgos;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;95,41
09 Burgos;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;93,37
09 Burgos;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;756
09 Burgos;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;749
09 Burgos;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;733
09 Burgos;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
09 Burgos;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,07
09 Burgos;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,96
09 Burgos;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;940
09 Burgos;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;918
09 Burgos;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
09 Burgos;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,66
09 Burgos;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;173
09 Burgos;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;170
09 Burgos;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
09 Burgos;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;98,27
09 Burgos;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;767
09 Burgos;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;748
09 Burgos;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
09 Burgos;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;97,52
09 Burgos;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.320
09 Burgos;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.307
09 Burgos;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.294
09 Burgos;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
09 Burgos;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,02
09 Burgos;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;98,03
09 Burgos;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;186
09 Burgos;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;184
09 Burgos;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;180
09 Burgos;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
09 Burgos;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,92
09 Burgos;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;96,77
09 Burgos;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.134
09 Burgos;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.123
09 Burgos;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.114
09 Burgos;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
09 Burgos;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,03
09 Burgos;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,24
09 Burgos;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.332
09 Burgos;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.319
09 Burgos;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
09 Burgos;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;99,02
09 Burgos;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;175
09 Burgos;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;168
09 Burgos;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
09 Burgos;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;96
09 Burgos;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.157
09 Burgos;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.151
09 Burgos;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
09 Burgos;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,48
09 Burgos;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;69
09 Burgos;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;69
09 Burgos;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;69
09 Burgos;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
09 Burgos;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
09 Burgos;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
09 Burgos;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
09 Burgos;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
09 Burgos;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
09 Burgos;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;8
09 Burgos;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;8
09 Burgos;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;8
09 Burgos;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
09 Burgos;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
09 Burgos;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
09 Burgos;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
09 Burgos;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
09 Burgos;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
09 Burgos;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;61
09 Burgos;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;61
09 Burgos;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;61
09 Burgos;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
09 Burgos;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
09 Burgos;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
09 Burgos;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
09 Burgos;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
09 Burgos;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
09 Burgos;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;79
09 Burgos;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;76
09 Burgos;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
09 Burgos;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;96,2
09 Burgos;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
09 Burgos;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
09 Burgos;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
09 Burgos;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
09 Burgos;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;8
09 Burgos;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;5
09 Burgos;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
09 Burgos;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;62,5
09 Burgos;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
09 Burgos;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
09 Burgos;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
09 Burgos;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
09 Burgos;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;71
09 Burgos;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;71
09 Burgos;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
09 Burgos;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
09 Burgos;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
09 Burgos;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
09 Burgos;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
09 Burgos;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
09 Burgos;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
09 Burgos;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
09 Burgos;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
09 Burgos;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
09 Burgos;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
09 Burgos;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
09 Burgos;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
09 Burgos;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
09 Burgos;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
09 Burgos;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
09 Burgos;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
09 Burgos;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
09 Burgos;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
09 Burgos;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
09 Burgos;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
09 Burgos;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
09 Burgos;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
09 Burgos;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
09 Burgos;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
09 Burgos;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
09 Burgos;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
09 Burgos;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
09 Burgos;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
09 Burgos;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
09 Burgos;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;44
09 Burgos;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;44
09 Burgos;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;44
09 Burgos;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
09 Burgos;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
09 Burgos;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
09 Burgos;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;11
09 Burgos;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;11
09 Burgos;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;11
09 Burgos;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
09 Burgos;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
09 Burgos;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
09 Burgos;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;33
09 Burgos;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;33
09 Burgos;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;33
09 Burgos;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
09 Burgos;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
09 Burgos;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
09 Burgos;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;49
09 Burgos;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;48
09 Burgos;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
09 Burgos;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,96
09 Burgos;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;13
09 Burgos;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;12
09 Burgos;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
09 Burgos;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;92,31
09 Burgos;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;36
09 Burgos;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;36
09 Burgos;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
09 Burgos;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
09 Burgos;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
09 Burgos;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
09 Burgos;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
09 Burgos;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
09 Burgos;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
09 Burgos;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
09 Burgos;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;8.649
10 Cáceres;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
10 Cáceres;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;8.123
10 Cáceres;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;7.718
10 Cáceres;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
10 Cáceres;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
10 Cáceres;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,92
10 Cáceres;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;89,24
10 Cáceres;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;2.693
10 Cáceres;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
10 Cáceres;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;2.445
10 Cáceres;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;2.255
10 Cáceres;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
10 Cáceres;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
10 Cáceres;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;90,79
10 Cáceres;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;83,74
10 Cáceres;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;5.956
10 Cáceres;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
10 Cáceres;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;5.678
10 Cáceres;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;5.463
10 Cáceres;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
10 Cáceres;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
10 Cáceres;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,33
10 Cáceres;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;91,72
10 Cáceres;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;8.660
10 Cáceres;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;8.128
10 Cáceres;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
10 Cáceres;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
10 Cáceres;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
10 Cáceres;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
10 Cáceres;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,86
10 Cáceres;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;2.512
10 Cáceres;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;2.245
10 Cáceres;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
10 Cáceres;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
10 Cáceres;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
10 Cáceres;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
10 Cáceres;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;89,37
10 Cáceres;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;6.148
10 Cáceres;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;5.883
10 Cáceres;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
10 Cáceres;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
10 Cáceres;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
10 Cáceres;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
10 Cáceres;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,69
10 Cáceres;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
10 Cáceres;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
10 Cáceres;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
10 Cáceres;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
10 Cáceres;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
10 Cáceres;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
10 Cáceres;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
10 Cáceres;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
10 Cáceres;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
10 Cáceres;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
10 Cáceres;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
10 Cáceres;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
10 Cáceres;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
10 Cáceres;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
10 Cáceres;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
10 Cáceres;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
10 Cáceres;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
10 Cáceres;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
10 Cáceres;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
10 Cáceres;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
10 Cáceres;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
10 Cáceres;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
10 Cáceres;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
10 Cáceres;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
10 Cáceres;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;6.656
10 Cáceres;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;6.169
10 Cáceres;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;5.804
10 Cáceres;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
10 Cáceres;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;92,68
10 Cáceres;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;87,2
10 Cáceres;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;2.244
10 Cáceres;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;2.008
10 Cáceres;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.836
10 Cáceres;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
10 Cáceres;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;89,48
10 Cáceres;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;81,82
10 Cáceres;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;4.412
10 Cáceres;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;4.161
10 Cáceres;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;3.968
10 Cáceres;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
10 Cáceres;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;94,31
10 Cáceres;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;89,94
10 Cáceres;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;6.618
10 Cáceres;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;6.144
10 Cáceres;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
10 Cáceres;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;92,84
10 Cáceres;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;2.074
10 Cáceres;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.848
10 Cáceres;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
10 Cáceres;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;89,1
10 Cáceres;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;4.544
10 Cáceres;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;4.296
10 Cáceres;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
10 Cáceres;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;94,54
10 Cáceres;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;876
10 Cáceres;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;858
10 Cáceres;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;836
10 Cáceres;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
10 Cáceres;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;97,95
10 Cáceres;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;95,43
10 Cáceres;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;212
10 Cáceres;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;207
10 Cáceres;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;196
10 Cáceres;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
10 Cáceres;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,64
10 Cáceres;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;92,45
10 Cáceres;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;664
10 Cáceres;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;651
10 Cáceres;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;640
10 Cáceres;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
10 Cáceres;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,04
10 Cáceres;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,39
10 Cáceres;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;869
10 Cáceres;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;849
10 Cáceres;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
10 Cáceres;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,7
10 Cáceres;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;200
10 Cáceres;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;189
10 Cáceres;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
10 Cáceres;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;94,5
10 Cáceres;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;669
10 Cáceres;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;660
10 Cáceres;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
10 Cáceres;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,65
10 Cáceres;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.071
10 Cáceres;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.051
10 Cáceres;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.033
10 Cáceres;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
10 Cáceres;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,13
10 Cáceres;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,45
10 Cáceres;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;229
10 Cáceres;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;222
10 Cáceres;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;215
10 Cáceres;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
10 Cáceres;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;96,94
10 Cáceres;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;93,89
10 Cáceres;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;842
10 Cáceres;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;829
10 Cáceres;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;818
10 Cáceres;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
10 Cáceres;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,46
10 Cáceres;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,15
10 Cáceres;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.124
10 Cáceres;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.087
10 Cáceres;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
10 Cáceres;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;96,71
10 Cáceres;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;227
10 Cáceres;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;198
10 Cáceres;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
10 Cáceres;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;87,22
10 Cáceres;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;897
10 Cáceres;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;889
10 Cáceres;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
10 Cáceres;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,11
10 Cáceres;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;34
10 Cáceres;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;33
10 Cáceres;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;33
10 Cáceres;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
10 Cáceres;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;97,06
10 Cáceres;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,06
10 Cáceres;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;7
10 Cáceres;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;7
10 Cáceres;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;7
10 Cáceres;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
10 Cáceres;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
10 Cáceres;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
10 Cáceres;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;27
10 Cáceres;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;26
10 Cáceres;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;26
10 Cáceres;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
10 Cáceres;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,3
10 Cáceres;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,3
10 Cáceres;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;34
10 Cáceres;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;34
10 Cáceres;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
10 Cáceres;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
10 Cáceres;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;9
10 Cáceres;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;9
10 Cáceres;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
10 Cáceres;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
10 Cáceres;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;25
10 Cáceres;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;25
10 Cáceres;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
10 Cáceres;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
10 Cáceres;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;12
10 Cáceres;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;12
10 Cáceres;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;12
10 Cáceres;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
10 Cáceres;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
10 Cáceres;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
10 Cáceres;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1
10 Cáceres;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1
10 Cáceres;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1
10 Cáceres;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
10 Cáceres;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
10 Cáceres;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
10 Cáceres;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;11
10 Cáceres;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;11
10 Cáceres;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;11
10 Cáceres;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
10 Cáceres;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
10 Cáceres;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
10 Cáceres;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;15
10 Cáceres;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;14
10 Cáceres;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
10 Cáceres;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,33
10 Cáceres;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;2
10 Cáceres;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1
10 Cáceres;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
10 Cáceres;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;50
10 Cáceres;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;13
10 Cáceres;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;13
10 Cáceres;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
10 Cáceres;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
10 Cáceres;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
10 Cáceres;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
10 Cáceres;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
10 Cáceres;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
10 Cáceres;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
10 Cáceres;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
10 Cáceres;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;26.506
11 Cádiz;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
11 Cádiz;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;24.773
11 Cádiz;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;23.623
11 Cádiz;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
11 Cádiz;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
11 Cádiz;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,46
11 Cádiz;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;89,12
11 Cádiz;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;9.573
11 Cádiz;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
11 Cádiz;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;8.661
11 Cádiz;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;8.096
11 Cádiz;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
11 Cádiz;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
11 Cádiz;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;90,47
11 Cádiz;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;84,57
11 Cádiz;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;16.933
11 Cádiz;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
11 Cádiz;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;16.112
11 Cádiz;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;15.527
11 Cádiz;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
11 Cádiz;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
11 Cádiz;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,15
11 Cádiz;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;91,7
11 Cádiz;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;27.037
11 Cádiz;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;25.514
11 Cádiz;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
11 Cádiz;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
11 Cádiz;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
11 Cádiz;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
11 Cádiz;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,37
11 Cádiz;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;9.022
11 Cádiz;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;8.277
11 Cádiz;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
11 Cádiz;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
11 Cádiz;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
11 Cádiz;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
11 Cádiz;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,74
11 Cádiz;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;18.015
11 Cádiz;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;17.237
11 Cádiz;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
11 Cádiz;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
11 Cádiz;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
11 Cádiz;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
11 Cádiz;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,68
11 Cádiz;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
11 Cádiz;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
11 Cádiz;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
11 Cádiz;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
11 Cádiz;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
11 Cádiz;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
11 Cádiz;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
11 Cádiz;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
11 Cádiz;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
11 Cádiz;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
11 Cádiz;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
11 Cádiz;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
11 Cádiz;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
11 Cádiz;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
11 Cádiz;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
11 Cádiz;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
11 Cádiz;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
11 Cádiz;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
11 Cádiz;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
11 Cádiz;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
11 Cádiz;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
11 Cádiz;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
11 Cádiz;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
11 Cádiz;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
11 Cádiz;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;19.781
11 Cádiz;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;18.179
11 Cádiz;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;17.151
11 Cádiz;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
11 Cádiz;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;91,9
11 Cádiz;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;86,7
11 Cádiz;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;7.643
11 Cádiz;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;6.790
11 Cádiz;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;6.274
11 Cádiz;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
11 Cádiz;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;88,84
11 Cádiz;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;82,09
11 Cádiz;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;12.138
11 Cádiz;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;11.389
11 Cádiz;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;10.877
11 Cádiz;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
11 Cádiz;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;93,83
11 Cádiz;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;89,61
11 Cádiz;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;19.936
11 Cádiz;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;18.545
11 Cádiz;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
11 Cádiz;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,02
11 Cádiz;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;7.150
11 Cádiz;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;6.454
11 Cádiz;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
11 Cádiz;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,27
11 Cádiz;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;12.786
11 Cádiz;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;12.091
11 Cádiz;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
11 Cádiz;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;94,56
11 Cádiz;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;2.984
11 Cádiz;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;2.904
11 Cádiz;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;2.832
11 Cádiz;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
11 Cádiz;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;97,32
11 Cádiz;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;94,91
11 Cádiz;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;987
11 Cádiz;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;946
11 Cádiz;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;921
11 Cádiz;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
11 Cádiz;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;95,85
11 Cádiz;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;93,31
11 Cádiz;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.997
11 Cádiz;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.958
11 Cádiz;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.911
11 Cádiz;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
11 Cádiz;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,05
11 Cádiz;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;95,69
11 Cádiz;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;3.143
11 Cádiz;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;3.058
11 Cádiz;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
11 Cádiz;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,3
11 Cádiz;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;961
11 Cádiz;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;927
11 Cádiz;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
11 Cádiz;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;96,46
11 Cádiz;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;2.182
11 Cádiz;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;2.131
11 Cádiz;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
11 Cádiz;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;97,66
11 Cádiz;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;3.552
11 Cádiz;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;3.501
11 Cádiz;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;3.455
11 Cádiz;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
11 Cádiz;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,56
11 Cádiz;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,27
11 Cádiz;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;918
11 Cádiz;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;900
11 Cádiz;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;878
11 Cádiz;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
11 Cádiz;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,04
11 Cádiz;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;95,64
11 Cádiz;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;2.634
11 Cádiz;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;2.601
11 Cádiz;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;2.577
11 Cádiz;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
11 Cádiz;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,75
11 Cádiz;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,84
11 Cádiz;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;3.746
11 Cádiz;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;3.703
11 Cádiz;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
11 Cádiz;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,85
11 Cádiz;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;892
11 Cádiz;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;879
11 Cádiz;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
11 Cádiz;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;98,54
11 Cádiz;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;2.854
11 Cádiz;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;2.824
11 Cádiz;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
11 Cádiz;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,95
11 Cádiz;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;139
11 Cádiz;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;139
11 Cádiz;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;136
11 Cádiz;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
11 Cádiz;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
11 Cádiz;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,84
11 Cádiz;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;19
11 Cádiz;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;19
11 Cádiz;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;18
11 Cádiz;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
11 Cádiz;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
11 Cádiz;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;94,74
11 Cádiz;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;120
11 Cádiz;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;120
11 Cádiz;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;118
11 Cádiz;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
11 Cádiz;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
11 Cádiz;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,33
11 Cádiz;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;154
11 Cádiz;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;151
11 Cádiz;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
11 Cádiz;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,05
11 Cádiz;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;14
11 Cádiz;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;13
11 Cádiz;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
11 Cádiz;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;92,86
11 Cádiz;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;140
11 Cádiz;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;138
11 Cádiz;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
11 Cádiz;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,57
11 Cádiz;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;50
11 Cádiz;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;50
11 Cádiz;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;49
11 Cádiz;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
11 Cádiz;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
11 Cádiz;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;98
11 Cádiz;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;6
11 Cádiz;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;6
11 Cádiz;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;5
11 Cádiz;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
11 Cádiz;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
11 Cádiz;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;83,33
11 Cádiz;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;44
11 Cádiz;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;44
11 Cádiz;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;44
11 Cádiz;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
11 Cádiz;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
11 Cádiz;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
11 Cádiz;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;58
11 Cádiz;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;57
11 Cádiz;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
11 Cádiz;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,28
11 Cádiz;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;5
11 Cádiz;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;4
11 Cádiz;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
11 Cádiz;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;80
11 Cádiz;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;53
11 Cádiz;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;53
11 Cádiz;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
11 Cádiz;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
11 Cádiz;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
11 Cádiz;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
11 Cádiz;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
11 Cádiz;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
11 Cádiz;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
11 Cádiz;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
11 Cádiz;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;14.348
39 Cantabria;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
39 Cantabria;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;13.659
39 Cantabria;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;13.126
39 Cantabria;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
39 Cantabria;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
39 Cantabria;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;95,2
39 Cantabria;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;91,48
39 Cantabria;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;4.378
39 Cantabria;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
39 Cantabria;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;4.050
39 Cantabria;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;3.802
39 Cantabria;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
39 Cantabria;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
39 Cantabria;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;92,51
39 Cantabria;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;86,84
39 Cantabria;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;9.970
39 Cantabria;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
39 Cantabria;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;9.609
39 Cantabria;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;9.324
39 Cantabria;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
39 Cantabria;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
39 Cantabria;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,38
39 Cantabria;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;93,52
39 Cantabria;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;14.550
39 Cantabria;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;13.887
39 Cantabria;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
39 Cantabria;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
39 Cantabria;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
39 Cantabria;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
39 Cantabria;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,44
39 Cantabria;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;4.155
39 Cantabria;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;3.834
39 Cantabria;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
39 Cantabria;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
39 Cantabria;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
39 Cantabria;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
39 Cantabria;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;92,27
39 Cantabria;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;10.395
39 Cantabria;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;10.053
39 Cantabria;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
39 Cantabria;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
39 Cantabria;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
39 Cantabria;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
39 Cantabria;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,71
39 Cantabria;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
39 Cantabria;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
39 Cantabria;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
39 Cantabria;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
39 Cantabria;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
39 Cantabria;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
39 Cantabria;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
39 Cantabria;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
39 Cantabria;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
39 Cantabria;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
39 Cantabria;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
39 Cantabria;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
39 Cantabria;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
39 Cantabria;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
39 Cantabria;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
39 Cantabria;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
39 Cantabria;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
39 Cantabria;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
39 Cantabria;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
39 Cantabria;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
39 Cantabria;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
39 Cantabria;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
39 Cantabria;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
39 Cantabria;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
39 Cantabria;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;10.714
39 Cantabria;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;10.073
39 Cantabria;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;9.609
39 Cantabria;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
39 Cantabria;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,02
39 Cantabria;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;89,69
39 Cantabria;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;3.590
39 Cantabria;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;3.276
39 Cantabria;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;3.065
39 Cantabria;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
39 Cantabria;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,25
39 Cantabria;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;85,38
39 Cantabria;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;7.124
39 Cantabria;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;6.797
39 Cantabria;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;6.544
39 Cantabria;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
39 Cantabria;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,41
39 Cantabria;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;91,86
39 Cantabria;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;10.712
39 Cantabria;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;10.139
39 Cantabria;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
39 Cantabria;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,65
39 Cantabria;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;3.368
39 Cantabria;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;3.102
39 Cantabria;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
39 Cantabria;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;92,1
39 Cantabria;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;7.344
39 Cantabria;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;7.037
39 Cantabria;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
39 Cantabria;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,82
39 Cantabria;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.471
39 Cantabria;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.447
39 Cantabria;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.413
39 Cantabria;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
39 Cantabria;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,37
39 Cantabria;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,06
39 Cantabria;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;385
39 Cantabria;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;376
39 Cantabria;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;362
39 Cantabria;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
39 Cantabria;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,66
39 Cantabria;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;94,03
39 Cantabria;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.086
39 Cantabria;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.071
39 Cantabria;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.051
39 Cantabria;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
39 Cantabria;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,62
39 Cantabria;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,78
39 Cantabria;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.569
39 Cantabria;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.538
39 Cantabria;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
39 Cantabria;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,02
39 Cantabria;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;374
39 Cantabria;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;361
39 Cantabria;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
39 Cantabria;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;96,52
39 Cantabria;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.195
39 Cantabria;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.177
39 Cantabria;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
39 Cantabria;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,49
39 Cantabria;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;2.020
39 Cantabria;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.997
39 Cantabria;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.964
39 Cantabria;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
39 Cantabria;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,86
39 Cantabria;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,23
39 Cantabria;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;391
39 Cantabria;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;386
39 Cantabria;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;365
39 Cantabria;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
39 Cantabria;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,72
39 Cantabria;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;93,35
39 Cantabria;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.629
39 Cantabria;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.611
39 Cantabria;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.599
39 Cantabria;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
39 Cantabria;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,9
39 Cantabria;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,16
39 Cantabria;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;2.113
39 Cantabria;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;2.061
39 Cantabria;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
39 Cantabria;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,54
39 Cantabria;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;396
39 Cantabria;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;360
39 Cantabria;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
39 Cantabria;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,91
39 Cantabria;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.717
39 Cantabria;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.701
39 Cantabria;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
39 Cantabria;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,07
39 Cantabria;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
39 Cantabria;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;99
39 Cantabria;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;97
39 Cantabria;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
39 Cantabria;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99
39 Cantabria;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97
39 Cantabria;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;8
39 Cantabria;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;8
39 Cantabria;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;6
39 Cantabria;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
39 Cantabria;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
39 Cantabria;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;75
39 Cantabria;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;92
39 Cantabria;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;91
39 Cantabria;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;91
39 Cantabria;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
39 Cantabria;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,91
39 Cantabria;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,91
39 Cantabria;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;107
39 Cantabria;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;100
39 Cantabria;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
39 Cantabria;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,46
39 Cantabria;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;13
39 Cantabria;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;7
39 Cantabria;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
39 Cantabria;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;53,85
39 Cantabria;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;94
39 Cantabria;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;93
39 Cantabria;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
39 Cantabria;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,94
39 Cantabria;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;43
39 Cantabria;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;43
39 Cantabria;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;43
39 Cantabria;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
39 Cantabria;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
39 Cantabria;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
39 Cantabria;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;4
39 Cantabria;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;4
39 Cantabria;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;4
39 Cantabria;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
39 Cantabria;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
39 Cantabria;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
39 Cantabria;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;39
39 Cantabria;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;39
39 Cantabria;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;39
39 Cantabria;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
39 Cantabria;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
39 Cantabria;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
39 Cantabria;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;49
39 Cantabria;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;49
39 Cantabria;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
39 Cantabria;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
39 Cantabria;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;4
39 Cantabria;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;4
39 Cantabria;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
39 Cantabria;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
39 Cantabria;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;45
39 Cantabria;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;45
39 Cantabria;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
39 Cantabria;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
39 Cantabria;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
39 Cantabria;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
39 Cantabria;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
39 Cantabria;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
39 Cantabria;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
39 Cantabria;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
39 Cantabria;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;16.160
12 Castellón/Castelló;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;15.287
12 Castellón/Castelló;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;14.633
12 Castellón/Castelló;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,6
12 Castellón/Castelló;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;90,55
12 Castellón/Castelló;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;5.342
12 Castellón/Castelló;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;4.840
12 Castellón/Castelló;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;4.496
12 Castellón/Castelló;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;90,6
12 Castellón/Castelló;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;84,16
12 Castellón/Castelló;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;10.818
12 Castellón/Castelló;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;10.447
12 Castellón/Castelló;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;10.137
12 Castellón/Castelló;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,57
12 Castellón/Castelló;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;93,7
12 Castellón/Castelló;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;16.436
12 Castellón/Castelló;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;15.599
12 Castellón/Castelló;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,91
12 Castellón/Castelló;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;5.097
12 Castellón/Castelló;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;4.643
12 Castellón/Castelló;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,09
12 Castellón/Castelló;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;11.339
12 Castellón/Castelló;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;10.956
12 Castellón/Castelló;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,62
12 Castellón/Castelló;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;11.895
12 Castellón/Castelló;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;11.077
12 Castellón/Castelló;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;10.491
12 Castellón/Castelló;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,12
12 Castellón/Castelló;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;88,2
12 Castellón/Castelló;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;4.410
12 Castellón/Castelló;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;3.929
12 Castellón/Castelló;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;3.611
12 Castellón/Castelló;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;89,09
12 Castellón/Castelló;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;81,88
12 Castellón/Castelló;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;7.485
12 Castellón/Castelló;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;7.148
12 Castellón/Castelló;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;6.880
12 Castellón/Castelló;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,5
12 Castellón/Castelló;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;91,92
12 Castellón/Castelló;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;12.004
12 Castellón/Castelló;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;11.235
12 Castellón/Castelló;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,59
12 Castellón/Castelló;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;4.186
12 Castellón/Castelló;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;3.758
12 Castellón/Castelló;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;89,78
12 Castellón/Castelló;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;7.818
12 Castellón/Castelló;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;7.477
12 Castellón/Castelló;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,64
12 Castellón/Castelló;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.790
12 Castellón/Castelló;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.759
12 Castellón/Castelló;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.709
12 Castellón/Castelló;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,27
12 Castellón/Castelló;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;95,47
12 Castellón/Castelló;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;477
12 Castellón/Castelló;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;463
12 Castellón/Castelló;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;442
12 Castellón/Castelló;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,06
12 Castellón/Castelló;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;92,66
12 Castellón/Castelló;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.313
12 Castellón/Castelló;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.296
12 Castellón/Castelló;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.267
12 Castellón/Castelló;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,71
12 Castellón/Castelló;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,5
12 Castellón/Castelló;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.885
12 Castellón/Castelló;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.837
12 Castellón/Castelló;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,45
12 Castellón/Castelló;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;467
12 Castellón/Castelló;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;446
12 Castellón/Castelló;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;95,5
12 Castellón/Castelló;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.418
12 Castellón/Castelló;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.391
12 Castellón/Castelló;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,1
12 Castellón/Castelló;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;2.289
12 Castellón/Castelló;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;2.266
12 Castellón/Castelló;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;2.252
12 Castellón/Castelló;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99
12 Castellón/Castelló;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;98,38
12 Castellón/Castelló;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;437
12 Castellón/Castelló;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;430
12 Castellón/Castelló;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;425
12 Castellón/Castelló;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,4
12 Castellón/Castelló;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;97,25
12 Castellón/Castelló;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.852
12 Castellón/Castelló;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.836
12 Castellón/Castelló;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.827
12 Castellón/Castelló;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,14
12 Castellón/Castelló;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,65
12 Castellón/Castelló;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;2.344
12 Castellón/Castelló;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;2.327
12 Castellón/Castelló;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;99,27
12 Castellón/Castelló;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;421
12 Castellón/Castelló;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;416
12 Castellón/Castelló;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;98,81
12 Castellón/Castelló;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.923
12 Castellón/Castelló;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.911
12 Castellón/Castelló;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,38
12 Castellón/Castelló;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;119
12 Castellón/Castelló;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;118
12 Castellón/Castelló;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;115
12 Castellón/Castelló;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,16
12 Castellón/Castelló;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,64
12 Castellón/Castelló;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;12
12 Castellón/Castelló;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;12
12 Castellón/Castelló;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;12
12 Castellón/Castelló;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
12 Castellón/Castelló;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
12 Castellón/Castelló;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;107
12 Castellón/Castelló;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;106
12 Castellón/Castelló;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;103
12 Castellón/Castelló;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,07
12 Castellón/Castelló;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,26
12 Castellón/Castelló;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;128
12 Castellón/Castelló;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;127
12 Castellón/Castelló;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;99,22
12 Castellón/Castelló;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;16
12 Castellón/Castelló;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;16
12 Castellón/Castelló;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
12 Castellón/Castelló;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;112
12 Castellón/Castelló;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;111
12 Castellón/Castelló;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,11
12 Castellón/Castelló;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;67
12 Castellón/Castelló;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;67
12 Castellón/Castelló;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;66
12 Castellón/Castelló;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
12 Castellón/Castelló;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;98,51
12 Castellón/Castelló;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;6
12 Castellón/Castelló;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;6
12 Castellón/Castelló;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;6
12 Castellón/Castelló;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
12 Castellón/Castelló;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
12 Castellón/Castelló;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;61
12 Castellón/Castelló;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;61
12 Castellón/Castelló;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;60
12 Castellón/Castelló;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
12 Castellón/Castelló;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
12 Castellón/Castelló;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,36
12 Castellón/Castelló;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;75
12 Castellón/Castelló;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;73
12 Castellón/Castelló;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,33
12 Castellón/Castelló;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;7
12 Castellón/Castelló;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;7
12 Castellón/Castelló;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
12 Castellón/Castelló;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;68
12 Castellón/Castelló;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;66
12 Castellón/Castelló;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
12 Castellón/Castelló;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;97,06
12 Castellón/Castelló;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;11.335
13 Ciudad Real;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
13 Ciudad Real;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;10.704
13 Ciudad Real;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;10.208
13 Ciudad Real;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
13 Ciudad Real;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
13 Ciudad Real;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,43
13 Ciudad Real;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;90,06
13 Ciudad Real;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;3.566
13 Ciudad Real;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
13 Ciudad Real;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;3.254
13 Ciudad Real;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;3.015
13 Ciudad Real;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
13 Ciudad Real;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
13 Ciudad Real;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,25
13 Ciudad Real;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;84,55
13 Ciudad Real;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;7.769
13 Ciudad Real;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
13 Ciudad Real;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;7.450
13 Ciudad Real;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;7.193
13 Ciudad Real;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
13 Ciudad Real;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
13 Ciudad Real;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,89
13 Ciudad Real;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;92,59
13 Ciudad Real;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;11.340
13 Ciudad Real;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;10.715
13 Ciudad Real;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
13 Ciudad Real;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
13 Ciudad Real;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
13 Ciudad Real;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
13 Ciudad Real;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,49
13 Ciudad Real;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;3.324
13 Ciudad Real;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;2.997
13 Ciudad Real;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
13 Ciudad Real;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
13 Ciudad Real;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
13 Ciudad Real;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
13 Ciudad Real;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,16
13 Ciudad Real;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;8.016
13 Ciudad Real;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;7.718
13 Ciudad Real;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
13 Ciudad Real;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
13 Ciudad Real;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
13 Ciudad Real;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
13 Ciudad Real;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,28
13 Ciudad Real;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
13 Ciudad Real;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
13 Ciudad Real;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
13 Ciudad Real;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
13 Ciudad Real;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
13 Ciudad Real;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
13 Ciudad Real;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
13 Ciudad Real;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
13 Ciudad Real;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
13 Ciudad Real;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
13 Ciudad Real;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
13 Ciudad Real;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
13 Ciudad Real;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
13 Ciudad Real;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
13 Ciudad Real;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
13 Ciudad Real;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
13 Ciudad Real;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
13 Ciudad Real;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
13 Ciudad Real;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
13 Ciudad Real;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
13 Ciudad Real;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
13 Ciudad Real;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
13 Ciudad Real;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
13 Ciudad Real;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
13 Ciudad Real;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;8.508
13 Ciudad Real;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;7.920
13 Ciudad Real;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;7.471
13 Ciudad Real;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
13 Ciudad Real;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,09
13 Ciudad Real;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;87,81
13 Ciudad Real;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;2.967
13 Ciudad Real;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;2.666
13 Ciudad Real;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;2.448
13 Ciudad Real;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
13 Ciudad Real;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;89,86
13 Ciudad Real;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;82,51
13 Ciudad Real;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;5.541
13 Ciudad Real;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;5.254
13 Ciudad Real;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;5.023
13 Ciudad Real;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
13 Ciudad Real;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;94,82
13 Ciudad Real;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;90,65
13 Ciudad Real;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;8.495
13 Ciudad Real;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;7.937
13 Ciudad Real;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
13 Ciudad Real;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,43
13 Ciudad Real;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;2.754
13 Ciudad Real;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;2.468
13 Ciudad Real;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
13 Ciudad Real;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;89,62
13 Ciudad Real;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;5.741
13 Ciudad Real;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;5.469
13 Ciudad Real;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
13 Ciudad Real;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,26
13 Ciudad Real;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.227
13 Ciudad Real;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.202
13 Ciudad Real;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.177
13 Ciudad Real;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
13 Ciudad Real;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;97,96
13 Ciudad Real;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;95,93
13 Ciudad Real;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;297
13 Ciudad Real;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;291
13 Ciudad Real;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;281
13 Ciudad Real;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
13 Ciudad Real;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,98
13 Ciudad Real;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;94,61
13 Ciudad Real;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;930
13 Ciudad Real;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;911
13 Ciudad Real;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;896
13 Ciudad Real;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
13 Ciudad Real;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;97,96
13 Ciudad Real;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,34
13 Ciudad Real;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.244
13 Ciudad Real;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.211
13 Ciudad Real;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
13 Ciudad Real;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,35
13 Ciudad Real;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;292
13 Ciudad Real;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;276
13 Ciudad Real;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
13 Ciudad Real;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;94,52
13 Ciudad Real;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;952
13 Ciudad Real;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;935
13 Ciudad Real;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
13 Ciudad Real;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,21
13 Ciudad Real;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.522
13 Ciudad Real;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.504
13 Ciudad Real;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.482
13 Ciudad Real;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
13 Ciudad Real;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,82
13 Ciudad Real;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,37
13 Ciudad Real;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;293
13 Ciudad Real;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;288
13 Ciudad Real;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;277
13 Ciudad Real;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
13 Ciudad Real;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,29
13 Ciudad Real;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;94,54
13 Ciudad Real;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.229
13 Ciudad Real;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.216
13 Ciudad Real;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.205
13 Ciudad Real;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
13 Ciudad Real;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,94
13 Ciudad Real;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,05
13 Ciudad Real;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.512
13 Ciudad Real;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.484
13 Ciudad Real;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
13 Ciudad Real;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,15
13 Ciudad Real;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;262
13 Ciudad Real;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;243
13 Ciudad Real;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
13 Ciudad Real;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;92,75
13 Ciudad Real;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.250
13 Ciudad Real;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.241
13 Ciudad Real;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
13 Ciudad Real;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,28
13 Ciudad Real;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;62
13 Ciudad Real;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;62
13 Ciudad Real;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;62
13 Ciudad Real;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
13 Ciudad Real;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
13 Ciudad Real;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
13 Ciudad Real;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;6
13 Ciudad Real;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;6
13 Ciudad Real;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;6
13 Ciudad Real;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
13 Ciudad Real;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
13 Ciudad Real;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
13 Ciudad Real;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;56
13 Ciudad Real;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;56
13 Ciudad Real;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;56
13 Ciudad Real;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
13 Ciudad Real;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
13 Ciudad Real;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
13 Ciudad Real;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;67
13 Ciudad Real;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;62
13 Ciudad Real;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
13 Ciudad Real;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;92,54
13 Ciudad Real;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;12
13 Ciudad Real;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;7
13 Ciudad Real;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
13 Ciudad Real;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;58,33
13 Ciudad Real;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;55
13 Ciudad Real;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;55
13 Ciudad Real;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
13 Ciudad Real;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
13 Ciudad Real;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;16
13 Ciudad Real;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;16
13 Ciudad Real;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;16
13 Ciudad Real;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
13 Ciudad Real;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
13 Ciudad Real;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
13 Ciudad Real;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;3
13 Ciudad Real;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;3
13 Ciudad Real;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;3
13 Ciudad Real;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
13 Ciudad Real;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
13 Ciudad Real;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
13 Ciudad Real;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;13
13 Ciudad Real;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;13
13 Ciudad Real;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;13
13 Ciudad Real;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
13 Ciudad Real;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
13 Ciudad Real;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
13 Ciudad Real;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;22
13 Ciudad Real;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;21
13 Ciudad Real;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
13 Ciudad Real;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,45
13 Ciudad Real;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;4
13 Ciudad Real;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;3
13 Ciudad Real;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
13 Ciudad Real;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;75
13 Ciudad Real;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;18
13 Ciudad Real;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;18
13 Ciudad Real;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
13 Ciudad Real;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
13 Ciudad Real;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;17.438
14 Córdoba;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
14 Córdoba;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;16.473
14 Córdoba;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;15.777
14 Córdoba;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
14 Córdoba;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
14 Córdoba;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,47
14 Córdoba;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;90,47
14 Córdoba;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;5.471
14 Córdoba;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
14 Córdoba;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;5.008
14 Córdoba;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;4.687
14 Córdoba;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
14 Córdoba;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
14 Córdoba;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,54
14 Córdoba;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;85,67
14 Córdoba;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;11.967
14 Córdoba;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
14 Córdoba;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;11.465
14 Córdoba;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;11.090
14 Córdoba;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
14 Córdoba;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
14 Córdoba;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,81
14 Córdoba;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;92,67
14 Córdoba;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;17.542
14 Córdoba;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;16.575
14 Córdoba;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
14 Córdoba;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
14 Córdoba;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
14 Córdoba;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
14 Córdoba;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,49
14 Córdoba;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;5.125
14 Córdoba;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;4.695
14 Córdoba;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
14 Córdoba;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
14 Córdoba;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
14 Córdoba;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
14 Córdoba;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,61
14 Córdoba;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;12.417
14 Córdoba;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;11.880
14 Córdoba;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
14 Córdoba;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
14 Córdoba;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
14 Córdoba;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
14 Córdoba;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,68
14 Córdoba;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
14 Córdoba;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
14 Córdoba;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
14 Córdoba;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
14 Córdoba;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
14 Córdoba;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
14 Córdoba;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
14 Córdoba;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
14 Córdoba;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
14 Córdoba;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
14 Córdoba;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
14 Córdoba;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
14 Córdoba;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
14 Córdoba;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
14 Córdoba;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
14 Córdoba;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
14 Córdoba;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
14 Córdoba;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
14 Córdoba;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
14 Córdoba;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
14 Córdoba;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
14 Córdoba;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
14 Córdoba;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
14 Córdoba;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
14 Córdoba;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;13.083
14 Córdoba;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;12.188
14 Córdoba;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;11.551
14 Córdoba;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
14 Córdoba;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,16
14 Córdoba;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;88,29
14 Córdoba;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;4.544
14 Córdoba;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;4.100
14 Córdoba;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;3.800
14 Córdoba;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
14 Córdoba;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;90,23
14 Córdoba;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;83,63
14 Córdoba;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;8.539
14 Córdoba;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;8.088
14 Córdoba;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;7.751
14 Córdoba;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
14 Córdoba;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;94,72
14 Córdoba;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;90,77
14 Córdoba;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;13.109
14 Córdoba;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;12.211
14 Córdoba;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
14 Córdoba;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,15
14 Córdoba;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;4.243
14 Córdoba;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;3.832
14 Córdoba;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
14 Córdoba;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,31
14 Córdoba;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;8.866
14 Córdoba;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;8.379
14 Córdoba;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
14 Córdoba;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;94,51
14 Córdoba;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.822
14 Córdoba;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.793
14 Córdoba;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.759
14 Córdoba;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
14 Córdoba;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,41
14 Córdoba;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,54
14 Córdoba;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;476
14 Córdoba;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;470
14 Córdoba;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;457
14 Córdoba;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
14 Córdoba;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,74
14 Córdoba;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;96,01
14 Córdoba;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.346
14 Córdoba;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.323
14 Córdoba;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.302
14 Córdoba;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
14 Córdoba;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,29
14 Córdoba;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,73
14 Córdoba;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.920
14 Córdoba;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.875
14 Córdoba;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
14 Córdoba;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,66
14 Córdoba;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;475
14 Córdoba;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;463
14 Córdoba;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
14 Córdoba;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;97,47
14 Córdoba;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.445
14 Córdoba;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.412
14 Córdoba;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
14 Córdoba;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;97,72
14 Córdoba;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;2.390
14 Córdoba;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;2.355
14 Córdoba;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;2.330
14 Córdoba;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
14 Córdoba;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,54
14 Córdoba;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,49
14 Córdoba;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;436
14 Córdoba;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;426
14 Córdoba;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;418
14 Córdoba;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
14 Córdoba;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,71
14 Córdoba;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;95,87
14 Córdoba;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.954
14 Córdoba;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.929
14 Córdoba;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.912
14 Córdoba;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
14 Córdoba;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,72
14 Córdoba;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,85
14 Córdoba;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;2.365
14 Córdoba;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;2.341
14 Córdoba;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
14 Córdoba;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,99
14 Córdoba;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;400
14 Córdoba;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;393
14 Córdoba;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
14 Córdoba;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;98,25
14 Córdoba;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.965
14 Córdoba;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.948
14 Córdoba;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
14 Córdoba;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,13
14 Córdoba;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;89
14 Córdoba;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;83
14 Córdoba;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;83
14 Córdoba;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
14 Córdoba;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,26
14 Córdoba;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;93,26
14 Córdoba;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;11
14 Córdoba;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;8
14 Córdoba;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;8
14 Córdoba;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
14 Córdoba;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;72,73
14 Córdoba;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;72,73
14 Córdoba;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;78
14 Córdoba;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;75
14 Córdoba;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;75
14 Córdoba;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
14 Córdoba;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,15
14 Córdoba;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,15
14 Córdoba;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;93
14 Córdoba;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;93
14 Córdoba;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
14 Córdoba;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
14 Córdoba;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;4
14 Córdoba;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;4
14 Córdoba;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
14 Córdoba;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
14 Córdoba;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;89
14 Córdoba;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;89
14 Córdoba;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
14 Córdoba;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
14 Córdoba;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;54
14 Córdoba;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;54
14 Córdoba;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;54
14 Córdoba;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
14 Córdoba;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
14 Córdoba;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
14 Córdoba;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;4
14 Córdoba;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;4
14 Córdoba;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;4
14 Córdoba;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
14 Córdoba;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
14 Córdoba;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
14 Córdoba;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;50
14 Córdoba;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;50
14 Córdoba;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;50
14 Córdoba;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
14 Córdoba;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
14 Córdoba;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
14 Córdoba;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;55
14 Córdoba;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;55
14 Córdoba;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
14 Córdoba;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
14 Córdoba;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;3
14 Córdoba;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;3
14 Córdoba;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
14 Córdoba;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
14 Córdoba;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;52
14 Córdoba;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;52
14 Córdoba;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
14 Córdoba;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
14 Córdoba;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
14 Córdoba;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
14 Córdoba;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
14 Córdoba;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
14 Córdoba;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
14 Córdoba;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
14 Córdoba;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;28.344
15 Coruña, A;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
15 Coruña, A;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;27.085
15 Coruña, A;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;26.142
15 Coruña, A;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
15 Coruña, A;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
15 Coruña, A;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;95,56
15 Coruña, A;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;92,23
15 Coruña, A;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;8.625
15 Coruña, A;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
15 Coruña, A;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;7.995
15 Coruña, A;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;7.567
15 Coruña, A;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
15 Coruña, A;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
15 Coruña, A;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;92,7
15 Coruña, A;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;87,73
15 Coruña, A;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;19.719
15 Coruña, A;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
15 Coruña, A;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;19.090
15 Coruña, A;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;18.575
15 Coruña, A;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
15 Coruña, A;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
15 Coruña, A;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,81
15 Coruña, A;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;94,2
15 Coruña, A;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;28.455
15 Coruña, A;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;27.277
15 Coruña, A;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
15 Coruña, A;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
15 Coruña, A;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
15 Coruña, A;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
15 Coruña, A;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,86
15 Coruña, A;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;8.037
15 Coruña, A;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;7.452
15 Coruña, A;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
15 Coruña, A;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
15 Coruña, A;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
15 Coruña, A;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
15 Coruña, A;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;92,72
15 Coruña, A;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;20.418
15 Coruña, A;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;19.825
15 Coruña, A;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
15 Coruña, A;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
15 Coruña, A;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
15 Coruña, A;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
15 Coruña, A;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;97,1
15 Coruña, A;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
15 Coruña, A;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
15 Coruña, A;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
15 Coruña, A;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
15 Coruña, A;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
15 Coruña, A;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
15 Coruña, A;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
15 Coruña, A;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
15 Coruña, A;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
15 Coruña, A;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
15 Coruña, A;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
15 Coruña, A;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
15 Coruña, A;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
15 Coruña, A;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
15 Coruña, A;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
15 Coruña, A;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
15 Coruña, A;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
15 Coruña, A;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
15 Coruña, A;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
15 Coruña, A;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
15 Coruña, A;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
15 Coruña, A;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
15 Coruña, A;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
15 Coruña, A;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
15 Coruña, A;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;21.124
15 Coruña, A;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;19.960
15 Coruña, A;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;19.096
15 Coruña, A;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
15 Coruña, A;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,49
15 Coruña, A;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;90,4
15 Coruña, A;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;7.132
15 Coruña, A;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;6.532
15 Coruña, A;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;6.130
15 Coruña, A;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
15 Coruña, A;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,59
15 Coruña, A;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;85,95
15 Coruña, A;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;13.992
15 Coruña, A;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;13.428
15 Coruña, A;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;12.966
15 Coruña, A;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
15 Coruña, A;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,97
15 Coruña, A;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;92,67
15 Coruña, A;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;21.141
15 Coruña, A;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;20.082
15 Coruña, A;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
15 Coruña, A;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,99
15 Coruña, A;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;6.703
15 Coruña, A;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;6.190
15 Coruña, A;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
15 Coruña, A;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;92,35
15 Coruña, A;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;14.438
15 Coruña, A;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;13.892
15 Coruña, A;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
15 Coruña, A;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,22
15 Coruña, A;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;3.098
15 Coruña, A;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;3.045
15 Coruña, A;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;2.997
15 Coruña, A;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
15 Coruña, A;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,29
15 Coruña, A;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,74
15 Coruña, A;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;766
15 Coruña, A;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;751
15 Coruña, A;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;733
15 Coruña, A;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
15 Coruña, A;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,04
15 Coruña, A;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;95,69
15 Coruña, A;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;2.332
15 Coruña, A;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;2.294
15 Coruña, A;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;2.264
15 Coruña, A;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
15 Coruña, A;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,37
15 Coruña, A;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,08
15 Coruña, A;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;3.083
15 Coruña, A;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;3.038
15 Coruña, A;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
15 Coruña, A;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,54
15 Coruña, A;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;652
15 Coruña, A;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;634
15 Coruña, A;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
15 Coruña, A;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;97,24
15 Coruña, A;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;2.431
15 Coruña, A;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;2.404
15 Coruña, A;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
15 Coruña, A;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,89
15 Coruña, A;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;3.783
15 Coruña, A;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;3.742
15 Coruña, A;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;3.711
15 Coruña, A;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
15 Coruña, A;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,92
15 Coruña, A;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;98,1
15 Coruña, A;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;682
15 Coruña, A;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;668
15 Coruña, A;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;660
15 Coruña, A;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
15 Coruña, A;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,95
15 Coruña, A;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;96,77
15 Coruña, A;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;3.101
15 Coruña, A;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;3.074
15 Coruña, A;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;3.051
15 Coruña, A;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
15 Coruña, A;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,13
15 Coruña, A;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,39
15 Coruña, A;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;3.877
15 Coruña, A;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;3.811
15 Coruña, A;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
15 Coruña, A;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,3
15 Coruña, A;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;638
15 Coruña, A;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;592
15 Coruña, A;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
15 Coruña, A;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;92,79
15 Coruña, A;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;3.239
15 Coruña, A;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;3.219
15 Coruña, A;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
15 Coruña, A;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,38
15 Coruña, A;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;208
15 Coruña, A;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;208
15 Coruña, A;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;208
15 Coruña, A;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
15 Coruña, A;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
15 Coruña, A;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
15 Coruña, A;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;29
15 Coruña, A;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;29
15 Coruña, A;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;29
15 Coruña, A;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
15 Coruña, A;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
15 Coruña, A;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
15 Coruña, A;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;179
15 Coruña, A;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;179
15 Coruña, A;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;179
15 Coruña, A;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
15 Coruña, A;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
15 Coruña, A;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
15 Coruña, A;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;225
15 Coruña, A;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;218
15 Coruña, A;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
15 Coruña, A;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;96,89
15 Coruña, A;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;29
15 Coruña, A;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;22
15 Coruña, A;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
15 Coruña, A;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;75,86
15 Coruña, A;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;196
15 Coruña, A;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;196
15 Coruña, A;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
15 Coruña, A;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
15 Coruña, A;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;131
15 Coruña, A;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;130
15 Coruña, A;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;130
15 Coruña, A;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
15 Coruña, A;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,24
15 Coruña, A;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;99,24
15 Coruña, A;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;16
15 Coruña, A;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;15
15 Coruña, A;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;15
15 Coruña, A;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
15 Coruña, A;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;93,75
15 Coruña, A;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;93,75
15 Coruña, A;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;115
15 Coruña, A;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;115
15 Coruña, A;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;115
15 Coruña, A;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
15 Coruña, A;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
15 Coruña, A;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
15 Coruña, A;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;129
15 Coruña, A;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;128
15 Coruña, A;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
15 Coruña, A;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;99,22
15 Coruña, A;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;15
15 Coruña, A;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;14
15 Coruña, A;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
15 Coruña, A;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;93,33
15 Coruña, A;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;114
15 Coruña, A;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;114
15 Coruña, A;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
15 Coruña, A;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
15 Coruña, A;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;4.883
16 Cuenca;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
16 Cuenca;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;4.616
16 Cuenca;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;4.407
16 Cuenca;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
16 Cuenca;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
16 Cuenca;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,53
16 Cuenca;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;90,25
16 Cuenca;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1.444
16 Cuenca;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
16 Cuenca;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1.324
16 Cuenca;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.231
16 Cuenca;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
16 Cuenca;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
16 Cuenca;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,69
16 Cuenca;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;85,25
16 Cuenca;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;3.439
16 Cuenca;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
16 Cuenca;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;3.292
16 Cuenca;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;3.176
16 Cuenca;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
16 Cuenca;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
16 Cuenca;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,73
16 Cuenca;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;92,35
16 Cuenca;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;4.872
16 Cuenca;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;4.611
16 Cuenca;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
16 Cuenca;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
16 Cuenca;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
16 Cuenca;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
16 Cuenca;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,64
16 Cuenca;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1.355
16 Cuenca;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.233
16 Cuenca;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
16 Cuenca;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
16 Cuenca;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
16 Cuenca;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
16 Cuenca;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91
16 Cuenca;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;3.517
16 Cuenca;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;3.378
16 Cuenca;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
16 Cuenca;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
16 Cuenca;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
16 Cuenca;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
16 Cuenca;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,05
16 Cuenca;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
16 Cuenca;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
16 Cuenca;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
16 Cuenca;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
16 Cuenca;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
16 Cuenca;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
16 Cuenca;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
16 Cuenca;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
16 Cuenca;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
16 Cuenca;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
16 Cuenca;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
16 Cuenca;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
16 Cuenca;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
16 Cuenca;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
16 Cuenca;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
16 Cuenca;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
16 Cuenca;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
16 Cuenca;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
16 Cuenca;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
16 Cuenca;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
16 Cuenca;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
16 Cuenca;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
16 Cuenca;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
16 Cuenca;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
16 Cuenca;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;3.766
16 Cuenca;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;3.512
16 Cuenca;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;3.328
16 Cuenca;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
16 Cuenca;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,26
16 Cuenca;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;88,37
16 Cuenca;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1.230
16 Cuenca;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1.115
16 Cuenca;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.032
16 Cuenca;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
16 Cuenca;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;90,65
16 Cuenca;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;83,9
16 Cuenca;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;2.536
16 Cuenca;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;2.397
16 Cuenca;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;2.296
16 Cuenca;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
16 Cuenca;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;94,52
16 Cuenca;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;90,54
16 Cuenca;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;3.716
16 Cuenca;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;3.482
16 Cuenca;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
16 Cuenca;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,7
16 Cuenca;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1.144
16 Cuenca;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.036
16 Cuenca;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
16 Cuenca;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,56
16 Cuenca;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;2.572
16 Cuenca;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;2.446
16 Cuenca;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
16 Cuenca;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,1
16 Cuenca;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;469
16 Cuenca;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;458
16 Cuenca;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;450
16 Cuenca;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
16 Cuenca;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;97,65
16 Cuenca;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;95,95
16 Cuenca;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;105
16 Cuenca;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;101
16 Cuenca;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;99
16 Cuenca;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
16 Cuenca;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;96,19
16 Cuenca;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;94,29
16 Cuenca;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;364
16 Cuenca;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;357
16 Cuenca;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;351
16 Cuenca;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
16 Cuenca;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,08
16 Cuenca;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,43
16 Cuenca;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;466
16 Cuenca;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;462
16 Cuenca;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
16 Cuenca;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;99,14
16 Cuenca;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;107
16 Cuenca;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;105
16 Cuenca;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
16 Cuenca;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;98,13
16 Cuenca;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;359
16 Cuenca;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;357
16 Cuenca;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
16 Cuenca;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,44
16 Cuenca;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;617
16 Cuenca;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;615
16 Cuenca;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;598
16 Cuenca;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
16 Cuenca;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,68
16 Cuenca;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,92
16 Cuenca;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;106
16 Cuenca;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;105
16 Cuenca;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;97
16 Cuenca;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
16 Cuenca;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;99,06
16 Cuenca;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;91,51
16 Cuenca;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;511
16 Cuenca;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;510
16 Cuenca;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;501
16 Cuenca;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
16 Cuenca;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,8
16 Cuenca;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,04
16 Cuenca;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;653
16 Cuenca;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;632
16 Cuenca;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
16 Cuenca;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;96,78
16 Cuenca;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;98
16 Cuenca;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;88
16 Cuenca;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
16 Cuenca;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;89,8
16 Cuenca;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;555
16 Cuenca;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;544
16 Cuenca;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
16 Cuenca;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,02
16 Cuenca;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;20
16 Cuenca;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;20
16 Cuenca;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;20
16 Cuenca;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
16 Cuenca;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
16 Cuenca;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
16 Cuenca;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1
16 Cuenca;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1
16 Cuenca;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1
16 Cuenca;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
16 Cuenca;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
16 Cuenca;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
16 Cuenca;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;19
16 Cuenca;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;19
16 Cuenca;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;19
16 Cuenca;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
16 Cuenca;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
16 Cuenca;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
16 Cuenca;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;26
16 Cuenca;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;24
16 Cuenca;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
16 Cuenca;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;92,31
16 Cuenca;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;4
16 Cuenca;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;2
16 Cuenca;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
16 Cuenca;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;50
16 Cuenca;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;22
16 Cuenca;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;22
16 Cuenca;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
16 Cuenca;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
16 Cuenca;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;11
16 Cuenca;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;11
16 Cuenca;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;11
16 Cuenca;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
16 Cuenca;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
16 Cuenca;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
16 Cuenca;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;2
16 Cuenca;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;2
16 Cuenca;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;2
16 Cuenca;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
16 Cuenca;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
16 Cuenca;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
16 Cuenca;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;9
16 Cuenca;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;9
16 Cuenca;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;9
16 Cuenca;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
16 Cuenca;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
16 Cuenca;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
16 Cuenca;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;11
16 Cuenca;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;11
16 Cuenca;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
16 Cuenca;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
16 Cuenca;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;2
16 Cuenca;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;2
16 Cuenca;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
16 Cuenca;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
16 Cuenca;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;9
16 Cuenca;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;9
16 Cuenca;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
16 Cuenca;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
16 Cuenca;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
16 Cuenca;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
16 Cuenca;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
16 Cuenca;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
16 Cuenca;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
16 Cuenca;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
16 Cuenca;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;18.033
20 Gipuzkoa;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
20 Gipuzkoa;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;17.177
20 Gipuzkoa;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;16.537
20 Gipuzkoa;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;95,25
20 Gipuzkoa;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;91,7
20 Gipuzkoa;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;5.327
20 Gipuzkoa;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
20 Gipuzkoa;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;4.910
20 Gipuzkoa;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;4.627
20 Gipuzkoa;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;92,17
20 Gipuzkoa;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;86,86
20 Gipuzkoa;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;12.706
20 Gipuzkoa;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
20 Gipuzkoa;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;12.267
20 Gipuzkoa;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;11.910
20 Gipuzkoa;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,54
20 Gipuzkoa;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;93,74
20 Gipuzkoa;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;17.925
20 Gipuzkoa;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;17.162
20 Gipuzkoa;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
20 Gipuzkoa;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
20 Gipuzkoa;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,74
20 Gipuzkoa;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;4.818
20 Gipuzkoa;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;4.484
20 Gipuzkoa;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
20 Gipuzkoa;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
20 Gipuzkoa;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;93,07
20 Gipuzkoa;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;13.107
20 Gipuzkoa;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;12.678
20 Gipuzkoa;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
20 Gipuzkoa;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
20 Gipuzkoa;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,73
20 Gipuzkoa;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
20 Gipuzkoa;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
20 Gipuzkoa;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
20 Gipuzkoa;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
20 Gipuzkoa;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
20 Gipuzkoa;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
20 Gipuzkoa;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
20 Gipuzkoa;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
20 Gipuzkoa;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
20 Gipuzkoa;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
20 Gipuzkoa;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
20 Gipuzkoa;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
20 Gipuzkoa;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
20 Gipuzkoa;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
20 Gipuzkoa;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
20 Gipuzkoa;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
20 Gipuzkoa;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
20 Gipuzkoa;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
20 Gipuzkoa;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;12.347
20 Gipuzkoa;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;11.573
20 Gipuzkoa;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;11.001
20 Gipuzkoa;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,73
20 Gipuzkoa;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;89,1
20 Gipuzkoa;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;4.310
20 Gipuzkoa;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;3.914
20 Gipuzkoa;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;3.649
20 Gipuzkoa;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;90,81
20 Gipuzkoa;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;84,66
20 Gipuzkoa;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;8.037
20 Gipuzkoa;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;7.659
20 Gipuzkoa;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;7.352
20 Gipuzkoa;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,3
20 Gipuzkoa;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;91,48
20 Gipuzkoa;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;12.206
20 Gipuzkoa;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;11.511
20 Gipuzkoa;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,31
20 Gipuzkoa;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;3.916
20 Gipuzkoa;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;3.596
20 Gipuzkoa;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,83
20 Gipuzkoa;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;8.290
20 Gipuzkoa;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;7.915
20 Gipuzkoa;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,48
20 Gipuzkoa;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;2.122
20 Gipuzkoa;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;2.072
20 Gipuzkoa;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;2.036
20 Gipuzkoa;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;97,64
20 Gipuzkoa;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;95,95
20 Gipuzkoa;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;501
20 Gipuzkoa;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;484
20 Gipuzkoa;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;472
20 Gipuzkoa;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;96,61
20 Gipuzkoa;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;94,21
20 Gipuzkoa;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.621
20 Gipuzkoa;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.588
20 Gipuzkoa;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.564
20 Gipuzkoa;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;97,96
20 Gipuzkoa;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,48
20 Gipuzkoa;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;2.093
20 Gipuzkoa;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;2.056
20 Gipuzkoa;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,23
20 Gipuzkoa;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;445
20 Gipuzkoa;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;436
20 Gipuzkoa;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;97,98
20 Gipuzkoa;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.648
20 Gipuzkoa;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.620
20 Gipuzkoa;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,3
20 Gipuzkoa;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;3.306
20 Gipuzkoa;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;3.274
20 Gipuzkoa;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;3.242
20 Gipuzkoa;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,03
20 Gipuzkoa;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;98,06
20 Gipuzkoa;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;492
20 Gipuzkoa;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;488
20 Gipuzkoa;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;482
20 Gipuzkoa;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;99,19
20 Gipuzkoa;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;97,97
20 Gipuzkoa;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;2.814
20 Gipuzkoa;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;2.786
20 Gipuzkoa;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;2.760
20 Gipuzkoa;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99
20 Gipuzkoa;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,08
20 Gipuzkoa;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;3.364
20 Gipuzkoa;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;3.333
20 Gipuzkoa;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;99,08
20 Gipuzkoa;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;438
20 Gipuzkoa;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;433
20 Gipuzkoa;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;98,86
20 Gipuzkoa;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;2.926
20 Gipuzkoa;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;2.900
20 Gipuzkoa;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,11
20 Gipuzkoa;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;176
20 Gipuzkoa;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;176
20 Gipuzkoa;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;176
20 Gipuzkoa;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
20 Gipuzkoa;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
20 Gipuzkoa;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;16
20 Gipuzkoa;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;16
20 Gipuzkoa;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;16
20 Gipuzkoa;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
20 Gipuzkoa;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
20 Gipuzkoa;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;160
20 Gipuzkoa;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;160
20 Gipuzkoa;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;160
20 Gipuzkoa;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
20 Gipuzkoa;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
20 Gipuzkoa;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;181
20 Gipuzkoa;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;181
20 Gipuzkoa;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
20 Gipuzkoa;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;13
20 Gipuzkoa;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;13
20 Gipuzkoa;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
20 Gipuzkoa;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;168
20 Gipuzkoa;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;168
20 Gipuzkoa;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
20 Gipuzkoa;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;82
20 Gipuzkoa;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;82
20 Gipuzkoa;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;82
20 Gipuzkoa;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
20 Gipuzkoa;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
20 Gipuzkoa;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;8
20 Gipuzkoa;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;8
20 Gipuzkoa;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;8
20 Gipuzkoa;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
20 Gipuzkoa;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
20 Gipuzkoa;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;74
20 Gipuzkoa;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;74
20 Gipuzkoa;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;74
20 Gipuzkoa;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
20 Gipuzkoa;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
20 Gipuzkoa;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
20 Gipuzkoa;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;81
20 Gipuzkoa;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;81
20 Gipuzkoa;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
20 Gipuzkoa;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;6
20 Gipuzkoa;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;6
20 Gipuzkoa;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
20 Gipuzkoa;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;75
20 Gipuzkoa;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;75
20 Gipuzkoa;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
20 Gipuzkoa;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
20 Gipuzkoa;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;23.605
17 Girona;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
17 Girona;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;22.340
17 Girona;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;21.481
17 Girona;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
17 Girona;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
17 Girona;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
17 Girona;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,64
17 Girona;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;91
17 Girona;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
17 Girona;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
17 Girona;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
17 Girona;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;7.498
17 Girona;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
17 Girona;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;6.846
17 Girona;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;6.416
17 Girona;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
17 Girona;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
17 Girona;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
17 Girona;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,3
17 Girona;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;85,57
17 Girona;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
17 Girona;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
17 Girona;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
17 Girona;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;16.107
17 Girona;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
17 Girona;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;15.494
17 Girona;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;15.065
17 Girona;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
17 Girona;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
17 Girona;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
17 Girona;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,19
17 Girona;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;93,53
17 Girona;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
17 Girona;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
17 Girona;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
17 Girona;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;24.243
17 Girona;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;23.182
17 Girona;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
17 Girona;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
17 Girona;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
17 Girona;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
17 Girona;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,62
17 Girona;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
17 Girona;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
17 Girona;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
17 Girona;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
17 Girona;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
17 Girona;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;7.252
17 Girona;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;6.718
17 Girona;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
17 Girona;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
17 Girona;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
17 Girona;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
17 Girona;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;92,64
17 Girona;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
17 Girona;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
17 Girona;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
17 Girona;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
17 Girona;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
17 Girona;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;16.991
17 Girona;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;16.464
17 Girona;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
17 Girona;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
17 Girona;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
17 Girona;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
17 Girona;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,9
17 Girona;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
17 Girona;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
17 Girona;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
17 Girona;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
17 Girona;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
17 Girona;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
17 Girona;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
17 Girona;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
17 Girona;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
17 Girona;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
17 Girona;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
17 Girona;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
17 Girona;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
17 Girona;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
17 Girona;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
17 Girona;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
17 Girona;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
17 Girona;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
17 Girona;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
17 Girona;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
17 Girona;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
17 Girona;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
17 Girona;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
17 Girona;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
17 Girona;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
17 Girona;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
17 Girona;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
17 Girona;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
17 Girona;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
17 Girona;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
17 Girona;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
17 Girona;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
17 Girona;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
17 Girona;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
17 Girona;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
17 Girona;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
17 Girona;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
17 Girona;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
17 Girona;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
17 Girona;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
17 Girona;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
17 Girona;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
17 Girona;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
17 Girona;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
17 Girona;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
17 Girona;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
17 Girona;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
17 Girona;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
17 Girona;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
17 Girona;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
17 Girona;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
17 Girona;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
17 Girona;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
17 Girona;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
17 Girona;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
17 Girona;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
17 Girona;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
17 Girona;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
17 Girona;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
17 Girona;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
17 Girona;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
17 Girona;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
17 Girona;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
17 Girona;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
17 Girona;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
17 Girona;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;17.168
17 Girona;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
17 Girona;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;15.988
17 Girona;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;15.205
17 Girona;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
17 Girona;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
17 Girona;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,13
17 Girona;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;88,57
17 Girona;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;6.253
17 Girona;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
17 Girona;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;5.624
17 Girona;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;5.218
17 Girona;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
17 Girona;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
17 Girona;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;89,94
17 Girona;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;83,45
17 Girona;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;10.915
17 Girona;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
17 Girona;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;10.364
17 Girona;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;9.987
17 Girona;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
17 Girona;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
17 Girona;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;94,95
17 Girona;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;91,5
17 Girona;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;17.343
17 Girona;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;16.362
17 Girona;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
17 Girona;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
17 Girona;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
17 Girona;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
17 Girona;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,34
17 Girona;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;6.039
17 Girona;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;5.528
17 Girona;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
17 Girona;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
17 Girona;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
17 Girona;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
17 Girona;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,54
17 Girona;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;11.304
17 Girona;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;10.834
17 Girona;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
17 Girona;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
17 Girona;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
17 Girona;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
17 Girona;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,84
17 Girona;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
17 Girona;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
17 Girona;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
17 Girona;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
17 Girona;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
17 Girona;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
17 Girona;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
17 Girona;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
17 Girona;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
17 Girona;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
17 Girona;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
17 Girona;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
17 Girona;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
17 Girona;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
17 Girona;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
17 Girona;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
17 Girona;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
17 Girona;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
17 Girona;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
17 Girona;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
17 Girona;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
17 Girona;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
17 Girona;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
17 Girona;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
17 Girona;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;2.625
17 Girona;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
17 Girona;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;2.580
17 Girona;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;2.544
17 Girona;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
17 Girona;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
17 Girona;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,29
17 Girona;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,91
17 Girona;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;615
17 Girona;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
17 Girona;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;601
17 Girona;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;586
17 Girona;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
17 Girona;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
17 Girona;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,72
17 Girona;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;95,28
17 Girona;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;2.010
17 Girona;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
17 Girona;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.979
17 Girona;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.958
17 Girona;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
17 Girona;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
17 Girona;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,46
17 Girona;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,41
17 Girona;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;2.791
17 Girona;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;2.747
17 Girona;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
17 Girona;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
17 Girona;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
17 Girona;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
17 Girona;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,42
17 Girona;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;621
17 Girona;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;606
17 Girona;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
17 Girona;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
17 Girona;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
17 Girona;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
17 Girona;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;97,58
17 Girona;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;2.170
17 Girona;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;2.141
17 Girona;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
17 Girona;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
17 Girona;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
17 Girona;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
17 Girona;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,66
17 Girona;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
17 Girona;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
17 Girona;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
17 Girona;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
17 Girona;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
17 Girona;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
17 Girona;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
17 Girona;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
17 Girona;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
17 Girona;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
17 Girona;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
17 Girona;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
17 Girona;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
17 Girona;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
17 Girona;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
17 Girona;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
17 Girona;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
17 Girona;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
17 Girona;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
17 Girona;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
17 Girona;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
17 Girona;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
17 Girona;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
17 Girona;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
17 Girona;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;3.563
17 Girona;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
17 Girona;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;3.523
17 Girona;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;3.483
17 Girona;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
17 Girona;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
17 Girona;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,88
17 Girona;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,75
17 Girona;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;608
17 Girona;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
17 Girona;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;599
17 Girona;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;590
17 Girona;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
17 Girona;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
17 Girona;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,52
17 Girona;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;97,04
17 Girona;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;2.955
17 Girona;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
17 Girona;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;2.924
17 Girona;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;2.893
17 Girona;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
17 Girona;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
17 Girona;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,95
17 Girona;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,9
17 Girona;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;3.848
17 Girona;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;3.812
17 Girona;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
17 Girona;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
17 Girona;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
17 Girona;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
17 Girona;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;99,06
17 Girona;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;574
17 Girona;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;566
17 Girona;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
17 Girona;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
17 Girona;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
17 Girona;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
17 Girona;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;98,61
17 Girona;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;3.274
17 Girona;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;3.246
17 Girona;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
17 Girona;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
17 Girona;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
17 Girona;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
17 Girona;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,14
17 Girona;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
17 Girona;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
17 Girona;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
17 Girona;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
17 Girona;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
17 Girona;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
17 Girona;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
17 Girona;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
17 Girona;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
17 Girona;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
17 Girona;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
17 Girona;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
17 Girona;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
17 Girona;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
17 Girona;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
17 Girona;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
17 Girona;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
17 Girona;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
17 Girona;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
17 Girona;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
17 Girona;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
17 Girona;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
17 Girona;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
17 Girona;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
17 Girona;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;161
17 Girona;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
17 Girona;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;161
17 Girona;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;161
17 Girona;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
17 Girona;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
17 Girona;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
17 Girona;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
17 Girona;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
17 Girona;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
17 Girona;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
17 Girona;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
17 Girona;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;13
17 Girona;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
17 Girona;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;13
17 Girona;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;13
17 Girona;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
17 Girona;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
17 Girona;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
17 Girona;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
17 Girona;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
17 Girona;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
17 Girona;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
17 Girona;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
17 Girona;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;148
17 Girona;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
17 Girona;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;148
17 Girona;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;148
17 Girona;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
17 Girona;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
17 Girona;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
17 Girona;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
17 Girona;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
17 Girona;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
17 Girona;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
17 Girona;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
17 Girona;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;175
17 Girona;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;175
17 Girona;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
17 Girona;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
17 Girona;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
17 Girona;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
17 Girona;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
17 Girona;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
17 Girona;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
17 Girona;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
17 Girona;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
17 Girona;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
17 Girona;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;12
17 Girona;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;12
17 Girona;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
17 Girona;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
17 Girona;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
17 Girona;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
17 Girona;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
17 Girona;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
17 Girona;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
17 Girona;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
17 Girona;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
17 Girona;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
17 Girona;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;163
17 Girona;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;163
17 Girona;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
17 Girona;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
17 Girona;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
17 Girona;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
17 Girona;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
17 Girona;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
17 Girona;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
17 Girona;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
17 Girona;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
17 Girona;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
17 Girona;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
17 Girona;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
17 Girona;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
17 Girona;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
17 Girona;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
17 Girona;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
17 Girona;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
17 Girona;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
17 Girona;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
17 Girona;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
17 Girona;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
17 Girona;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
17 Girona;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
17 Girona;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
17 Girona;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
17 Girona;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
17 Girona;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
17 Girona;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
17 Girona;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
17 Girona;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
17 Girona;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
17 Girona;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
17 Girona;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
17 Girona;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
17 Girona;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
17 Girona;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
17 Girona;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
17 Girona;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
17 Girona;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
17 Girona;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
17 Girona;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
17 Girona;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
17 Girona;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
17 Girona;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
17 Girona;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
17 Girona;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
17 Girona;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
17 Girona;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
17 Girona;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
17 Girona;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
17 Girona;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
17 Girona;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
17 Girona;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
17 Girona;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
17 Girona;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
17 Girona;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
17 Girona;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
17 Girona;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
17 Girona;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
17 Girona;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
17 Girona;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
17 Girona;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
17 Girona;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
17 Girona;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
17 Girona;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
17 Girona;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
17 Girona;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
17 Girona;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
17 Girona;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
17 Girona;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
17 Girona;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;88
17 Girona;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
17 Girona;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;88
17 Girona;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;88
17 Girona;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
17 Girona;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
17 Girona;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
17 Girona;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
17 Girona;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;9
17 Girona;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
17 Girona;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;9
17 Girona;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;9
17 Girona;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
17 Girona;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
17 Girona;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
17 Girona;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
17 Girona;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;79
17 Girona;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
17 Girona;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;79
17 Girona;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;79
17 Girona;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
17 Girona;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
17 Girona;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
17 Girona;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
17 Girona;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;86
17 Girona;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;86
17 Girona;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
17 Girona;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
17 Girona;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
17 Girona;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
17 Girona;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
17 Girona;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;6
17 Girona;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;6
17 Girona;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
17 Girona;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
17 Girona;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
17 Girona;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
17 Girona;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
17 Girona;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;80
17 Girona;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;80
17 Girona;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
17 Girona;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
17 Girona;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
17 Girona;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
17 Girona;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
17 Girona;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
17 Girona;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
17 Girona;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
17 Girona;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
17 Girona;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
17 Girona;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
17 Girona;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
17 Girona;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
17 Girona;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
17 Girona;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
17 Girona;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
17 Girona;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
17 Girona;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
17 Girona;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
17 Girona;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
17 Girona;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
17 Girona;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
17 Girona;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
17 Girona;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
17 Girona;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
17 Girona;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
17 Girona;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
17 Girona;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
17 Girona;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
17 Girona;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
17 Girona;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
17 Girona;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
17 Girona;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
17 Girona;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
17 Girona;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
17 Girona;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
17 Girona;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
17 Girona;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
17 Girona;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
17 Girona;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
17 Girona;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
17 Girona;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;21.554
18 Granada;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
18 Granada;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;20.261
18 Granada;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;19.180
18 Granada;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
18 Granada;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
18 Granada;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
18 Granada;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94
18 Granada;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;88,99
18 Granada;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
18 Granada;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
18 Granada;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
18 Granada;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;7.630
18 Granada;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
18 Granada;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;6.958
18 Granada;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;6.437
18 Granada;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
18 Granada;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
18 Granada;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
18 Granada;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,19
18 Granada;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;84,36
18 Granada;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
18 Granada;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
18 Granada;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
18 Granada;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;13.924
18 Granada;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
18 Granada;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;13.303
18 Granada;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;12.743
18 Granada;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
18 Granada;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
18 Granada;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
18 Granada;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,54
18 Granada;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;91,52
18 Granada;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
18 Granada;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
18 Granada;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
18 Granada;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;21.698
18 Granada;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;20.335
18 Granada;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
18 Granada;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
18 Granada;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
18 Granada;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
18 Granada;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,72
18 Granada;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
18 Granada;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
18 Granada;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
18 Granada;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
18 Granada;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
18 Granada;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;7.141
18 Granada;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;6.477
18 Granada;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
18 Granada;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
18 Granada;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
18 Granada;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
18 Granada;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,7
18 Granada;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
18 Granada;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
18 Granada;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
18 Granada;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
18 Granada;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
18 Granada;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;14.557
18 Granada;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;13.858
18 Granada;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
18 Granada;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
18 Granada;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
18 Granada;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
18 Granada;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,2
18 Granada;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
18 Granada;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
18 Granada;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
18 Granada;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
18 Granada;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
18 Granada;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
18 Granada;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
18 Granada;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
18 Granada;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
18 Granada;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
18 Granada;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
18 Granada;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
18 Granada;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
18 Granada;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
18 Granada;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
18 Granada;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
18 Granada;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
18 Granada;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
18 Granada;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
18 Granada;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
18 Granada;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
18 Granada;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
18 Granada;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
18 Granada;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
18 Granada;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
18 Granada;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
18 Granada;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
18 Granada;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
18 Granada;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
18 Granada;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
18 Granada;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
18 Granada;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
18 Granada;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
18 Granada;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
18 Granada;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
18 Granada;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
18 Granada;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
18 Granada;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
18 Granada;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
18 Granada;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
18 Granada;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
18 Granada;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
18 Granada;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
18 Granada;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
18 Granada;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
18 Granada;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
18 Granada;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
18 Granada;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
18 Granada;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
18 Granada;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
18 Granada;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
18 Granada;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
18 Granada;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
18 Granada;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
18 Granada;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
18 Granada;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
18 Granada;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
18 Granada;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
18 Granada;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
18 Granada;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
18 Granada;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
18 Granada;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
18 Granada;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
18 Granada;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
18 Granada;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
18 Granada;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;16.328
18 Granada;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
18 Granada;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;15.114
18 Granada;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;14.186
18 Granada;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
18 Granada;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
18 Granada;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;92,56
18 Granada;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;86,88
18 Granada;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;6.300
18 Granada;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
18 Granada;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;5.652
18 Granada;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;5.188
18 Granada;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
18 Granada;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
18 Granada;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;89,71
18 Granada;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;82,35
18 Granada;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;10.028
18 Granada;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
18 Granada;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;9.462
18 Granada;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;8.998
18 Granada;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
18 Granada;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
18 Granada;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;94,36
18 Granada;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;89,73
18 Granada;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;16.331
18 Granada;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;15.113
18 Granada;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
18 Granada;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
18 Granada;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
18 Granada;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
18 Granada;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;92,54
18 Granada;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;5.900
18 Granada;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;5.284
18 Granada;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
18 Granada;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
18 Granada;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
18 Granada;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
18 Granada;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;89,56
18 Granada;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;10.431
18 Granada;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;9.829
18 Granada;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
18 Granada;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
18 Granada;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
18 Granada;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
18 Granada;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;94,23
18 Granada;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
18 Granada;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
18 Granada;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
18 Granada;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
18 Granada;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
18 Granada;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
18 Granada;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
18 Granada;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
18 Granada;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
18 Granada;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
18 Granada;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
18 Granada;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
18 Granada;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
18 Granada;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
18 Granada;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
18 Granada;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
18 Granada;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
18 Granada;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
18 Granada;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
18 Granada;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
18 Granada;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
18 Granada;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
18 Granada;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
18 Granada;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
18 Granada;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;2.336
18 Granada;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
18 Granada;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;2.287
18 Granada;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;2.207
18 Granada;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
18 Granada;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
18 Granada;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;97,9
18 Granada;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;94,48
18 Granada;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;673
18 Granada;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
18 Granada;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;657
18 Granada;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;626
18 Granada;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
18 Granada;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
18 Granada;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,62
18 Granada;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;93,02
18 Granada;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.663
18 Granada;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
18 Granada;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.630
18 Granada;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.581
18 Granada;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
18 Granada;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
18 Granada;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,02
18 Granada;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;95,07
18 Granada;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;2.379
18 Granada;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;2.306
18 Granada;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
18 Granada;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
18 Granada;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
18 Granada;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
18 Granada;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;96,93
18 Granada;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;646
18 Granada;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;619
18 Granada;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
18 Granada;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
18 Granada;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
18 Granada;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
18 Granada;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;95,82
18 Granada;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.733
18 Granada;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.687
18 Granada;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
18 Granada;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
18 Granada;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
18 Granada;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
18 Granada;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;97,35
18 Granada;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
18 Granada;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
18 Granada;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
18 Granada;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
18 Granada;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
18 Granada;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
18 Granada;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
18 Granada;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
18 Granada;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
18 Granada;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
18 Granada;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
18 Granada;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
18 Granada;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
18 Granada;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
18 Granada;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
18 Granada;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
18 Granada;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
18 Granada;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
18 Granada;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
18 Granada;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
18 Granada;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
18 Granada;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
18 Granada;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
18 Granada;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
18 Granada;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;2.742
18 Granada;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
18 Granada;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;2.713
18 Granada;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;2.640
18 Granada;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
18 Granada;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
18 Granada;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,94
18 Granada;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,28
18 Granada;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;639
18 Granada;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
18 Granada;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;632
18 Granada;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;606
18 Granada;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
18 Granada;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
18 Granada;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,9
18 Granada;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;94,84
18 Granada;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;2.103
18 Granada;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
18 Granada;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;2.081
18 Granada;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;2.034
18 Granada;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
18 Granada;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
18 Granada;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,95
18 Granada;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,72
18 Granada;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;2.827
18 Granada;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;2.756
18 Granada;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
18 Granada;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
18 Granada;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
18 Granada;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
18 Granada;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,49
18 Granada;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;585
18 Granada;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;564
18 Granada;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
18 Granada;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
18 Granada;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
18 Granada;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
18 Granada;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;96,41
18 Granada;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;2.242
18 Granada;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;2.192
18 Granada;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
18 Granada;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
18 Granada;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
18 Granada;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
18 Granada;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;97,77
18 Granada;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
18 Granada;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
18 Granada;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
18 Granada;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
18 Granada;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
18 Granada;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
18 Granada;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
18 Granada;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
18 Granada;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
18 Granada;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
18 Granada;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
18 Granada;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
18 Granada;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
18 Granada;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
18 Granada;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
18 Granada;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
18 Granada;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
18 Granada;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
18 Granada;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
18 Granada;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
18 Granada;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
18 Granada;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
18 Granada;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
18 Granada;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
18 Granada;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
18 Granada;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
18 Granada;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;100
18 Granada;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;100
18 Granada;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
18 Granada;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
18 Granada;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
18 Granada;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
18 Granada;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
18 Granada;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
18 Granada;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
18 Granada;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
18 Granada;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;12
18 Granada;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
18 Granada;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;12
18 Granada;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;12
18 Granada;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
18 Granada;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
18 Granada;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
18 Granada;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
18 Granada;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
18 Granada;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
18 Granada;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
18 Granada;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
18 Granada;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;88
18 Granada;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
18 Granada;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;88
18 Granada;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;88
18 Granada;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
18 Granada;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
18 Granada;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
18 Granada;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
18 Granada;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
18 Granada;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
18 Granada;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
18 Granada;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
18 Granada;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;108
18 Granada;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;107
18 Granada;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
18 Granada;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
18 Granada;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
18 Granada;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
18 Granada;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;99,07
18 Granada;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
18 Granada;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
18 Granada;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
18 Granada;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
18 Granada;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
18 Granada;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;9
18 Granada;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;9
18 Granada;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
18 Granada;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
18 Granada;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
18 Granada;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
18 Granada;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
18 Granada;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
18 Granada;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
18 Granada;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
18 Granada;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
18 Granada;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
18 Granada;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;99
18 Granada;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;98
18 Granada;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
18 Granada;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
18 Granada;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
18 Granada;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
18 Granada;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,99
18 Granada;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
18 Granada;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
18 Granada;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
18 Granada;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
18 Granada;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
18 Granada;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
18 Granada;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
18 Granada;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
18 Granada;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
18 Granada;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
18 Granada;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
18 Granada;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
18 Granada;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
18 Granada;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
18 Granada;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
18 Granada;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
18 Granada;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
18 Granada;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
18 Granada;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
18 Granada;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
18 Granada;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
18 Granada;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
18 Granada;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
18 Granada;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
18 Granada;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
18 Granada;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
18 Granada;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
18 Granada;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
18 Granada;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
18 Granada;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
18 Granada;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
18 Granada;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
18 Granada;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
18 Granada;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
18 Granada;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
18 Granada;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
18 Granada;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
18 Granada;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
18 Granada;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
18 Granada;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
18 Granada;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
18 Granada;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
18 Granada;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
18 Granada;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
18 Granada;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
18 Granada;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
18 Granada;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
18 Granada;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
18 Granada;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
18 Granada;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
18 Granada;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
18 Granada;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
18 Granada;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
18 Granada;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
18 Granada;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
18 Granada;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
18 Granada;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
18 Granada;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
18 Granada;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
18 Granada;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
18 Granada;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
18 Granada;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
18 Granada;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
18 Granada;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
18 Granada;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
18 Granada;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;48
18 Granada;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
18 Granada;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;47
18 Granada;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;47
18 Granada;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
18 Granada;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
18 Granada;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;97,92
18 Granada;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,92
18 Granada;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;6
18 Granada;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
18 Granada;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;5
18 Granada;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;5
18 Granada;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
18 Granada;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
18 Granada;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;83,33
18 Granada;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;83,33
18 Granada;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;42
18 Granada;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
18 Granada;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;42
18 Granada;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;42
18 Granada;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
18 Granada;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
18 Granada;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
18 Granada;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
18 Granada;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;53
18 Granada;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;53
18 Granada;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
18 Granada;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
18 Granada;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
18 Granada;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
18 Granada;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
18 Granada;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1
18 Granada;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1
18 Granada;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
18 Granada;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
18 Granada;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
18 Granada;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
18 Granada;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
18 Granada;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;52
18 Granada;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;52
18 Granada;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
18 Granada;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
18 Granada;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
18 Granada;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
18 Granada;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
18 Granada;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
18 Granada;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
18 Granada;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
18 Granada;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
18 Granada;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
18 Granada;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
18 Granada;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
18 Granada;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
18 Granada;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
18 Granada;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
18 Granada;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
18 Granada;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
18 Granada;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
18 Granada;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
18 Granada;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
18 Granada;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
18 Granada;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
18 Granada;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
18 Granada;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
18 Granada;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
18 Granada;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
18 Granada;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
18 Granada;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
18 Granada;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
18 Granada;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
18 Granada;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
18 Granada;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
18 Granada;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
18 Granada;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
18 Granada;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
18 Granada;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
18 Granada;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
18 Granada;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
18 Granada;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
18 Granada;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
18 Granada;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
18 Granada;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;4.816
19 Guadalajara;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
19 Guadalajara;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;4.536
19 Guadalajara;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;4.304
19 Guadalajara;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
19 Guadalajara;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
19 Guadalajara;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,19
19 Guadalajara;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;89,37
19 Guadalajara;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1.663
19 Guadalajara;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
19 Guadalajara;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1.508
19 Guadalajara;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.375
19 Guadalajara;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
19 Guadalajara;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
19 Guadalajara;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;90,68
19 Guadalajara;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;82,68
19 Guadalajara;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;3.153
19 Guadalajara;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
19 Guadalajara;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;3.028
19 Guadalajara;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;2.929
19 Guadalajara;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
19 Guadalajara;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
19 Guadalajara;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,04
19 Guadalajara;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;92,9
19 Guadalajara;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;4.863
19 Guadalajara;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;4.556
19 Guadalajara;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
19 Guadalajara;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
19 Guadalajara;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
19 Guadalajara;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
19 Guadalajara;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,69
19 Guadalajara;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1.579
19 Guadalajara;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.397
19 Guadalajara;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
19 Guadalajara;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
19 Guadalajara;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
19 Guadalajara;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
19 Guadalajara;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;88,47
19 Guadalajara;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;3.284
19 Guadalajara;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;3.159
19 Guadalajara;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
19 Guadalajara;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
19 Guadalajara;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
19 Guadalajara;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
19 Guadalajara;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,19
19 Guadalajara;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
19 Guadalajara;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
19 Guadalajara;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
19 Guadalajara;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
19 Guadalajara;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
19 Guadalajara;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
19 Guadalajara;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
19 Guadalajara;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
19 Guadalajara;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
19 Guadalajara;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
19 Guadalajara;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
19 Guadalajara;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
19 Guadalajara;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
19 Guadalajara;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
19 Guadalajara;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
19 Guadalajara;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
19 Guadalajara;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
19 Guadalajara;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
19 Guadalajara;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
19 Guadalajara;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
19 Guadalajara;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
19 Guadalajara;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
19 Guadalajara;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
19 Guadalajara;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
19 Guadalajara;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;3.606
19 Guadalajara;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;3.346
19 Guadalajara;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;3.144
19 Guadalajara;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
19 Guadalajara;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;92,79
19 Guadalajara;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;87,19
19 Guadalajara;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1.379
19 Guadalajara;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1.233
19 Guadalajara;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.115
19 Guadalajara;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
19 Guadalajara;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;89,41
19 Guadalajara;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;80,86
19 Guadalajara;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;2.227
19 Guadalajara;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;2.113
19 Guadalajara;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;2.029
19 Guadalajara;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
19 Guadalajara;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;94,88
19 Guadalajara;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;91,11
19 Guadalajara;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;3.634
19 Guadalajara;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;3.370
19 Guadalajara;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
19 Guadalajara;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;92,74
19 Guadalajara;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1.322
19 Guadalajara;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.168
19 Guadalajara;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
19 Guadalajara;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;88,35
19 Guadalajara;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;2.312
19 Guadalajara;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;2.202
19 Guadalajara;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
19 Guadalajara;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,24
19 Guadalajara;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;552
19 Guadalajara;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;539
19 Guadalajara;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;518
19 Guadalajara;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
19 Guadalajara;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;97,64
19 Guadalajara;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;93,84
19 Guadalajara;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;146
19 Guadalajara;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;139
19 Guadalajara;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;130
19 Guadalajara;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
19 Guadalajara;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;95,21
19 Guadalajara;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;89,04
19 Guadalajara;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;406
19 Guadalajara;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;400
19 Guadalajara;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;388
19 Guadalajara;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
19 Guadalajara;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,52
19 Guadalajara;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;95,57
19 Guadalajara;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;548
19 Guadalajara;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;527
19 Guadalajara;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
19 Guadalajara;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;96,17
19 Guadalajara;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;125
19 Guadalajara;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;117
19 Guadalajara;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
19 Guadalajara;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;93,6
19 Guadalajara;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;423
19 Guadalajara;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;410
19 Guadalajara;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
19 Guadalajara;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,93
19 Guadalajara;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;602
19 Guadalajara;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;595
19 Guadalajara;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;586
19 Guadalajara;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
19 Guadalajara;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,84
19 Guadalajara;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,34
19 Guadalajara;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;131
19 Guadalajara;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;129
19 Guadalajara;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;123
19 Guadalajara;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
19 Guadalajara;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,47
19 Guadalajara;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;93,89
19 Guadalajara;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;471
19 Guadalajara;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;466
19 Guadalajara;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;463
19 Guadalajara;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
19 Guadalajara;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,94
19 Guadalajara;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,3
19 Guadalajara;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;619
19 Guadalajara;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;603
19 Guadalajara;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
19 Guadalajara;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,42
19 Guadalajara;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;122
19 Guadalajara;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;108
19 Guadalajara;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
19 Guadalajara;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;88,52
19 Guadalajara;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;497
19 Guadalajara;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;495
19 Guadalajara;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
19 Guadalajara;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,6
19 Guadalajara;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;35
19 Guadalajara;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;35
19 Guadalajara;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;35
19 Guadalajara;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
19 Guadalajara;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
19 Guadalajara;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
19 Guadalajara;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;6
19 Guadalajara;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;6
19 Guadalajara;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;6
19 Guadalajara;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
19 Guadalajara;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
19 Guadalajara;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
19 Guadalajara;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;29
19 Guadalajara;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;29
19 Guadalajara;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;29
19 Guadalajara;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
19 Guadalajara;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
19 Guadalajara;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
19 Guadalajara;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;39
19 Guadalajara;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;34
19 Guadalajara;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
19 Guadalajara;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;87,18
19 Guadalajara;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;8
19 Guadalajara;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;3
19 Guadalajara;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
19 Guadalajara;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;37,5
19 Guadalajara;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;31
19 Guadalajara;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;31
19 Guadalajara;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
19 Guadalajara;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
19 Guadalajara;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;21
19 Guadalajara;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;21
19 Guadalajara;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;21
19 Guadalajara;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
19 Guadalajara;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
19 Guadalajara;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
19 Guadalajara;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1
19 Guadalajara;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1
19 Guadalajara;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1
19 Guadalajara;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
19 Guadalajara;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
19 Guadalajara;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
19 Guadalajara;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;20
19 Guadalajara;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;20
19 Guadalajara;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;20
19 Guadalajara;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
19 Guadalajara;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
19 Guadalajara;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
19 Guadalajara;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;23
19 Guadalajara;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;22
19 Guadalajara;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
19 Guadalajara;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,65
19 Guadalajara;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;2
19 Guadalajara;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1
19 Guadalajara;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
19 Guadalajara;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;50
19 Guadalajara;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;21
19 Guadalajara;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;21
19 Guadalajara;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
19 Guadalajara;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
19 Guadalajara;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;10.251
21 Huelva;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
21 Huelva;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;9.629
21 Huelva;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;9.195
21 Huelva;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
21 Huelva;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
21 Huelva;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,93
21 Huelva;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;89,7
21 Huelva;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;3.520
21 Huelva;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
21 Huelva;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;3.204
21 Huelva;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;2.987
21 Huelva;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
21 Huelva;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
21 Huelva;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,02
21 Huelva;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;84,86
21 Huelva;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;6.731
21 Huelva;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
21 Huelva;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;6.425
21 Huelva;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;6.208
21 Huelva;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
21 Huelva;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
21 Huelva;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,45
21 Huelva;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;92,23
21 Huelva;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;10.526
21 Huelva;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;9.914
21 Huelva;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
21 Huelva;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
21 Huelva;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
21 Huelva;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
21 Huelva;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,19
21 Huelva;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
21 Huelva;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;3.361
21 Huelva;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;3.060
21 Huelva;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
21 Huelva;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
21 Huelva;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
21 Huelva;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
21 Huelva;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,04
21 Huelva;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
21 Huelva;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;7.165
21 Huelva;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;6.854
21 Huelva;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
21 Huelva;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
21 Huelva;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
21 Huelva;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
21 Huelva;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,66
21 Huelva;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
21 Huelva;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
21 Huelva;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
21 Huelva;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
21 Huelva;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
21 Huelva;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
21 Huelva;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
21 Huelva;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
21 Huelva;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
21 Huelva;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
21 Huelva;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
21 Huelva;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
21 Huelva;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
21 Huelva;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
21 Huelva;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
21 Huelva;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
21 Huelva;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
21 Huelva;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
21 Huelva;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
21 Huelva;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
21 Huelva;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
21 Huelva;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
21 Huelva;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
21 Huelva;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
21 Huelva;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
21 Huelva;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
21 Huelva;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
21 Huelva;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
21 Huelva;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
21 Huelva;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
21 Huelva;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
21 Huelva;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;7.824
21 Huelva;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;7.251
21 Huelva;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;6.867
21 Huelva;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
21 Huelva;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;92,68
21 Huelva;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;87,77
21 Huelva;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;2.955
21 Huelva;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;2.656
21 Huelva;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;2.460
21 Huelva;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
21 Huelva;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;89,88
21 Huelva;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;83,25
21 Huelva;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;4.869
21 Huelva;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;4.595
21 Huelva;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;4.407
21 Huelva;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
21 Huelva;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;94,37
21 Huelva;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;90,51
21 Huelva;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;7.925
21 Huelva;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;7.369
21 Huelva;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
21 Huelva;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;92,98
21 Huelva;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;2.785
21 Huelva;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;2.511
21 Huelva;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
21 Huelva;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,16
21 Huelva;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;5.140
21 Huelva;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;4.858
21 Huelva;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
21 Huelva;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;94,51
21 Huelva;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.142
21 Huelva;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.114
21 Huelva;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.078
21 Huelva;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
21 Huelva;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;97,55
21 Huelva;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;94,4
21 Huelva;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;309
21 Huelva;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;298
21 Huelva;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;282
21 Huelva;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
21 Huelva;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;96,44
21 Huelva;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;91,26
21 Huelva;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;833
21 Huelva;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;816
21 Huelva;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;796
21 Huelva;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
21 Huelva;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;97,96
21 Huelva;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;95,56
21 Huelva;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.235
21 Huelva;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.194
21 Huelva;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
21 Huelva;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;96,68
21 Huelva;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;320
21 Huelva;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;301
21 Huelva;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
21 Huelva;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;94,06
21 Huelva;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;915
21 Huelva;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;893
21 Huelva;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
21 Huelva;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;97,6
21 Huelva;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.208
21 Huelva;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.190
21 Huelva;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.176
21 Huelva;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
21 Huelva;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,51
21 Huelva;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,35
21 Huelva;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;240
21 Huelva;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;234
21 Huelva;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;229
21 Huelva;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
21 Huelva;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,5
21 Huelva;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;95,42
21 Huelva;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;968
21 Huelva;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;956
21 Huelva;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;947
21 Huelva;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
21 Huelva;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,76
21 Huelva;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,83
21 Huelva;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.280
21 Huelva;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.265
21 Huelva;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
21 Huelva;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,83
21 Huelva;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;238
21 Huelva;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;230
21 Huelva;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
21 Huelva;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;96,64
21 Huelva;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.042
21 Huelva;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.035
21 Huelva;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
21 Huelva;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,33
21 Huelva;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;51
21 Huelva;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;49
21 Huelva;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;49
21 Huelva;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
21 Huelva;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;96,08
21 Huelva;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,08
21 Huelva;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
21 Huelva;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
21 Huelva;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
21 Huelva;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;12
21 Huelva;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;12
21 Huelva;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;12
21 Huelva;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
21 Huelva;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
21 Huelva;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
21 Huelva;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
21 Huelva;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
21 Huelva;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
21 Huelva;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;39
21 Huelva;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;37
21 Huelva;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;37
21 Huelva;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
21 Huelva;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;94,87
21 Huelva;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;94,87
21 Huelva;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
21 Huelva;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
21 Huelva;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
21 Huelva;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;58
21 Huelva;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;58
21 Huelva;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
21 Huelva;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
21 Huelva;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
21 Huelva;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
21 Huelva;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
21 Huelva;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
21 Huelva;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;14
21 Huelva;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;14
21 Huelva;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
21 Huelva;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
21 Huelva;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
21 Huelva;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
21 Huelva;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
21 Huelva;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
21 Huelva;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;44
21 Huelva;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;44
21 Huelva;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
21 Huelva;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
21 Huelva;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
21 Huelva;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
21 Huelva;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
21 Huelva;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
21 Huelva;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
21 Huelva;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
21 Huelva;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
21 Huelva;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
21 Huelva;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
21 Huelva;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
21 Huelva;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
21 Huelva;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
21 Huelva;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
21 Huelva;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
21 Huelva;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
21 Huelva;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
21 Huelva;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
21 Huelva;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
21 Huelva;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
21 Huelva;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
21 Huelva;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
21 Huelva;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
21 Huelva;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
21 Huelva;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
21 Huelva;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
21 Huelva;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
21 Huelva;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
21 Huelva;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
21 Huelva;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;26
21 Huelva;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;25
21 Huelva;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;25
21 Huelva;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
21 Huelva;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;96,15
21 Huelva;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,15
21 Huelva;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;4
21 Huelva;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;4
21 Huelva;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;4
21 Huelva;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
21 Huelva;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
21 Huelva;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
21 Huelva;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;22
21 Huelva;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;21
21 Huelva;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;21
21 Huelva;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
21 Huelva;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,45
21 Huelva;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;95,45
21 Huelva;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;28
21 Huelva;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;28
21 Huelva;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
21 Huelva;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
21 Huelva;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;4
21 Huelva;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;4
21 Huelva;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
21 Huelva;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
21 Huelva;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;24
21 Huelva;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;24
21 Huelva;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
21 Huelva;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
21 Huelva;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
21 Huelva;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
21 Huelva;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
21 Huelva;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
21 Huelva;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
21 Huelva;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
21 Huelva;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;6.304
22 Huesca;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
22 Huesca;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;6.002
22 Huesca;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;5.696
22 Huesca;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
22 Huesca;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
22 Huesca;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;95,21
22 Huesca;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;90,36
22 Huesca;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1.649
22 Huesca;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
22 Huesca;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1.514
22 Huesca;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.398
22 Huesca;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
22 Huesca;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
22 Huesca;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,81
22 Huesca;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;84,78
22 Huesca;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;4.655
22 Huesca;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
22 Huesca;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;4.488
22 Huesca;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;4.298
22 Huesca;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
22 Huesca;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
22 Huesca;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,41
22 Huesca;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;92,33
22 Huesca;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;6.348
22 Huesca;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;5.981
22 Huesca;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
22 Huesca;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
22 Huesca;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
22 Huesca;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
22 Huesca;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,22
22 Huesca;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
22 Huesca;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1.555
22 Huesca;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.404
22 Huesca;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
22 Huesca;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
22 Huesca;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
22 Huesca;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
22 Huesca;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,29
22 Huesca;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
22 Huesca;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;4.793
22 Huesca;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;4.577
22 Huesca;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
22 Huesca;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
22 Huesca;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
22 Huesca;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
22 Huesca;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,49
22 Huesca;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
22 Huesca;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
22 Huesca;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
22 Huesca;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
22 Huesca;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
22 Huesca;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
22 Huesca;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
22 Huesca;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
22 Huesca;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
22 Huesca;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
22 Huesca;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
22 Huesca;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
22 Huesca;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
22 Huesca;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
22 Huesca;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
22 Huesca;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
22 Huesca;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
22 Huesca;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
22 Huesca;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
22 Huesca;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
22 Huesca;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
22 Huesca;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
22 Huesca;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
22 Huesca;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
22 Huesca;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
22 Huesca;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
22 Huesca;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
22 Huesca;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
22 Huesca;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
22 Huesca;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
22 Huesca;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
22 Huesca;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;4.552
22 Huesca;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;4.266
22 Huesca;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;4.013
22 Huesca;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
22 Huesca;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,72
22 Huesca;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;88,16
22 Huesca;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1.360
22 Huesca;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1.229
22 Huesca;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.126
22 Huesca;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
22 Huesca;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;90,37
22 Huesca;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;82,79
22 Huesca;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;3.192
22 Huesca;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;3.037
22 Huesca;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;2.887
22 Huesca;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
22 Huesca;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,14
22 Huesca;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;90,44
22 Huesca;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;4.543
22 Huesca;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;4.241
22 Huesca;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
22 Huesca;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,35
22 Huesca;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1.279
22 Huesca;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.152
22 Huesca;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
22 Huesca;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,07
22 Huesca;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;3.264
22 Huesca;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;3.089
22 Huesca;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
22 Huesca;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;94,64
22 Huesca;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;720
22 Huesca;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;713
22 Huesca;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;684
22 Huesca;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
22 Huesca;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,03
22 Huesca;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;95
22 Huesca;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;124
22 Huesca;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;121
22 Huesca;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;114
22 Huesca;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
22 Huesca;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,58
22 Huesca;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;91,94
22 Huesca;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;596
22 Huesca;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;592
22 Huesca;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;570
22 Huesca;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
22 Huesca;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,33
22 Huesca;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;95,64
22 Huesca;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;734
22 Huesca;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;699
22 Huesca;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
22 Huesca;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,23
22 Huesca;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;121
22 Huesca;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;112
22 Huesca;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
22 Huesca;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;92,56
22 Huesca;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;613
22 Huesca;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;587
22 Huesca;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
22 Huesca;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,76
22 Huesca;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;980
22 Huesca;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;971
22 Huesca;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;948
22 Huesca;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
22 Huesca;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,08
22 Huesca;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,73
22 Huesca;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;155
22 Huesca;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;154
22 Huesca;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;148
22 Huesca;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
22 Huesca;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;99,35
22 Huesca;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;95,48
22 Huesca;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;825
22 Huesca;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;817
22 Huesca;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;800
22 Huesca;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
22 Huesca;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,03
22 Huesca;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,97
22 Huesca;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.015
22 Huesca;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;987
22 Huesca;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
22 Huesca;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,24
22 Huesca;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;146
22 Huesca;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;132
22 Huesca;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
22 Huesca;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,41
22 Huesca;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;869
22 Huesca;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;855
22 Huesca;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
22 Huesca;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,39
22 Huesca;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;39
22 Huesca;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;39
22 Huesca;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;38
22 Huesca;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
22 Huesca;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
22 Huesca;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,44
22 Huesca;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
22 Huesca;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
22 Huesca;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
22 Huesca;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;7
22 Huesca;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;7
22 Huesca;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;7
22 Huesca;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
22 Huesca;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
22 Huesca;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
22 Huesca;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
22 Huesca;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
22 Huesca;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
22 Huesca;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;32
22 Huesca;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;32
22 Huesca;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;31
22 Huesca;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
22 Huesca;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
22 Huesca;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,88
22 Huesca;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
22 Huesca;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
22 Huesca;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
22 Huesca;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;44
22 Huesca;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;42
22 Huesca;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
22 Huesca;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,45
22 Huesca;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
22 Huesca;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
22 Huesca;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
22 Huesca;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
22 Huesca;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;7
22 Huesca;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;6
22 Huesca;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
22 Huesca;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;85,71
22 Huesca;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
22 Huesca;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
22 Huesca;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
22 Huesca;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
22 Huesca;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;37
22 Huesca;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;36
22 Huesca;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
22 Huesca;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;97,3
22 Huesca;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
22 Huesca;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
22 Huesca;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
22 Huesca;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
22 Huesca;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
22 Huesca;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
22 Huesca;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
22 Huesca;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
22 Huesca;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
22 Huesca;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
22 Huesca;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
22 Huesca;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
22 Huesca;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
22 Huesca;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
22 Huesca;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
22 Huesca;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
22 Huesca;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
22 Huesca;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
22 Huesca;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
22 Huesca;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
22 Huesca;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
22 Huesca;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
22 Huesca;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
22 Huesca;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
22 Huesca;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
22 Huesca;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
22 Huesca;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
22 Huesca;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
22 Huesca;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;13
22 Huesca;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;13
22 Huesca;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;13
22 Huesca;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
22 Huesca;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
22 Huesca;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
22 Huesca;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;3
22 Huesca;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;3
22 Huesca;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;3
22 Huesca;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
22 Huesca;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
22 Huesca;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
22 Huesca;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;10
22 Huesca;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;10
22 Huesca;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;10
22 Huesca;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
22 Huesca;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
22 Huesca;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
22 Huesca;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;12
22 Huesca;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;12
22 Huesca;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
22 Huesca;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
22 Huesca;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;2
22 Huesca;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;2
22 Huesca;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
22 Huesca;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
22 Huesca;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;10
22 Huesca;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;10
22 Huesca;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
22 Huesca;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
22 Huesca;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
22 Huesca;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
22 Huesca;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
22 Huesca;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
22 Huesca;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
22 Huesca;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
22 Huesca;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;12.895
23 Jaén;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
23 Jaén;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;12.173
23 Jaén;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;11.618
23 Jaén;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
23 Jaén;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
23 Jaén;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,4
23 Jaén;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;90,1
23 Jaén;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;4.023
23 Jaén;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
23 Jaén;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;3.687
23 Jaén;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;3.430
23 Jaén;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
23 Jaén;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
23 Jaén;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,65
23 Jaén;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;85,26
23 Jaén;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;8.872
23 Jaén;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
23 Jaén;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;8.486
23 Jaén;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;8.188
23 Jaén;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
23 Jaén;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
23 Jaén;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,65
23 Jaén;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;92,29
23 Jaén;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;13.125
23 Jaén;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;12.382
23 Jaén;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
23 Jaén;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
23 Jaén;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
23 Jaén;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
23 Jaén;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,34
23 Jaén;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
23 Jaén;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;3.752
23 Jaén;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;3.414
23 Jaén;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
23 Jaén;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
23 Jaén;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
23 Jaén;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
23 Jaén;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,99
23 Jaén;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
23 Jaén;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;9.373
23 Jaén;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;8.968
23 Jaén;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
23 Jaén;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
23 Jaén;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
23 Jaén;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
23 Jaén;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,68
23 Jaén;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
23 Jaén;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
23 Jaén;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
23 Jaén;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
23 Jaén;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
23 Jaén;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
23 Jaén;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
23 Jaén;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
23 Jaén;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
23 Jaén;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
23 Jaén;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
23 Jaén;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
23 Jaén;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
23 Jaén;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
23 Jaén;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
23 Jaén;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
23 Jaén;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
23 Jaén;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
23 Jaén;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
23 Jaén;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
23 Jaén;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
23 Jaén;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
23 Jaén;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
23 Jaén;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
23 Jaén;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
23 Jaén;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
23 Jaén;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
23 Jaén;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
23 Jaén;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
23 Jaén;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
23 Jaén;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
23 Jaén;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;9.925
23 Jaén;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;9.242
23 Jaén;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;8.732
23 Jaén;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
23 Jaén;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,12
23 Jaén;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;87,98
23 Jaén;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;3.430
23 Jaén;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;3.109
23 Jaén;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;2.861
23 Jaén;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
23 Jaén;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;90,64
23 Jaén;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;83,41
23 Jaén;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;6.495
23 Jaén;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;6.133
23 Jaén;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;5.871
23 Jaén;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
23 Jaén;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;94,43
23 Jaén;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;90,39
23 Jaén;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;10.120
23 Jaén;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;9.426
23 Jaén;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
23 Jaén;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,14
23 Jaén;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;3.187
23 Jaén;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;2.863
23 Jaén;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
23 Jaén;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;89,83
23 Jaén;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;6.933
23 Jaén;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;6.563
23 Jaén;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
23 Jaén;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;94,66
23 Jaén;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.346
23 Jaén;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.326
23 Jaén;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.294
23 Jaén;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
23 Jaén;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,51
23 Jaén;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,14
23 Jaén;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;306
23 Jaén;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;298
23 Jaén;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;290
23 Jaén;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
23 Jaén;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,39
23 Jaén;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;94,77
23 Jaén;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.040
23 Jaén;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.028
23 Jaén;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.004
23 Jaén;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
23 Jaén;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,85
23 Jaén;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,54
23 Jaén;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.376
23 Jaén;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.340
23 Jaén;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
23 Jaén;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,38
23 Jaén;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;298
23 Jaén;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;288
23 Jaén;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
23 Jaén;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;96,64
23 Jaén;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.078
23 Jaén;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.052
23 Jaén;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
23 Jaén;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;97,59
23 Jaén;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.554
23 Jaén;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.535
23 Jaén;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.522
23 Jaén;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
23 Jaén;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,78
23 Jaén;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,94
23 Jaén;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;275
23 Jaén;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;268
23 Jaén;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;267
23 Jaén;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
23 Jaén;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,45
23 Jaén;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;97,09
23 Jaén;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.279
23 Jaén;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.267
23 Jaén;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.255
23 Jaén;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
23 Jaén;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,06
23 Jaén;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,12
23 Jaén;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.553
23 Jaén;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.540
23 Jaén;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
23 Jaén;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;99,16
23 Jaén;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;258
23 Jaén;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;254
23 Jaén;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
23 Jaén;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;98,45
23 Jaén;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.295
23 Jaén;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.286
23 Jaén;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
23 Jaén;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,31
23 Jaén;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;43
23 Jaén;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;43
23 Jaén;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;43
23 Jaén;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
23 Jaén;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
23 Jaén;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
23 Jaén;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
23 Jaén;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
23 Jaén;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
23 Jaén;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;6
23 Jaén;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;6
23 Jaén;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;6
23 Jaén;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
23 Jaén;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
23 Jaén;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
23 Jaén;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
23 Jaén;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
23 Jaén;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
23 Jaén;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;37
23 Jaén;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;37
23 Jaén;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;37
23 Jaén;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
23 Jaén;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
23 Jaén;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
23 Jaén;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
23 Jaén;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
23 Jaén;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
23 Jaén;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;48
23 Jaén;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;48
23 Jaén;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
23 Jaén;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
23 Jaén;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
23 Jaén;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
23 Jaén;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
23 Jaén;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
23 Jaén;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;5
23 Jaén;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;5
23 Jaén;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
23 Jaén;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
23 Jaén;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
23 Jaén;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
23 Jaén;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
23 Jaén;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
23 Jaén;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;43
23 Jaén;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;43
23 Jaén;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
23 Jaén;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
23 Jaén;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
23 Jaén;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
23 Jaén;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
23 Jaén;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
23 Jaén;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
23 Jaén;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
23 Jaén;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
23 Jaén;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
23 Jaén;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
23 Jaén;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
23 Jaén;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
23 Jaén;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
23 Jaén;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
23 Jaén;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
23 Jaén;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
23 Jaén;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
23 Jaén;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
23 Jaén;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
23 Jaén;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
23 Jaén;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
23 Jaén;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
23 Jaén;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
23 Jaén;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
23 Jaén;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
23 Jaén;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
23 Jaén;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
23 Jaén;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
23 Jaén;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
23 Jaén;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;27
23 Jaén;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;27
23 Jaén;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;27
23 Jaén;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
23 Jaén;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
23 Jaén;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
23 Jaén;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;6
23 Jaén;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;6
23 Jaén;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;6
23 Jaén;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
23 Jaén;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
23 Jaén;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
23 Jaén;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;21
23 Jaén;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;21
23 Jaén;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;21
23 Jaén;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
23 Jaén;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
23 Jaén;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
23 Jaén;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;28
23 Jaén;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;28
23 Jaén;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
23 Jaén;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
23 Jaén;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;4
23 Jaén;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;4
23 Jaén;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
23 Jaén;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
23 Jaén;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;24
23 Jaén;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;24
23 Jaén;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
23 Jaén;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
23 Jaén;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
23 Jaén;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
23 Jaén;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
23 Jaén;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
23 Jaén;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
23 Jaén;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
23 Jaén;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
24 León;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
24 León;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;10.033
24 León;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
24 León;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;9.536
24 León;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;9.141
24 León;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
24 León;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
24 León;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
24 León;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
24 León;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
24 León;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
24 León;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
24 León;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
24 León;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;95,05
24 León;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;91,11
24 León;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
24 León;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
24 León;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
24 León;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
24 León;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
24 León;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;2.719
24 León;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
24 León;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;2.491
24 León;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;2.311
24 León;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
24 León;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
24 León;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
24 León;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
24 León;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
24 León;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
24 León;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
24 León;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,61
24 León;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;84,99
24 León;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
24 León;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
24 León;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
24 León;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
24 León;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
24 León;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;7.314
24 León;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
24 León;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;7.045
24 León;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;6.830
24 León;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
24 León;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
24 León;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
24 León;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,32
24 León;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;93,38
24 León;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
24 León;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
24 León;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
24 León;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
24 León;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
24 León;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;10.017
24 León;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
24 León;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;9.516
24 León;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
24 León;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
24 León;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
24 León;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
24 León;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
24 León;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
24 León;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
24 León;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
24 León;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
24 León;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95
24 León;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
24 León;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
24 León;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
24 León;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
24 León;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
24 León;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
24 León;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
24 León;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;2.532
24 León;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;2.288
24 León;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
24 León;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
24 León;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
24 León;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
24 León;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
24 León;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
24 León;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
24 León;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
24 León;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,36
24 León;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
24 León;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
24 León;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
24 León;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
24 León;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
24 León;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
24 León;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
24 León;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;7.485
24 León;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;7.228
24 León;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
24 León;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
24 León;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
24 León;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
24 León;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,57
24 León;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
24 León;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
24 León;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
24 León;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
24 León;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
24 León;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
24 León;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
24 León;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
24 León;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
24 León;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
24 León;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
24 León;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
24 León;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
24 León;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
24 León;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
24 León;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
24 León;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
24 León;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
24 León;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
24 León;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
24 León;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
24 León;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
24 León;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
24 León;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
24 León;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
24 León;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
24 León;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
24 León;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
24 León;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
24 León;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
24 León;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
24 León;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
24 León;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
24 León;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
24 León;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
24 León;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
24 León;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
24 León;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
24 León;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
24 León;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
24 León;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
24 León;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
24 León;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
24 León;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
24 León;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
24 León;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
24 León;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
24 León;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
24 León;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
24 León;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
24 León;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
24 León;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
24 León;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
24 León;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
24 León;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
24 León;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
24 León;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
24 León;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
24 León;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
24 León;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
24 León;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
24 León;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
24 León;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
24 León;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
24 León;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
24 León;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
24 León;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
24 León;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
24 León;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
24 León;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
24 León;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
24 León;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
24 León;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
24 León;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
24 León;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
24 León;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
24 León;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
24 León;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
24 León;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
24 León;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
24 León;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
24 León;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
24 León;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
24 León;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
24 León;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
24 León;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
24 León;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
24 León;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
24 León;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
24 León;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
24 León;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
24 León;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
24 León;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
24 León;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
24 León;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
24 León;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
24 León;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
24 León;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
24 León;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
24 León;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
24 León;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
24 León;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
24 León;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
24 León;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;7.605
24 León;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
24 León;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;7.138
24 León;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;6.786
24 León;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
24 León;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
24 León;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
24 León;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
24 León;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,86
24 León;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;89,23
24 León;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
24 León;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
24 León;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
24 León;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;2.266
24 León;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
24 León;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;2.047
24 León;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.882
24 León;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
24 León;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
24 León;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
24 León;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;90,34
24 León;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;83,05
24 León;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
24 León;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
24 León;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
24 León;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;5.339
24 León;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
24 León;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;5.091
24 León;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;4.904
24 León;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
24 León;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
24 León;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
24 León;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,35
24 León;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;91,85
24 León;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
24 León;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
24 León;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
24 León;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;7.526
24 León;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
24 León;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;7.081
24 León;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
24 León;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
24 León;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
24 León;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
24 León;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
24 León;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,09
24 León;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
24 León;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
24 León;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
24 León;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
24 León;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
24 León;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;2.093
24 León;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.877
24 León;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
24 León;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
24 León;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
24 León;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
24 León;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;89,68
24 León;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
24 León;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
24 León;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
24 León;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
24 León;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
24 León;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;5.433
24 León;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;5.204
24 León;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
24 León;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
24 León;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
24 León;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
24 León;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,79
24 León;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
24 León;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
24 León;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
24 León;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
24 León;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
24 León;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
24 León;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
24 León;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
24 León;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
24 León;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
24 León;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
24 León;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
24 León;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
24 León;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
24 León;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
24 León;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
24 León;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
24 León;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
24 León;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
24 León;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
24 León;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
24 León;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
24 León;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
24 León;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
24 León;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
24 León;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
24 León;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
24 León;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
24 León;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
24 León;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
24 León;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
24 León;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
24 León;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
24 León;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
24 León;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
24 León;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
24 León;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
24 León;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
24 León;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
24 León;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
24 León;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
24 León;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
24 León;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
24 León;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
24 León;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
24 León;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
24 León;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
24 León;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
24 León;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
24 León;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
24 León;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
24 León;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
24 León;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
24 León;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
24 León;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
24 León;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
24 León;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
24 León;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
24 León;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
24 León;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
24 León;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
24 León;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
24 León;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
24 León;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
24 León;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
24 León;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
24 León;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
24 León;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
24 León;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
24 León;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
24 León;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
24 León;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
24 León;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
24 León;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
24 León;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.036
24 León;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
24 León;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.016
24 León;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;989
24 León;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
24 León;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
24 León;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
24 León;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
24 León;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,07
24 León;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;95,46
24 León;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
24 León;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
24 León;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
24 León;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;205
24 León;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
24 León;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;197
24 León;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;190
24 León;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
24 León;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
24 León;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
24 León;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;96,1
24 León;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;92,68
24 León;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
24 León;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
24 León;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
24 León;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;831
24 León;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
24 León;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;819
24 León;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;799
24 León;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
24 León;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
24 León;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
24 León;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,56
24 León;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,15
24 León;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
24 León;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
24 León;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
24 León;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.057
24 León;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
24 León;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.030
24 León;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
24 León;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
24 León;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
24 León;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
24 León;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
24 León;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,45
24 León;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
24 León;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
24 León;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
24 León;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
24 León;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
24 León;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;215
24 León;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;207
24 León;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
24 León;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
24 León;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
24 León;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
24 León;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;96,28
24 León;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
24 León;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
24 León;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
24 León;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
24 León;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
24 León;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;842
24 León;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;823
24 León;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
24 León;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
24 León;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
24 León;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
24 León;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;97,74
24 León;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
24 León;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
24 León;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
24 León;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
24 León;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
24 León;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
24 León;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
24 León;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
24 León;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
24 León;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
24 León;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
24 León;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
24 León;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
24 León;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
24 León;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
24 León;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
24 León;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
24 León;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
24 León;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
24 León;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
24 León;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
24 León;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
24 León;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
24 León;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
24 León;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
24 León;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
24 León;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
24 León;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
24 León;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
24 León;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
24 León;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
24 León;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
24 León;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
24 León;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
24 León;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
24 León;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
24 León;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
24 León;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
24 León;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
24 León;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
24 León;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
24 León;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
24 León;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
24 León;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
24 León;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
24 León;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
24 León;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
24 León;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
24 León;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
24 León;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
24 León;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
24 León;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
24 León;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
24 León;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
24 León;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
24 León;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
24 León;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
24 León;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
24 León;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
24 León;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
24 León;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
24 León;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
24 León;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
24 León;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
24 León;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
24 León;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
24 León;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
24 León;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
24 León;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
24 León;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
24 León;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
24 León;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
24 León;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
24 León;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
24 León;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.298
24 León;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
24 León;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.289
24 León;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.273
24 León;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
24 León;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
24 León;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
24 León;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
24 León;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,31
24 León;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;98,07
24 León;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
24 León;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
24 León;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
24 León;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;234
24 León;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
24 León;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;233
24 León;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;225
24 León;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
24 León;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
24 León;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
24 León;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;99,57
24 León;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;96,15
24 León;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
24 León;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
24 León;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
24 León;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.064
24 León;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
24 León;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.056
24 León;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.048
24 León;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
24 León;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
24 León;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
24 León;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,25
24 León;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,5
24 León;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
24 León;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
24 León;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
24 León;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.335
24 León;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
24 León;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.312
24 León;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
24 León;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
24 León;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
24 León;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
24 León;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
24 León;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,28
24 León;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
24 León;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
24 León;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
24 León;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
24 León;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
24 León;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;208
24 León;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;194
24 León;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
24 León;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
24 León;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
24 León;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
24 León;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;93,27
24 León;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
24 León;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
24 León;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
24 León;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
24 León;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
24 León;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.127
24 León;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.118
24 León;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
24 León;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
24 León;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
24 León;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
24 León;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,2
24 León;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
24 León;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
24 León;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
24 León;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
24 León;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
24 León;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
24 León;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
24 León;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
24 León;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
24 León;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
24 León;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
24 León;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
24 León;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
24 León;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
24 León;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
24 León;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
24 León;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
24 León;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
24 León;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
24 León;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
24 León;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
24 León;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
24 León;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
24 León;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
24 León;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
24 León;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
24 León;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
24 León;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
24 León;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
24 León;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
24 León;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
24 León;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
24 León;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
24 León;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
24 León;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
24 León;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
24 León;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
24 León;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
24 León;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
24 León;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
24 León;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
24 León;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
24 León;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
24 León;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
24 León;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
24 León;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
24 León;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
24 León;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
24 León;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
24 León;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
24 León;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
24 León;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
24 León;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
24 León;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
24 León;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
24 León;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
24 León;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
24 León;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
24 León;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
24 León;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
24 León;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
24 León;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
24 León;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
24 León;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
24 León;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
24 León;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
24 León;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
24 León;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
24 León;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
24 León;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
24 León;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
24 León;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
24 León;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
24 León;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
24 León;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
24 León;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;67
24 León;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
24 León;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;66
24 León;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;66
24 León;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
24 León;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
24 León;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
24 León;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
24 León;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
24 León;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
24 León;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
24 León;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
24 León;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,51
24 León;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;98,51
24 León;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
24 León;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
24 León;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
24 León;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
24 León;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
24 León;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;8
24 León;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
24 León;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;8
24 León;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;8
24 León;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
24 León;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
24 León;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
24 León;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
24 León;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
24 León;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
24 León;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
24 León;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
24 León;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
24 León;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
24 León;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
24 León;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
24 León;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
24 León;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
24 León;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;59
24 León;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
24 León;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;58
24 León;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;58
24 León;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
24 León;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
24 León;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
24 León;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,31
24 León;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,31
24 León;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
24 León;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
24 León;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
24 León;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
24 León;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
24 León;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;71
24 León;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
24 León;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;66
24 León;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
24 León;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
24 León;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
24 León;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
24 León;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
24 León;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
24 León;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
24 León;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
24 León;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
24 León;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;92,96
24 León;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
24 León;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
24 León;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
24 León;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
24 León;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
24 León;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
24 León;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
24 León;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;11
24 León;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;6
24 León;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
24 León;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
24 León;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
24 León;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
24 León;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
24 León;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
24 León;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
24 León;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
24 León;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;54,55
24 León;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
24 León;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
24 León;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
24 León;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
24 León;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
24 León;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
24 León;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
24 León;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;60
24 León;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;60
24 León;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
24 León;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
24 León;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
24 León;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
24 León;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
24 León;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
24 León;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
24 León;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
24 León;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
24 León;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
24 León;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
24 León;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
24 León;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
24 León;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
24 León;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
24 León;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
24 León;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
24 León;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
24 León;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
24 León;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
24 León;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
24 León;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
24 León;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
24 León;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
24 León;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
24 León;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
24 León;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
24 León;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
24 León;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
24 León;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
24 León;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
24 León;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
24 León;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
24 León;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
24 León;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
24 León;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
24 León;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
24 León;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
24 León;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
24 León;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
24 León;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
24 León;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
24 León;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
24 León;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
24 León;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
24 León;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
24 León;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
24 León;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
24 León;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
24 León;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
24 León;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
24 León;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
24 León;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
24 León;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
24 León;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
24 León;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
24 León;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
24 León;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
24 León;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
24 León;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
24 León;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
24 León;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
24 León;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
24 León;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
24 León;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
24 León;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
24 León;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
24 León;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
24 León;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
24 León;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
24 León;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
24 León;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
24 León;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
24 León;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
24 León;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
24 León;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
24 León;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
24 León;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
24 León;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
24 León;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
24 León;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
24 León;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
24 León;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
24 León;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
24 León;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
24 León;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
24 León;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
24 León;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
24 León;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
24 León;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
24 León;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
24 León;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
24 León;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
24 León;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
24 León;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
24 León;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
24 León;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
24 León;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
24 León;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
24 León;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
24 León;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
24 León;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
24 León;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
24 León;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
24 León;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
24 León;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
24 León;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
24 León;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
24 León;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;27
24 León;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
24 León;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;27
24 León;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;27
24 León;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
24 León;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
24 León;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
24 León;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
24 León;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
24 León;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
24 León;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
24 León;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
24 León;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
24 León;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;6
24 León;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
24 León;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;6
24 León;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;6
24 León;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
24 León;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
24 León;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
24 León;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
24 León;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
24 León;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
24 León;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
24 León;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
24 León;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;21
24 León;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
24 León;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;21
24 León;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;21
24 León;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
24 León;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
24 León;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
24 León;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
24 León;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
24 León;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
24 León;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
24 León;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
24 León;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;28
24 León;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
24 León;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;27
24 León;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
24 León;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
24 León;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
24 León;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
24 León;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
24 León;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;96,43
24 León;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
24 León;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
24 León;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
24 León;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
24 León;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
24 León;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;5
24 León;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;4
24 León;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
24 León;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
24 León;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
24 León;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
24 León;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;80
24 León;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
24 León;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
24 León;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
24 León;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
24 León;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
24 León;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;23
24 León;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;23
24 León;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
24 León;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
24 León;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
24 León;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
24 León;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
24 León;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
24 León;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
24 León;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
24 León;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
24 León;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
24 León;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
24 León;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
24 León;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
24 León;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
24 León;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
24 León;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
24 León;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
24 León;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
24 León;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
24 León;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
24 León;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
24 León;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
24 León;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
24 León;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
24 León;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
24 León;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
24 León;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
24 León;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
24 León;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
24 León;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
24 León;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
24 León;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
24 León;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
24 León;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
24 León;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
24 León;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
24 León;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
24 León;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
24 León;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
24 León;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
24 León;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
24 León;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
24 León;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
24 León;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
24 León;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
24 León;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
24 León;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
24 León;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
24 León;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
24 León;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
24 León;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
24 León;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
24 León;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
24 León;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
24 León;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
24 León;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
24 León;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
24 León;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
24 León;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
24 León;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
24 León;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
24 León;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
24 León;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
24 León;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
24 León;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
24 León;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
24 León;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
24 León;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
24 León;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
24 León;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
24 León;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
24 León;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
24 León;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
24 León;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
24 León;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
24 León;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
24 León;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
24 León;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
24 León;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
24 León;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
24 León;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
24 León;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
24 León;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
24 León;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
24 León;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
24 León;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
24 León;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
24 León;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
24 León;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;11.998
25 Lleida;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
25 Lleida;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;11.397
25 Lleida;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;10.896
25 Lleida;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
25 Lleida;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
25 Lleida;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,99
25 Lleida;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;90,82
25 Lleida;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;3.480
25 Lleida;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
25 Lleida;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;3.191
25 Lleida;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;2.965
25 Lleida;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
25 Lleida;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
25 Lleida;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,7
25 Lleida;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;85,2
25 Lleida;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;8.518
25 Lleida;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
25 Lleida;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;8.206
25 Lleida;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;7.931
25 Lleida;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
25 Lleida;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
25 Lleida;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,34
25 Lleida;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;93,11
25 Lleida;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;11.975
25 Lleida;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;11.394
25 Lleida;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
25 Lleida;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
25 Lleida;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
25 Lleida;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
25 Lleida;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,15
25 Lleida;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
25 Lleida;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;3.244
25 Lleida;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;2.974
25 Lleida;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
25 Lleida;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
25 Lleida;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
25 Lleida;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
25 Lleida;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,68
25 Lleida;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
25 Lleida;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;8.731
25 Lleida;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;8.420
25 Lleida;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
25 Lleida;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
25 Lleida;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
25 Lleida;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
25 Lleida;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,44
25 Lleida;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
25 Lleida;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
25 Lleida;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
25 Lleida;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
25 Lleida;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
25 Lleida;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
25 Lleida;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
25 Lleida;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
25 Lleida;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
25 Lleida;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
25 Lleida;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
25 Lleida;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
25 Lleida;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
25 Lleida;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
25 Lleida;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
25 Lleida;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
25 Lleida;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
25 Lleida;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
25 Lleida;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
25 Lleida;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
25 Lleida;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
25 Lleida;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
25 Lleida;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
25 Lleida;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
25 Lleida;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
25 Lleida;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
25 Lleida;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
25 Lleida;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
25 Lleida;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
25 Lleida;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
25 Lleida;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
25 Lleida;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;8.577
25 Lleida;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;8.014
25 Lleida;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;7.605
25 Lleida;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
25 Lleida;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,44
25 Lleida;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;88,67
25 Lleida;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;2.837
25 Lleida;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;2.557
25 Lleida;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;2.370
25 Lleida;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
25 Lleida;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;90,13
25 Lleida;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;83,54
25 Lleida;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;5.740
25 Lleida;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;5.457
25 Lleida;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;5.235
25 Lleida;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
25 Lleida;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,07
25 Lleida;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;91,2
25 Lleida;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;8.559
25 Lleida;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;8.066
25 Lleida;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
25 Lleida;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,24
25 Lleida;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;2.661
25 Lleida;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;2.430
25 Lleida;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
25 Lleida;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,32
25 Lleida;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;5.898
25 Lleida;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;5.636
25 Lleida;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
25 Lleida;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,56
25 Lleida;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.373
25 Lleida;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.354
25 Lleida;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.305
25 Lleida;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
25 Lleida;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,62
25 Lleida;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;95,05
25 Lleida;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;333
25 Lleida;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;325
25 Lleida;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;304
25 Lleida;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
25 Lleida;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,6
25 Lleida;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;91,29
25 Lleida;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.040
25 Lleida;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.029
25 Lleida;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.001
25 Lleida;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
25 Lleida;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,94
25 Lleida;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,25
25 Lleida;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.342
25 Lleida;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.293
25 Lleida;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
25 Lleida;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;96,35
25 Lleida;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;290
25 Lleida;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;266
25 Lleida;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
25 Lleida;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,72
25 Lleida;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.052
25 Lleida;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.027
25 Lleida;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
25 Lleida;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;97,62
25 Lleida;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.900
25 Lleida;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.882
25 Lleida;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.839
25 Lleida;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
25 Lleida;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,05
25 Lleida;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,79
25 Lleida;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;298
25 Lleida;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;297
25 Lleida;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;279
25 Lleida;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
25 Lleida;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;99,66
25 Lleida;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;93,62
25 Lleida;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.602
25 Lleida;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.585
25 Lleida;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.560
25 Lleida;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
25 Lleida;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,94
25 Lleida;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,38
25 Lleida;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.922
25 Lleida;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.883
25 Lleida;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
25 Lleida;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,97
25 Lleida;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;284
25 Lleida;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;269
25 Lleida;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
25 Lleida;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;94,72
25 Lleida;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.638
25 Lleida;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.614
25 Lleida;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
25 Lleida;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,53
25 Lleida;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;98
25 Lleida;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;97
25 Lleida;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;97
25 Lleida;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
25 Lleida;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,98
25 Lleida;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;98,98
25 Lleida;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
25 Lleida;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
25 Lleida;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
25 Lleida;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;6
25 Lleida;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;6
25 Lleida;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;6
25 Lleida;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
25 Lleida;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
25 Lleida;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
25 Lleida;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
25 Lleida;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
25 Lleida;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
25 Lleida;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;92
25 Lleida;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;91
25 Lleida;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;91
25 Lleida;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
25 Lleida;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,91
25 Lleida;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,91
25 Lleida;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
25 Lleida;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
25 Lleida;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
25 Lleida;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;102
25 Lleida;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;102
25 Lleida;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
25 Lleida;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
25 Lleida;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
25 Lleida;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
25 Lleida;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
25 Lleida;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
25 Lleida;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;5
25 Lleida;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;5
25 Lleida;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
25 Lleida;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
25 Lleida;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
25 Lleida;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
25 Lleida;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
25 Lleida;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
25 Lleida;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;97
25 Lleida;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;97
25 Lleida;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
25 Lleida;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
25 Lleida;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
25 Lleida;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
25 Lleida;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
25 Lleida;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
25 Lleida;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
25 Lleida;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
25 Lleida;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
25 Lleida;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
25 Lleida;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
25 Lleida;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
25 Lleida;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
25 Lleida;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
25 Lleida;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
25 Lleida;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
25 Lleida;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
25 Lleida;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
25 Lleida;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
25 Lleida;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
25 Lleida;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
25 Lleida;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
25 Lleida;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
25 Lleida;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
25 Lleida;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
25 Lleida;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
25 Lleida;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
25 Lleida;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
25 Lleida;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
25 Lleida;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
25 Lleida;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;50
25 Lleida;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;50
25 Lleida;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;50
25 Lleida;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
25 Lleida;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
25 Lleida;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
25 Lleida;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;6
25 Lleida;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;6
25 Lleida;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;6
25 Lleida;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
25 Lleida;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
25 Lleida;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
25 Lleida;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;44
25 Lleida;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;44
25 Lleida;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;44
25 Lleida;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
25 Lleida;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
25 Lleida;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
25 Lleida;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;50
25 Lleida;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;50
25 Lleida;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
25 Lleida;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
25 Lleida;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;4
25 Lleida;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;4
25 Lleida;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
25 Lleida;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
25 Lleida;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;46
25 Lleida;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;46
25 Lleida;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
25 Lleida;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
25 Lleida;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
25 Lleida;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
25 Lleida;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
25 Lleida;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
25 Lleida;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
25 Lleida;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
25 Lleida;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;8.426
27 Lugo;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
27 Lugo;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;8.055
27 Lugo;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;7.717
27 Lugo;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
27 Lugo;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
27 Lugo;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;95,6
27 Lugo;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;91,59
27 Lugo;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;2.242
27 Lugo;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
27 Lugo;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;2.073
27 Lugo;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.943
27 Lugo;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
27 Lugo;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
27 Lugo;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;92,46
27 Lugo;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;86,66
27 Lugo;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;6.184
27 Lugo;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
27 Lugo;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;5.982
27 Lugo;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;5.774
27 Lugo;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
27 Lugo;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
27 Lugo;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,73
27 Lugo;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;93,37
27 Lugo;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;8.515
27 Lugo;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;8.093
27 Lugo;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
27 Lugo;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
27 Lugo;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
27 Lugo;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
27 Lugo;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,04
27 Lugo;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
27 Lugo;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;2.095
27 Lugo;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.920
27 Lugo;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
27 Lugo;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
27 Lugo;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
27 Lugo;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
27 Lugo;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,65
27 Lugo;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
27 Lugo;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;6.420
27 Lugo;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;6.173
27 Lugo;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
27 Lugo;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
27 Lugo;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
27 Lugo;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
27 Lugo;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,15
27 Lugo;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
27 Lugo;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
27 Lugo;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
27 Lugo;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
27 Lugo;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
27 Lugo;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
27 Lugo;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
27 Lugo;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
27 Lugo;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
27 Lugo;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
27 Lugo;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
27 Lugo;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
27 Lugo;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
27 Lugo;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
27 Lugo;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
27 Lugo;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
27 Lugo;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
27 Lugo;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
27 Lugo;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
27 Lugo;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
27 Lugo;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
27 Lugo;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
27 Lugo;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
27 Lugo;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
27 Lugo;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
27 Lugo;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
27 Lugo;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
27 Lugo;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
27 Lugo;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
27 Lugo;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
27 Lugo;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
27 Lugo;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;6.464
27 Lugo;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;6.108
27 Lugo;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;5.811
27 Lugo;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
27 Lugo;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,49
27 Lugo;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;89,9
27 Lugo;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1.918
27 Lugo;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1.751
27 Lugo;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.632
27 Lugo;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
27 Lugo;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,29
27 Lugo;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;85,09
27 Lugo;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;4.546
27 Lugo;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;4.357
27 Lugo;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;4.179
27 Lugo;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
27 Lugo;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,84
27 Lugo;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;91,93
27 Lugo;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;6.437
27 Lugo;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;6.078
27 Lugo;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
27 Lugo;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,42
27 Lugo;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1.759
27 Lugo;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.611
27 Lugo;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
27 Lugo;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,59
27 Lugo;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;4.678
27 Lugo;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;4.467
27 Lugo;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
27 Lugo;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,49
27 Lugo;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;899
27 Lugo;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;894
27 Lugo;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;872
27 Lugo;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
27 Lugo;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,44
27 Lugo;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97
27 Lugo;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;169
27 Lugo;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;169
27 Lugo;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;163
27 Lugo;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
27 Lugo;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
27 Lugo;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;96,45
27 Lugo;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;730
27 Lugo;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;725
27 Lugo;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;709
27 Lugo;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
27 Lugo;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,32
27 Lugo;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,12
27 Lugo;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;962
27 Lugo;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;929
27 Lugo;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
27 Lugo;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;96,57
27 Lugo;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;180
27 Lugo;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;168
27 Lugo;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
27 Lugo;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;93,33
27 Lugo;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;782
27 Lugo;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;761
27 Lugo;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
27 Lugo;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;97,31
27 Lugo;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.021
27 Lugo;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.011
27 Lugo;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;992
27 Lugo;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
27 Lugo;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,02
27 Lugo;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,16
27 Lugo;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;148
27 Lugo;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;146
27 Lugo;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;141
27 Lugo;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
27 Lugo;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,65
27 Lugo;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;95,27
27 Lugo;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;873
27 Lugo;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;865
27 Lugo;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;851
27 Lugo;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
27 Lugo;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,08
27 Lugo;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,48
27 Lugo;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.071
27 Lugo;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.043
27 Lugo;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
27 Lugo;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,39
27 Lugo;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;146
27 Lugo;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;133
27 Lugo;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
27 Lugo;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,1
27 Lugo;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;925
27 Lugo;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;910
27 Lugo;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
27 Lugo;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,38
27 Lugo;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;29
27 Lugo;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;29
27 Lugo;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;29
27 Lugo;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
27 Lugo;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
27 Lugo;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
27 Lugo;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
27 Lugo;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
27 Lugo;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
27 Lugo;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;5
27 Lugo;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;5
27 Lugo;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;5
27 Lugo;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
27 Lugo;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
27 Lugo;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
27 Lugo;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
27 Lugo;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
27 Lugo;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
27 Lugo;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;24
27 Lugo;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;24
27 Lugo;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;24
27 Lugo;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
27 Lugo;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
27 Lugo;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
27 Lugo;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
27 Lugo;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
27 Lugo;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
27 Lugo;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;32
27 Lugo;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;31
27 Lugo;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
27 Lugo;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;96,88
27 Lugo;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
27 Lugo;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
27 Lugo;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
27 Lugo;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
27 Lugo;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;8
27 Lugo;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;7
27 Lugo;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
27 Lugo;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;87,5
27 Lugo;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
27 Lugo;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
27 Lugo;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
27 Lugo;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
27 Lugo;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;24
27 Lugo;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;24
27 Lugo;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
27 Lugo;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
27 Lugo;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
27 Lugo;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
27 Lugo;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
27 Lugo;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
27 Lugo;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
27 Lugo;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
27 Lugo;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
27 Lugo;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
27 Lugo;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
27 Lugo;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
27 Lugo;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
27 Lugo;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
27 Lugo;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
27 Lugo;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
27 Lugo;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
27 Lugo;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
27 Lugo;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
27 Lugo;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
27 Lugo;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
27 Lugo;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
27 Lugo;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
27 Lugo;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
27 Lugo;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
27 Lugo;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
27 Lugo;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
27 Lugo;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
27 Lugo;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
27 Lugo;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
27 Lugo;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;13
27 Lugo;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;13
27 Lugo;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;13
27 Lugo;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
27 Lugo;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
27 Lugo;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
27 Lugo;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;2
27 Lugo;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;2
27 Lugo;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;2
27 Lugo;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
27 Lugo;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
27 Lugo;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
27 Lugo;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;11
27 Lugo;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;11
27 Lugo;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;11
27 Lugo;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
27 Lugo;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
27 Lugo;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
27 Lugo;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;13
27 Lugo;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;12
27 Lugo;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
27 Lugo;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;92,31
27 Lugo;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;2
27 Lugo;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1
27 Lugo;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
27 Lugo;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;50
27 Lugo;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;11
27 Lugo;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;11
27 Lugo;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
27 Lugo;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
27 Lugo;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
27 Lugo;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
27 Lugo;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
27 Lugo;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
27 Lugo;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
27 Lugo;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
27 Lugo;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;179.700
28 Madrid;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
28 Madrid;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;170.096
28 Madrid;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;163.132
28 Madrid;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
28 Madrid;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
28 Madrid;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,66
28 Madrid;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;90,78
28 Madrid;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;70.106
28 Madrid;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
28 Madrid;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;64.545
28 Madrid;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;60.622
28 Madrid;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
28 Madrid;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
28 Madrid;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;92,07
28 Madrid;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;86,47
28 Madrid;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;109.594
28 Madrid;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
28 Madrid;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;105.551
28 Madrid;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;102.510
28 Madrid;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
28 Madrid;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
28 Madrid;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,31
28 Madrid;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;93,54
28 Madrid;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;180.343
28 Madrid;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;171.565
28 Madrid;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
28 Madrid;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
28 Madrid;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
28 Madrid;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
28 Madrid;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,13
28 Madrid;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
28 Madrid;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;65.911
28 Madrid;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;60.906
28 Madrid;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
28 Madrid;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
28 Madrid;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
28 Madrid;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
28 Madrid;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;92,41
28 Madrid;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
28 Madrid;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;114.432
28 Madrid;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;110.659
28 Madrid;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
28 Madrid;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
28 Madrid;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
28 Madrid;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
28 Madrid;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,7
28 Madrid;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
28 Madrid;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
28 Madrid;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
28 Madrid;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
28 Madrid;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
28 Madrid;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
28 Madrid;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
28 Madrid;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
28 Madrid;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
28 Madrid;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
28 Madrid;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
28 Madrid;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
28 Madrid;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
28 Madrid;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
28 Madrid;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
28 Madrid;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
28 Madrid;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
28 Madrid;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
28 Madrid;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
28 Madrid;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
28 Madrid;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
28 Madrid;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
28 Madrid;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
28 Madrid;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
28 Madrid;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
28 Madrid;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
28 Madrid;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
28 Madrid;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
28 Madrid;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
28 Madrid;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
28 Madrid;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
28 Madrid;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;126.010
28 Madrid;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;117.097
28 Madrid;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;110.994
28 Madrid;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
28 Madrid;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;92,93
28 Madrid;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;88,08
28 Madrid;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;54.797
28 Madrid;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;49.540
28 Madrid;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;45.999
28 Madrid;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
28 Madrid;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;90,41
28 Madrid;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;83,94
28 Madrid;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;71.213
28 Madrid;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;67.557
28 Madrid;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;64.995
28 Madrid;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
28 Madrid;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;94,87
28 Madrid;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;91,27
28 Madrid;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;125.836
28 Madrid;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;117.943
28 Madrid;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
28 Madrid;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,73
28 Madrid;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;51.758
28 Madrid;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;47.154
28 Madrid;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
28 Madrid;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,1
28 Madrid;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;74.078
28 Madrid;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;70.789
28 Madrid;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
28 Madrid;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,56
28 Madrid;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;19.721
28 Madrid;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;19.376
28 Madrid;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;18.940
28 Madrid;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
28 Madrid;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,25
28 Madrid;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,04
28 Madrid;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;6.615
28 Madrid;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;6.448
28 Madrid;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;6.240
28 Madrid;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
28 Madrid;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,48
28 Madrid;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;94,33
28 Madrid;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;13.106
28 Madrid;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;12.928
28 Madrid;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;12.700
28 Madrid;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
28 Madrid;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,64
28 Madrid;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,9
28 Madrid;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;19.951
28 Madrid;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;19.552
28 Madrid;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
28 Madrid;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98
28 Madrid;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;6.137
28 Madrid;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;5.971
28 Madrid;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
28 Madrid;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;97,3
28 Madrid;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;13.814
28 Madrid;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;13.581
28 Madrid;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
28 Madrid;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,31
28 Madrid;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;29.757
28 Madrid;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;29.426
28 Madrid;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;29.016
28 Madrid;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
28 Madrid;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,89
28 Madrid;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,51
28 Madrid;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;7.922
28 Madrid;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;7.790
28 Madrid;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;7.623
28 Madrid;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
28 Madrid;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,33
28 Madrid;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;96,23
28 Madrid;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;21.835
28 Madrid;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;21.636
28 Madrid;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;21.393
28 Madrid;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
28 Madrid;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,09
28 Madrid;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,98
28 Madrid;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;30.194
28 Madrid;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;29.762
28 Madrid;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
28 Madrid;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,57
28 Madrid;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;7.324
28 Madrid;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;7.134
28 Madrid;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
28 Madrid;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;97,41
28 Madrid;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;22.870
28 Madrid;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;22.628
28 Madrid;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
28 Madrid;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,94
28 Madrid;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;2.397
28 Madrid;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;2.388
28 Madrid;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;2.380
28 Madrid;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
28 Madrid;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,62
28 Madrid;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;99,29
28 Madrid;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
28 Madrid;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
28 Madrid;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
28 Madrid;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;443
28 Madrid;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;439
28 Madrid;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;436
28 Madrid;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
28 Madrid;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;99,1
28 Madrid;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;98,42
28 Madrid;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
28 Madrid;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
28 Madrid;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
28 Madrid;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.954
28 Madrid;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.949
28 Madrid;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.944
28 Madrid;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
28 Madrid;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,74
28 Madrid;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;99,49
28 Madrid;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
28 Madrid;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
28 Madrid;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
28 Madrid;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;2.470
28 Madrid;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;2.436
28 Madrid;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
28 Madrid;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,62
28 Madrid;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
28 Madrid;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
28 Madrid;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
28 Madrid;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
28 Madrid;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;405
28 Madrid;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;377
28 Madrid;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
28 Madrid;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;93,09
28 Madrid;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
28 Madrid;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
28 Madrid;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
28 Madrid;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
28 Madrid;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;2.065
28 Madrid;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;2.059
28 Madrid;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
28 Madrid;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,71
28 Madrid;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
28 Madrid;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
28 Madrid;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
28 Madrid;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
28 Madrid;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
28 Madrid;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
28 Madrid;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
28 Madrid;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
28 Madrid;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
28 Madrid;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
28 Madrid;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
28 Madrid;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
28 Madrid;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
28 Madrid;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
28 Madrid;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
28 Madrid;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
28 Madrid;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
28 Madrid;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
28 Madrid;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
28 Madrid;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
28 Madrid;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
28 Madrid;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
28 Madrid;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
28 Madrid;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
28 Madrid;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
28 Madrid;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
28 Madrid;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
28 Madrid;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
28 Madrid;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.815
28 Madrid;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.809
28 Madrid;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.802
28 Madrid;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
28 Madrid;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,67
28 Madrid;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;99,28
28 Madrid;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;329
28 Madrid;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;328
28 Madrid;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;324
28 Madrid;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
28 Madrid;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;99,7
28 Madrid;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;98,48
28 Madrid;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.486
28 Madrid;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.481
28 Madrid;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.478
28 Madrid;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
28 Madrid;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,66
28 Madrid;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;99,46
28 Madrid;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.892
28 Madrid;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.872
28 Madrid;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
28 Madrid;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,94
28 Madrid;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;287
28 Madrid;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;270
28 Madrid;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
28 Madrid;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;94,08
28 Madrid;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.605
28 Madrid;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.602
28 Madrid;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
28 Madrid;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,81
28 Madrid;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
28 Madrid;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
28 Madrid;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
28 Madrid;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
28 Madrid;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
28 Madrid;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
28 Madrid;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;48.898
29 Málaga;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
29 Málaga;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;45.906
29 Málaga;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;43.874
29 Málaga;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
29 Málaga;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
29 Málaga;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,88
29 Málaga;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;89,73
29 Málaga;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;20.262
29 Málaga;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
29 Málaga;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;18.497
29 Málaga;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;17.307
29 Málaga;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
29 Málaga;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
29 Málaga;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,29
29 Málaga;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;85,42
29 Málaga;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;28.636
29 Málaga;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
29 Málaga;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;27.409
29 Málaga;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;26.567
29 Málaga;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
29 Málaga;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
29 Málaga;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,72
29 Málaga;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;92,77
29 Málaga;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;49.737
29 Málaga;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;47.168
29 Málaga;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
29 Málaga;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
29 Málaga;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
29 Málaga;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
29 Málaga;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,83
29 Málaga;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
29 Málaga;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;19.402
29 Málaga;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;17.907
29 Málaga;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
29 Málaga;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
29 Málaga;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
29 Málaga;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
29 Málaga;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;92,29
29 Málaga;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
29 Málaga;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;30.335
29 Málaga;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;29.261
29 Málaga;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
29 Málaga;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
29 Málaga;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
29 Málaga;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
29 Málaga;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,46
29 Málaga;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
29 Málaga;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
29 Málaga;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
29 Málaga;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
29 Málaga;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
29 Málaga;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
29 Málaga;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
29 Málaga;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
29 Málaga;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
29 Málaga;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
29 Málaga;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
29 Málaga;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
29 Málaga;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
29 Málaga;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
29 Málaga;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
29 Málaga;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
29 Málaga;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
29 Málaga;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
29 Málaga;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
29 Málaga;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
29 Málaga;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
29 Málaga;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
29 Málaga;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
29 Málaga;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
29 Málaga;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
29 Málaga;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
29 Málaga;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
29 Málaga;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
29 Málaga;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
29 Málaga;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
29 Málaga;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
29 Málaga;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;36.461
29 Málaga;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;33.691
29 Málaga;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;31.853
29 Málaga;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
29 Málaga;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;92,4
29 Málaga;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;87,36
29 Málaga;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;16.385
29 Málaga;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;14.714
29 Málaga;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;13.616
29 Málaga;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
29 Málaga;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;89,8
29 Málaga;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;83,1
29 Málaga;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;20.076
29 Málaga;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;18.977
29 Málaga;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;18.237
29 Málaga;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
29 Málaga;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;94,53
29 Málaga;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;90,84
29 Málaga;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;36.833
29 Málaga;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;34.447
29 Málaga;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
29 Málaga;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,52
29 Málaga;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;15.669
29 Málaga;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;14.251
29 Málaga;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
29 Málaga;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,95
29 Málaga;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;21.164
29 Málaga;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;20.196
29 Málaga;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
29 Málaga;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,43
29 Málaga;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;5.409
29 Málaga;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;5.285
29 Málaga;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;5.175
29 Málaga;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
29 Málaga;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;97,71
29 Málaga;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;95,67
29 Málaga;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1.866
29 Málaga;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1.812
29 Málaga;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.759
29 Málaga;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
29 Málaga;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,11
29 Málaga;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;94,27
29 Málaga;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;3.543
29 Málaga;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;3.473
29 Málaga;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;3.416
29 Málaga;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
29 Málaga;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,02
29 Málaga;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,42
29 Málaga;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;5.532
29 Málaga;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;5.421
29 Málaga;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
29 Málaga;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,99
29 Málaga;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1.812
29 Málaga;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.760
29 Málaga;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
29 Málaga;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;97,13
29 Málaga;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;3.720
29 Málaga;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;3.661
29 Málaga;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
29 Málaga;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,41
29 Málaga;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;6.672
29 Málaga;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;6.577
29 Málaga;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;6.493
29 Málaga;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
29 Málaga;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,58
29 Málaga;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,32
29 Málaga;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1.937
29 Málaga;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1.900
29 Málaga;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.861
29 Málaga;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
29 Málaga;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,09
29 Málaga;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;96,08
29 Málaga;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;4.735
29 Málaga;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;4.677
29 Málaga;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;4.632
29 Málaga;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
29 Málaga;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,78
29 Málaga;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,82
29 Málaga;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;6.988
29 Málaga;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;6.916
29 Málaga;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
29 Málaga;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,97
29 Málaga;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1.868
29 Málaga;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.843
29 Málaga;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
29 Málaga;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;98,66
29 Málaga;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;5.120
29 Málaga;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;5.073
29 Málaga;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
29 Málaga;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,08
29 Málaga;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;244
29 Málaga;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;242
29 Málaga;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;242
29 Málaga;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
29 Málaga;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,18
29 Málaga;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;99,18
29 Málaga;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
29 Málaga;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
29 Málaga;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
29 Málaga;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;50
29 Málaga;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;48
29 Málaga;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;48
29 Málaga;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
29 Málaga;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;96
29 Málaga;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;96
29 Málaga;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
29 Málaga;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
29 Málaga;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
29 Málaga;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;194
29 Málaga;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;194
29 Málaga;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;194
29 Málaga;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
29 Málaga;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
29 Málaga;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
29 Málaga;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
29 Málaga;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
29 Málaga;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
29 Málaga;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;269
29 Málaga;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;269
29 Málaga;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
29 Málaga;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
29 Málaga;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
29 Málaga;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
29 Málaga;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
29 Málaga;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
29 Málaga;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;39
29 Málaga;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;39
29 Málaga;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
29 Málaga;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
29 Málaga;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
29 Málaga;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
29 Málaga;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
29 Málaga;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
29 Málaga;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;230
29 Málaga;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;230
29 Málaga;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
29 Málaga;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
29 Málaga;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
29 Málaga;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
29 Málaga;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
29 Málaga;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
29 Málaga;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
29 Málaga;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
29 Málaga;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
29 Málaga;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
29 Málaga;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
29 Málaga;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
29 Málaga;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
29 Málaga;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
29 Málaga;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
29 Málaga;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
29 Málaga;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
29 Málaga;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
29 Málaga;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
29 Málaga;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
29 Málaga;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
29 Málaga;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
29 Málaga;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
29 Málaga;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
29 Málaga;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
29 Málaga;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
29 Málaga;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
29 Málaga;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
29 Málaga;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
29 Málaga;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
29 Málaga;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;112
29 Málaga;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;111
29 Málaga;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;111
29 Málaga;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
29 Málaga;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,11
29 Málaga;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;99,11
29 Málaga;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;24
29 Málaga;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;23
29 Málaga;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;23
29 Málaga;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
29 Málaga;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;95,83
29 Málaga;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;95,83
29 Málaga;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;88
29 Málaga;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;88
29 Málaga;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;88
29 Málaga;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
29 Málaga;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
29 Málaga;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
29 Málaga;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;115
29 Málaga;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;115
29 Málaga;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
29 Málaga;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
29 Málaga;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;14
29 Málaga;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;14
29 Málaga;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
29 Málaga;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
29 Málaga;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;101
29 Málaga;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;101
29 Málaga;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
29 Málaga;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
29 Málaga;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
29 Málaga;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
29 Málaga;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
29 Málaga;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
29 Málaga;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
29 Málaga;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
29 Málaga;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;35.651
30 Murcia;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
30 Murcia;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;33.758
30 Murcia;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;32.305
30 Murcia;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
30 Murcia;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
30 Murcia;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,69
30 Murcia;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;90,61
30 Murcia;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;11.816
30 Murcia;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
30 Murcia;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;10.817
30 Murcia;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;10.098
30 Murcia;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
30 Murcia;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
30 Murcia;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,55
30 Murcia;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;85,46
30 Murcia;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;23.835
30 Murcia;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
30 Murcia;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;22.941
30 Murcia;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;22.207
30 Murcia;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
30 Murcia;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
30 Murcia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,25
30 Murcia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;93,17
30 Murcia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;35.795
30 Murcia;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;33.992
30 Murcia;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
30 Murcia;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
30 Murcia;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
30 Murcia;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
30 Murcia;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,96
30 Murcia;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
30 Murcia;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;11.026
30 Murcia;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;10.115
30 Murcia;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
30 Murcia;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
30 Murcia;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
30 Murcia;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
30 Murcia;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,74
30 Murcia;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
30 Murcia;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;24.769
30 Murcia;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;23.877
30 Murcia;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
30 Murcia;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
30 Murcia;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
30 Murcia;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
30 Murcia;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,4
30 Murcia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
30 Murcia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
30 Murcia;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
30 Murcia;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
30 Murcia;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
30 Murcia;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
30 Murcia;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
30 Murcia;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
30 Murcia;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
30 Murcia;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
30 Murcia;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
30 Murcia;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
30 Murcia;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
30 Murcia;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
30 Murcia;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
30 Murcia;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
30 Murcia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
30 Murcia;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
30 Murcia;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
30 Murcia;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
30 Murcia;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
30 Murcia;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
30 Murcia;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
30 Murcia;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
30 Murcia;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
30 Murcia;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
30 Murcia;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
30 Murcia;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
30 Murcia;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
30 Murcia;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
30 Murcia;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
30 Murcia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;25.113
30 Murcia;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;23.382
30 Murcia;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;22.099
30 Murcia;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
30 Murcia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,11
30 Murcia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;88
30 Murcia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;9.426
30 Murcia;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;8.480
30 Murcia;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;7.827
30 Murcia;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
30 Murcia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;89,96
30 Murcia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;83,04
30 Murcia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;15.687
30 Murcia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;14.902
30 Murcia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;14.272
30 Murcia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
30 Murcia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95
30 Murcia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;90,98
30 Murcia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;25.000
30 Murcia;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;23.397
30 Murcia;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
30 Murcia;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,59
30 Murcia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;8.714
30 Murcia;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;7.892
30 Murcia;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
30 Murcia;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,57
30 Murcia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;16.286
30 Murcia;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;15.505
30 Murcia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
30 Murcia;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,2
30 Murcia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;4.279
30 Murcia;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;4.179
30 Murcia;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;4.075
30 Murcia;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
30 Murcia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;97,66
30 Murcia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;95,23
30 Murcia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1.196
30 Murcia;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1.162
30 Murcia;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.116
30 Murcia;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
30 Murcia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,16
30 Murcia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;93,31
30 Murcia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;3.083
30 Murcia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;3.017
30 Murcia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;2.959
30 Murcia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
30 Murcia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;97,86
30 Murcia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;95,98
30 Murcia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;4.351
30 Murcia;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;4.240
30 Murcia;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
30 Murcia;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,45
30 Murcia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1.148
30 Murcia;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.099
30 Murcia;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
30 Murcia;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;95,73
30 Murcia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;3.203
30 Murcia;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;3.141
30 Murcia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
30 Murcia;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,06
30 Murcia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;5.859
30 Murcia;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;5.801
30 Murcia;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;5.735
30 Murcia;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
30 Murcia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,01
30 Murcia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,88
30 Murcia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1.138
30 Murcia;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1.119
30 Murcia;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.099
30 Murcia;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
30 Murcia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,33
30 Murcia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;96,57
30 Murcia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;4.721
30 Murcia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;4.682
30 Murcia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;4.636
30 Murcia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
30 Murcia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,17
30 Murcia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,2
30 Murcia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;6.006
30 Murcia;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;5.917
30 Murcia;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
30 Murcia;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,52
30 Murcia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1.098
30 Murcia;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.058
30 Murcia;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
30 Murcia;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;96,36
30 Murcia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;4.908
30 Murcia;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;4.859
30 Murcia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
30 Murcia;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99
30 Murcia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;271
30 Murcia;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;268
30 Murcia;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;268
30 Murcia;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
30 Murcia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,89
30 Murcia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;98,89
30 Murcia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
30 Murcia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
30 Murcia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
30 Murcia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;38
30 Murcia;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;38
30 Murcia;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;38
30 Murcia;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
30 Murcia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
30 Murcia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
30 Murcia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
30 Murcia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
30 Murcia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
30 Murcia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;233
30 Murcia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;230
30 Murcia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;230
30 Murcia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
30 Murcia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,71
30 Murcia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,71
30 Murcia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
30 Murcia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
30 Murcia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
30 Murcia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;301
30 Murcia;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;301
30 Murcia;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
30 Murcia;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
30 Murcia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
30 Murcia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
30 Murcia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
30 Murcia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
30 Murcia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;47
30 Murcia;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;47
30 Murcia;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
30 Murcia;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
30 Murcia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
30 Murcia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
30 Murcia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
30 Murcia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
30 Murcia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;254
30 Murcia;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;254
30 Murcia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
30 Murcia;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
30 Murcia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
30 Murcia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
30 Murcia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
30 Murcia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
30 Murcia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
30 Murcia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
30 Murcia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
30 Murcia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
30 Murcia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
30 Murcia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
30 Murcia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
30 Murcia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
30 Murcia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
30 Murcia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
30 Murcia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
30 Murcia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
30 Murcia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
30 Murcia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
30 Murcia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
30 Murcia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
30 Murcia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
30 Murcia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
30 Murcia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
30 Murcia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
30 Murcia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
30 Murcia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
30 Murcia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
30 Murcia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
30 Murcia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;129
30 Murcia;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;128
30 Murcia;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;128
30 Murcia;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
30 Murcia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,22
30 Murcia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;99,22
30 Murcia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;18
30 Murcia;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;18
30 Murcia;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;18
30 Murcia;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
30 Murcia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
30 Murcia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
30 Murcia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;111
30 Murcia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;110
30 Murcia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;110
30 Murcia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
30 Murcia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,1
30 Murcia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;99,1
30 Murcia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;137
30 Murcia;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;137
30 Murcia;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
30 Murcia;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
30 Murcia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;19
30 Murcia;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;19
30 Murcia;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
30 Murcia;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
30 Murcia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;118
30 Murcia;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;118
30 Murcia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
30 Murcia;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
30 Murcia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
30 Murcia;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
30 Murcia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
30 Murcia;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
30 Murcia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
30 Murcia;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
30 Murcia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;14.775
31 Navarra;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
31 Navarra;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;14.031
31 Navarra;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;13.380
31 Navarra;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
31 Navarra;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
31 Navarra;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,96
31 Navarra;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;90,56
31 Navarra;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;4.419
31 Navarra;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
31 Navarra;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;4.051
31 Navarra;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;3.719
31 Navarra;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
31 Navarra;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
31 Navarra;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,67
31 Navarra;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;84,16
31 Navarra;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;10.356
31 Navarra;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
31 Navarra;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;9.980
31 Navarra;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;9.661
31 Navarra;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
31 Navarra;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
31 Navarra;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,37
31 Navarra;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;93,29
31 Navarra;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;14.748
31 Navarra;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;13.960
31 Navarra;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
31 Navarra;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
31 Navarra;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
31 Navarra;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
31 Navarra;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,66
31 Navarra;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
31 Navarra;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;4.129
31 Navarra;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;3.718
31 Navarra;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
31 Navarra;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
31 Navarra;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
31 Navarra;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
31 Navarra;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,05
31 Navarra;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
31 Navarra;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;10.619
31 Navarra;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;10.242
31 Navarra;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
31 Navarra;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
31 Navarra;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
31 Navarra;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
31 Navarra;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,45
31 Navarra;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
31 Navarra;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
31 Navarra;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
31 Navarra;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
31 Navarra;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
31 Navarra;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
31 Navarra;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
31 Navarra;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
31 Navarra;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
31 Navarra;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
31 Navarra;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
31 Navarra;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
31 Navarra;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
31 Navarra;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
31 Navarra;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
31 Navarra;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
31 Navarra;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
31 Navarra;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
31 Navarra;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
31 Navarra;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
31 Navarra;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
31 Navarra;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
31 Navarra;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
31 Navarra;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
31 Navarra;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
31 Navarra;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
31 Navarra;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
31 Navarra;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
31 Navarra;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
31 Navarra;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
31 Navarra;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
31 Navarra;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;10.140
31 Navarra;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;9.446
31 Navarra;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;8.869
31 Navarra;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
31 Navarra;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,16
31 Navarra;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;87,47
31 Navarra;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;3.534
31 Navarra;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;3.177
31 Navarra;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;2.872
31 Navarra;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
31 Navarra;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;89,9
31 Navarra;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;81,27
31 Navarra;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;6.606
31 Navarra;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;6.269
31 Navarra;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;5.997
31 Navarra;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
31 Navarra;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;94,9
31 Navarra;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;90,78
31 Navarra;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;10.091
31 Navarra;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;9.384
31 Navarra;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
31 Navarra;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;92,99
31 Navarra;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;3.320
31 Navarra;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;2.936
31 Navarra;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
31 Navarra;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;88,43
31 Navarra;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;6.771
31 Navarra;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;6.448
31 Navarra;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
31 Navarra;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,23
31 Navarra;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.686
31 Navarra;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.660
31 Navarra;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.621
31 Navarra;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
31 Navarra;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,46
31 Navarra;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,14
31 Navarra;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;405
31 Navarra;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;397
31 Navarra;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;382
31 Navarra;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
31 Navarra;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,02
31 Navarra;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;94,32
31 Navarra;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.281
31 Navarra;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.263
31 Navarra;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.239
31 Navarra;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
31 Navarra;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,59
31 Navarra;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,72
31 Navarra;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.676
31 Navarra;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.634
31 Navarra;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
31 Navarra;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,49
31 Navarra;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;375
31 Navarra;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;363
31 Navarra;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
31 Navarra;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;96,8
31 Navarra;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.301
31 Navarra;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.271
31 Navarra;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
31 Navarra;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;97,69
31 Navarra;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;2.663
31 Navarra;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;2.639
31 Navarra;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;2.608
31 Navarra;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
31 Navarra;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,1
31 Navarra;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,93
31 Navarra;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;435
31 Navarra;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;432
31 Navarra;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;422
31 Navarra;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
31 Navarra;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;99,31
31 Navarra;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;97,01
31 Navarra;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;2.228
31 Navarra;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;2.207
31 Navarra;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;2.186
31 Navarra;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
31 Navarra;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,06
31 Navarra;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,11
31 Navarra;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;2.680
31 Navarra;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;2.646
31 Navarra;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
31 Navarra;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,73
31 Navarra;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;395
31 Navarra;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;382
31 Navarra;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
31 Navarra;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;96,71
31 Navarra;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;2.285
31 Navarra;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;2.264
31 Navarra;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
31 Navarra;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,08
31 Navarra;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;189
31 Navarra;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;189
31 Navarra;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;186
31 Navarra;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
31 Navarra;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
31 Navarra;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;98,41
31 Navarra;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
31 Navarra;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
31 Navarra;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
31 Navarra;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;31
31 Navarra;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;31
31 Navarra;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;29
31 Navarra;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
31 Navarra;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
31 Navarra;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;93,55
31 Navarra;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
31 Navarra;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
31 Navarra;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
31 Navarra;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;158
31 Navarra;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;158
31 Navarra;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;157
31 Navarra;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
31 Navarra;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
31 Navarra;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;99,37
31 Navarra;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
31 Navarra;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
31 Navarra;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
31 Navarra;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;199
31 Navarra;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;195
31 Navarra;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
31 Navarra;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,99
31 Navarra;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
31 Navarra;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
31 Navarra;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
31 Navarra;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
31 Navarra;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;25
31 Navarra;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;23
31 Navarra;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
31 Navarra;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;92
31 Navarra;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
31 Navarra;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
31 Navarra;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
31 Navarra;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
31 Navarra;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;174
31 Navarra;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;172
31 Navarra;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
31 Navarra;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,85
31 Navarra;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
31 Navarra;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
31 Navarra;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
31 Navarra;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
31 Navarra;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
31 Navarra;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
31 Navarra;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
31 Navarra;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
31 Navarra;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
31 Navarra;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
31 Navarra;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
31 Navarra;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
31 Navarra;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
31 Navarra;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
31 Navarra;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
31 Navarra;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
31 Navarra;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
31 Navarra;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
31 Navarra;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
31 Navarra;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
31 Navarra;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
31 Navarra;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
31 Navarra;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
31 Navarra;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
31 Navarra;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
31 Navarra;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
31 Navarra;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
31 Navarra;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
31 Navarra;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;97
31 Navarra;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;97
31 Navarra;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;96
31 Navarra;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
31 Navarra;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
31 Navarra;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;98,97
31 Navarra;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;14
31 Navarra;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;14
31 Navarra;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;14
31 Navarra;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
31 Navarra;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
31 Navarra;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
31 Navarra;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;83
31 Navarra;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;83
31 Navarra;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;82
31 Navarra;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
31 Navarra;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
31 Navarra;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,8
31 Navarra;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;102
31 Navarra;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;101
31 Navarra;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
31 Navarra;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;99,02
31 Navarra;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;14
31 Navarra;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;14
31 Navarra;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
31 Navarra;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
31 Navarra;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;88
31 Navarra;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;87
31 Navarra;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
31 Navarra;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,86
31 Navarra;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
31 Navarra;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
31 Navarra;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
31 Navarra;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
31 Navarra;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
31 Navarra;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
31 Navarra;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;7.787
32 Ourense;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
32 Ourense;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;7.387
32 Ourense;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;7.081
32 Ourense;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
32 Ourense;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
32 Ourense;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,86
32 Ourense;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;90,93
32 Ourense;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;2.186
32 Ourense;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
32 Ourense;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1.994
32 Ourense;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.848
32 Ourense;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
32 Ourense;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
32 Ourense;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,22
32 Ourense;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;84,54
32 Ourense;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;5.601
32 Ourense;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
32 Ourense;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;5.393
32 Ourense;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;5.233
32 Ourense;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
32 Ourense;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
32 Ourense;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,29
32 Ourense;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;93,43
32 Ourense;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;7.721
32 Ourense;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;7.351
32 Ourense;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
32 Ourense;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
32 Ourense;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
32 Ourense;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
32 Ourense;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,21
32 Ourense;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
32 Ourense;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1.972
32 Ourense;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.784
32 Ourense;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
32 Ourense;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
32 Ourense;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
32 Ourense;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
32 Ourense;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,47
32 Ourense;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
32 Ourense;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;5.749
32 Ourense;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;5.567
32 Ourense;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
32 Ourense;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
32 Ourense;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
32 Ourense;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
32 Ourense;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,83
32 Ourense;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
32 Ourense;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
32 Ourense;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
32 Ourense;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
32 Ourense;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
32 Ourense;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
32 Ourense;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
32 Ourense;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
32 Ourense;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
32 Ourense;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
32 Ourense;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
32 Ourense;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
32 Ourense;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
32 Ourense;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
32 Ourense;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
32 Ourense;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
32 Ourense;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
32 Ourense;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
32 Ourense;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
32 Ourense;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
32 Ourense;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
32 Ourense;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
32 Ourense;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
32 Ourense;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
32 Ourense;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
32 Ourense;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
32 Ourense;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
32 Ourense;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
32 Ourense;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
32 Ourense;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
32 Ourense;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
32 Ourense;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;6.079
32 Ourense;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;5.708
32 Ourense;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;5.425
32 Ourense;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
32 Ourense;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,9
32 Ourense;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;89,24
32 Ourense;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1.883
32 Ourense;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1.699
32 Ourense;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.557
32 Ourense;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
32 Ourense;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;90,23
32 Ourense;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;82,69
32 Ourense;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;4.196
32 Ourense;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;4.009
32 Ourense;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;3.868
32 Ourense;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
32 Ourense;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,54
32 Ourense;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;92,18
32 Ourense;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;6.008
32 Ourense;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;5.675
32 Ourense;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
32 Ourense;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,46
32 Ourense;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1.681
32 Ourense;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.514
32 Ourense;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
32 Ourense;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,07
32 Ourense;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;4.327
32 Ourense;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;4.161
32 Ourense;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
32 Ourense;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,16
32 Ourense;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;787
32 Ourense;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;773
32 Ourense;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;760
32 Ourense;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
32 Ourense;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,22
32 Ourense;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,57
32 Ourense;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;154
32 Ourense;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;150
32 Ourense;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;147
32 Ourense;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
32 Ourense;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,4
32 Ourense;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;95,45
32 Ourense;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;633
32 Ourense;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;623
32 Ourense;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;613
32 Ourense;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
32 Ourense;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,42
32 Ourense;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,84
32 Ourense;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;767
32 Ourense;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;753
32 Ourense;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
32 Ourense;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,17
32 Ourense;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;144
32 Ourense;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;138
32 Ourense;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
32 Ourense;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;95,83
32 Ourense;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;623
32 Ourense;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;615
32 Ourense;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
32 Ourense;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,72
32 Ourense;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;865
32 Ourense;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;851
32 Ourense;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;841
32 Ourense;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
32 Ourense;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,38
32 Ourense;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,23
32 Ourense;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;143
32 Ourense;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;140
32 Ourense;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;139
32 Ourense;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
32 Ourense;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,9
32 Ourense;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;97,2
32 Ourense;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;722
32 Ourense;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;711
32 Ourense;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;702
32 Ourense;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
32 Ourense;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,48
32 Ourense;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,23
32 Ourense;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;888
32 Ourense;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;867
32 Ourense;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
32 Ourense;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,64
32 Ourense;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;138
32 Ourense;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;125
32 Ourense;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
32 Ourense;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,58
32 Ourense;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;750
32 Ourense;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;742
32 Ourense;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
32 Ourense;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,93
32 Ourense;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;40
32 Ourense;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;39
32 Ourense;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;39
32 Ourense;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
32 Ourense;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;97,5
32 Ourense;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,5
32 Ourense;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
32 Ourense;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
32 Ourense;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
32 Ourense;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;4
32 Ourense;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;3
32 Ourense;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;3
32 Ourense;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
32 Ourense;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;75
32 Ourense;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;75
32 Ourense;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
32 Ourense;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
32 Ourense;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
32 Ourense;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;36
32 Ourense;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;36
32 Ourense;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;36
32 Ourense;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
32 Ourense;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
32 Ourense;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
32 Ourense;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
32 Ourense;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
32 Ourense;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
32 Ourense;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;41
32 Ourense;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;39
32 Ourense;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
32 Ourense;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,12
32 Ourense;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
32 Ourense;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
32 Ourense;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
32 Ourense;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
32 Ourense;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;7
32 Ourense;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;5
32 Ourense;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
32 Ourense;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;71,43
32 Ourense;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
32 Ourense;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
32 Ourense;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
32 Ourense;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
32 Ourense;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;34
32 Ourense;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;34
32 Ourense;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
32 Ourense;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
32 Ourense;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
32 Ourense;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
32 Ourense;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
32 Ourense;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
32 Ourense;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
32 Ourense;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
32 Ourense;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
32 Ourense;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
32 Ourense;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
32 Ourense;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
32 Ourense;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
32 Ourense;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
32 Ourense;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
32 Ourense;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
32 Ourense;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
32 Ourense;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
32 Ourense;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
32 Ourense;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
32 Ourense;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
32 Ourense;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
32 Ourense;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
32 Ourense;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
32 Ourense;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
32 Ourense;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
32 Ourense;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
32 Ourense;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
32 Ourense;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
32 Ourense;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
32 Ourense;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;16
32 Ourense;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;16
32 Ourense;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;16
32 Ourense;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
32 Ourense;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
32 Ourense;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
32 Ourense;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;2
32 Ourense;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;2
32 Ourense;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;2
32 Ourense;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
32 Ourense;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
32 Ourense;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
32 Ourense;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;14
32 Ourense;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;14
32 Ourense;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;14
32 Ourense;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
32 Ourense;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
32 Ourense;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
32 Ourense;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;17
32 Ourense;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;17
32 Ourense;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
32 Ourense;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
32 Ourense;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;2
32 Ourense;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;2
32 Ourense;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
32 Ourense;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
32 Ourense;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;15
32 Ourense;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;15
32 Ourense;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
32 Ourense;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
32 Ourense;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
32 Ourense;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
32 Ourense;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
32 Ourense;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
32 Ourense;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
32 Ourense;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
32 Ourense;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;3.408
34 Palencia;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
34 Palencia;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;3.254
34 Palencia;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;3.125
34 Palencia;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
34 Palencia;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
34 Palencia;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;95,48
34 Palencia;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;91,7
34 Palencia;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;895
34 Palencia;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
34 Palencia;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;831
34 Palencia;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;775
34 Palencia;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
34 Palencia;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
34 Palencia;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;92,85
34 Palencia;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;86,59
34 Palencia;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;2.513
34 Palencia;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
34 Palencia;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;2.423
34 Palencia;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;2.350
34 Palencia;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
34 Palencia;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
34 Palencia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,42
34 Palencia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;93,51
34 Palencia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;3.419
34 Palencia;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;3.252
34 Palencia;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
34 Palencia;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
34 Palencia;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
34 Palencia;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
34 Palencia;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,12
34 Palencia;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
34 Palencia;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;840
34 Palencia;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;771
34 Palencia;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
34 Palencia;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
34 Palencia;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
34 Palencia;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
34 Palencia;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,79
34 Palencia;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
34 Palencia;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;2.579
34 Palencia;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;2.481
34 Palencia;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
34 Palencia;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
34 Palencia;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
34 Palencia;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
34 Palencia;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,2
34 Palencia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
34 Palencia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
34 Palencia;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
34 Palencia;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
34 Palencia;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
34 Palencia;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
34 Palencia;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
34 Palencia;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
34 Palencia;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
34 Palencia;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
34 Palencia;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
34 Palencia;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
34 Palencia;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
34 Palencia;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
34 Palencia;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
34 Palencia;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
34 Palencia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
34 Palencia;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
34 Palencia;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
34 Palencia;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
34 Palencia;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
34 Palencia;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
34 Palencia;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
34 Palencia;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
34 Palencia;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
34 Palencia;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
34 Palencia;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
34 Palencia;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
34 Palencia;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
34 Palencia;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
34 Palencia;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
34 Palencia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;2.603
34 Palencia;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;2.456
34 Palencia;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;2.344
34 Palencia;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
34 Palencia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,35
34 Palencia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;90,05
34 Palencia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;741
34 Palencia;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;678
34 Palencia;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;629
34 Palencia;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
34 Palencia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,5
34 Palencia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;84,89
34 Palencia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.862
34 Palencia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.778
34 Palencia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.715
34 Palencia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
34 Palencia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,49
34 Palencia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;92,11
34 Palencia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;2.582
34 Palencia;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;2.437
34 Palencia;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
34 Palencia;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,38
34 Palencia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;685
34 Palencia;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;626
34 Palencia;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
34 Palencia;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,39
34 Palencia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.897
34 Palencia;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.811
34 Palencia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
34 Palencia;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,47
34 Palencia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;360
34 Palencia;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;357
34 Palencia;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;346
34 Palencia;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
34 Palencia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,17
34 Palencia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,11
34 Palencia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;80
34 Palencia;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;80
34 Palencia;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;76
34 Palencia;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
34 Palencia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
34 Palencia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;95
34 Palencia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;280
34 Palencia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;277
34 Palencia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;270
34 Palencia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
34 Palencia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,93
34 Palencia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,43
34 Palencia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;374
34 Palencia;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;366
34 Palencia;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
34 Palencia;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,86
34 Palencia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;82
34 Palencia;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;81
34 Palencia;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
34 Palencia;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;98,78
34 Palencia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;292
34 Palencia;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;285
34 Palencia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
34 Palencia;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;97,6
34 Palencia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;408
34 Palencia;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;404
34 Palencia;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;398
34 Palencia;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
34 Palencia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,02
34 Palencia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,55
34 Palencia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;67
34 Palencia;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;66
34 Palencia;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;63
34 Palencia;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
34 Palencia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,51
34 Palencia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;94,03
34 Palencia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;341
34 Palencia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;338
34 Palencia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;335
34 Palencia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
34 Palencia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,12
34 Palencia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,24
34 Palencia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;424
34 Palencia;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;413
34 Palencia;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
34 Palencia;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,41
34 Palencia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;64
34 Palencia;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;58
34 Palencia;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
34 Palencia;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,63
34 Palencia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;360
34 Palencia;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;355
34 Palencia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
34 Palencia;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,61
34 Palencia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;25
34 Palencia;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;25
34 Palencia;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;25
34 Palencia;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
34 Palencia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
34 Palencia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
34 Palencia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
34 Palencia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
34 Palencia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
34 Palencia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;6
34 Palencia;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;6
34 Palencia;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;6
34 Palencia;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
34 Palencia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
34 Palencia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
34 Palencia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
34 Palencia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
34 Palencia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
34 Palencia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;19
34 Palencia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;19
34 Palencia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;19
34 Palencia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
34 Palencia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
34 Palencia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
34 Palencia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
34 Palencia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
34 Palencia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
34 Palencia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;26
34 Palencia;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;23
34 Palencia;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
34 Palencia;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;88,46
34 Palencia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
34 Palencia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
34 Palencia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
34 Palencia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
34 Palencia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;8
34 Palencia;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;5
34 Palencia;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
34 Palencia;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;62,5
34 Palencia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
34 Palencia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
34 Palencia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
34 Palencia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
34 Palencia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;18
34 Palencia;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;18
34 Palencia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
34 Palencia;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
34 Palencia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
34 Palencia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
34 Palencia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
34 Palencia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
34 Palencia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
34 Palencia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
34 Palencia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
34 Palencia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
34 Palencia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
34 Palencia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
34 Palencia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
34 Palencia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
34 Palencia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
34 Palencia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
34 Palencia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
34 Palencia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
34 Palencia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
34 Palencia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
34 Palencia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
34 Palencia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
34 Palencia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
34 Palencia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
34 Palencia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
34 Palencia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
34 Palencia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
34 Palencia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
34 Palencia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
34 Palencia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
34 Palencia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;12
34 Palencia;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;12
34 Palencia;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;12
34 Palencia;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
34 Palencia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
34 Palencia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
34 Palencia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1
34 Palencia;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1
34 Palencia;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1
34 Palencia;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
34 Palencia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
34 Palencia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
34 Palencia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;11
34 Palencia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;11
34 Palencia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;11
34 Palencia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
34 Palencia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
34 Palencia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
34 Palencia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;13
34 Palencia;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;13
34 Palencia;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
34 Palencia;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
34 Palencia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1
34 Palencia;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1
34 Palencia;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
34 Palencia;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
34 Palencia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;12
34 Palencia;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;12
34 Palencia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
34 Palencia;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
34 Palencia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
34 Palencia;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
34 Palencia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
34 Palencia;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
34 Palencia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
34 Palencia;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
34 Palencia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;27.967
35 Palmas, Las;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
35 Palmas, Las;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;26.378
35 Palmas, Las;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;25.199
35 Palmas, Las;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
35 Palmas, Las;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
35 Palmas, Las;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,32
35 Palmas, Las;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;90,1
35 Palmas, Las;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;10.294
35 Palmas, Las;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
35 Palmas, Las;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;9.424
35 Palmas, Las;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;8.825
35 Palmas, Las;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
35 Palmas, Las;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
35 Palmas, Las;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,55
35 Palmas, Las;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;85,73
35 Palmas, Las;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;17.673
35 Palmas, Las;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
35 Palmas, Las;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;16.954
35 Palmas, Las;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;16.374
35 Palmas, Las;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
35 Palmas, Las;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
35 Palmas, Las;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,93
35 Palmas, Las;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;92,65
35 Palmas, Las;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;27.846
35 Palmas, Las;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;26.428
35 Palmas, Las;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
35 Palmas, Las;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
35 Palmas, Las;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
35 Palmas, Las;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
35 Palmas, Las;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,91
35 Palmas, Las;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;9.624
35 Palmas, Las;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;8.908
35 Palmas, Las;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
35 Palmas, Las;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
35 Palmas, Las;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
35 Palmas, Las;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
35 Palmas, Las;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;92,56
35 Palmas, Las;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;18.222
35 Palmas, Las;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;17.520
35 Palmas, Las;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
35 Palmas, Las;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
35 Palmas, Las;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
35 Palmas, Las;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
35 Palmas, Las;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,15
35 Palmas, Las;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
35 Palmas, Las;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
35 Palmas, Las;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
35 Palmas, Las;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
35 Palmas, Las;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
35 Palmas, Las;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
35 Palmas, Las;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
35 Palmas, Las;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
35 Palmas, Las;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
35 Palmas, Las;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
35 Palmas, Las;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
35 Palmas, Las;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
35 Palmas, Las;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
35 Palmas, Las;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
35 Palmas, Las;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
35 Palmas, Las;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
35 Palmas, Las;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
35 Palmas, Las;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
35 Palmas, Las;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
35 Palmas, Las;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
35 Palmas, Las;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
35 Palmas, Las;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
35 Palmas, Las;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
35 Palmas, Las;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
35 Palmas, Las;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;19.692
35 Palmas, Las;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;18.241
35 Palmas, Las;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;17.203
35 Palmas, Las;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
35 Palmas, Las;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;92,63
35 Palmas, Las;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;87,36
35 Palmas, Las;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;7.991
35 Palmas, Las;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;7.181
35 Palmas, Las;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;6.640
35 Palmas, Las;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
35 Palmas, Las;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;89,86
35 Palmas, Las;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;83,09
35 Palmas, Las;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;11.701
35 Palmas, Las;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;11.060
35 Palmas, Las;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;10.563
35 Palmas, Las;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
35 Palmas, Las;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;94,52
35 Palmas, Las;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;90,27
35 Palmas, Las;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;19.576
35 Palmas, Las;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;18.279
35 Palmas, Las;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
35 Palmas, Las;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,37
35 Palmas, Las;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;7.498
35 Palmas, Las;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;6.827
35 Palmas, Las;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
35 Palmas, Las;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,05
35 Palmas, Las;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;12.078
35 Palmas, Las;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;11.452
35 Palmas, Las;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
35 Palmas, Las;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;94,82
35 Palmas, Las;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;3.411
35 Palmas, Las;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;3.322
35 Palmas, Las;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;3.241
35 Palmas, Las;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
35 Palmas, Las;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;97,39
35 Palmas, Las;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;95,02
35 Palmas, Las;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1.147
35 Palmas, Las;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1.108
35 Palmas, Las;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.074
35 Palmas, Las;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
35 Palmas, Las;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;96,6
35 Palmas, Las;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;93,64
35 Palmas, Las;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;2.264
35 Palmas, Las;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;2.214
35 Palmas, Las;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;2.167
35 Palmas, Las;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
35 Palmas, Las;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;97,79
35 Palmas, Las;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;95,72
35 Palmas, Las;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;3.361
35 Palmas, Las;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;3.302
35 Palmas, Las;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
35 Palmas, Las;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,24
35 Palmas, Las;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1.055
35 Palmas, Las;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.035
35 Palmas, Las;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
35 Palmas, Las;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;98,1
35 Palmas, Las;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;2.306
35 Palmas, Las;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;2.267
35 Palmas, Las;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
35 Palmas, Las;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,31
35 Palmas, Las;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;4.472
35 Palmas, Las;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;4.424
35 Palmas, Las;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;4.365
35 Palmas, Las;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
35 Palmas, Las;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,93
35 Palmas, Las;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,61
35 Palmas, Las;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1.102
35 Palmas, Las;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1.081
35 Palmas, Las;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.057
35 Palmas, Las;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
35 Palmas, Las;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,09
35 Palmas, Las;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;95,92
35 Palmas, Las;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;3.370
35 Palmas, Las;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;3.343
35 Palmas, Las;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;3.308
35 Palmas, Las;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
35 Palmas, Las;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,2
35 Palmas, Las;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,16
35 Palmas, Las;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;4.520
35 Palmas, Las;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;4.459
35 Palmas, Las;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
35 Palmas, Las;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,65
35 Palmas, Las;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1.033
35 Palmas, Las;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.008
35 Palmas, Las;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
35 Palmas, Las;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;97,58
35 Palmas, Las;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;3.487
35 Palmas, Las;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;3.451
35 Palmas, Las;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
35 Palmas, Las;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,97
35 Palmas, Las;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;260
35 Palmas, Las;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;259
35 Palmas, Las;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;258
35 Palmas, Las;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
35 Palmas, Las;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,62
35 Palmas, Las;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;99,23
35 Palmas, Las;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;37
35 Palmas, Las;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;37
35 Palmas, Las;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;37
35 Palmas, Las;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
35 Palmas, Las;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
35 Palmas, Las;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
35 Palmas, Las;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;223
35 Palmas, Las;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;222
35 Palmas, Las;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;221
35 Palmas, Las;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
35 Palmas, Las;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,55
35 Palmas, Las;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;99,1
35 Palmas, Las;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;258
35 Palmas, Las;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;257
35 Palmas, Las;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
35 Palmas, Las;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;99,61
35 Palmas, Las;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;25
35 Palmas, Las;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;25
35 Palmas, Las;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
35 Palmas, Las;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
35 Palmas, Las;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;233
35 Palmas, Las;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;232
35 Palmas, Las;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
35 Palmas, Las;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,57
35 Palmas, Las;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;132
35 Palmas, Las;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;132
35 Palmas, Las;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;132
35 Palmas, Las;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
35 Palmas, Las;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
35 Palmas, Las;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
35 Palmas, Las;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;17
35 Palmas, Las;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;17
35 Palmas, Las;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;17
35 Palmas, Las;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
35 Palmas, Las;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
35 Palmas, Las;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
35 Palmas, Las;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;115
35 Palmas, Las;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;115
35 Palmas, Las;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;115
35 Palmas, Las;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
35 Palmas, Las;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
35 Palmas, Las;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
35 Palmas, Las;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;131
35 Palmas, Las;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;131
35 Palmas, Las;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
35 Palmas, Las;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
35 Palmas, Las;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;13
35 Palmas, Las;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;13
35 Palmas, Las;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
35 Palmas, Las;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
35 Palmas, Las;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;118
35 Palmas, Las;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;118
35 Palmas, Las;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
35 Palmas, Las;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
35 Palmas, Las;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;25.001
36 Pontevedra;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
36 Pontevedra;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;23.799
36 Pontevedra;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;22.928
36 Pontevedra;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
36 Pontevedra;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
36 Pontevedra;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;95,19
36 Pontevedra;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;91,71
36 Pontevedra;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;7.208
36 Pontevedra;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
36 Pontevedra;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;6.658
36 Pontevedra;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;6.265
36 Pontevedra;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
36 Pontevedra;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
36 Pontevedra;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;92,37
36 Pontevedra;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;86,92
36 Pontevedra;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;17.793
36 Pontevedra;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
36 Pontevedra;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;17.141
36 Pontevedra;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;16.663
36 Pontevedra;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
36 Pontevedra;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
36 Pontevedra;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,34
36 Pontevedra;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;93,65
36 Pontevedra;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;25.028
36 Pontevedra;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;23.936
36 Pontevedra;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
36 Pontevedra;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
36 Pontevedra;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
36 Pontevedra;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
36 Pontevedra;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,64
36 Pontevedra;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;6.640
36 Pontevedra;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;6.129
36 Pontevedra;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
36 Pontevedra;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
36 Pontevedra;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
36 Pontevedra;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
36 Pontevedra;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;92,3
36 Pontevedra;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;18.388
36 Pontevedra;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;17.807
36 Pontevedra;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
36 Pontevedra;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
36 Pontevedra;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
36 Pontevedra;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
36 Pontevedra;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,84
36 Pontevedra;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
36 Pontevedra;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
36 Pontevedra;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
36 Pontevedra;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
36 Pontevedra;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
36 Pontevedra;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
36 Pontevedra;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
36 Pontevedra;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
36 Pontevedra;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
36 Pontevedra;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
36 Pontevedra;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
36 Pontevedra;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
36 Pontevedra;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
36 Pontevedra;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
36 Pontevedra;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
36 Pontevedra;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
36 Pontevedra;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
36 Pontevedra;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
36 Pontevedra;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
36 Pontevedra;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
36 Pontevedra;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
36 Pontevedra;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
36 Pontevedra;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
36 Pontevedra;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
36 Pontevedra;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;18.491
36 Pontevedra;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;17.358
36 Pontevedra;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;16.562
36 Pontevedra;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
36 Pontevedra;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,87
36 Pontevedra;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;89,57
36 Pontevedra;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;6.001
36 Pontevedra;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;5.468
36 Pontevedra;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;5.103
36 Pontevedra;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
36 Pontevedra;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,12
36 Pontevedra;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;85,04
36 Pontevedra;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;12.490
36 Pontevedra;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;11.890
36 Pontevedra;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;11.459
36 Pontevedra;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
36 Pontevedra;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,2
36 Pontevedra;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;91,75
36 Pontevedra;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;18.427
36 Pontevedra;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;17.437
36 Pontevedra;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
36 Pontevedra;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,63
36 Pontevedra;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;5.533
36 Pontevedra;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;5.076
36 Pontevedra;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
36 Pontevedra;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,74
36 Pontevedra;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;12.894
36 Pontevedra;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;12.361
36 Pontevedra;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
36 Pontevedra;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,87
36 Pontevedra;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;2.867
36 Pontevedra;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;2.823
36 Pontevedra;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;2.776
36 Pontevedra;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
36 Pontevedra;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,47
36 Pontevedra;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,83
36 Pontevedra;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;654
36 Pontevedra;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;642
36 Pontevedra;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;629
36 Pontevedra;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
36 Pontevedra;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,17
36 Pontevedra;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;96,18
36 Pontevedra;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;2.213
36 Pontevedra;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;2.181
36 Pontevedra;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;2.147
36 Pontevedra;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
36 Pontevedra;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,55
36 Pontevedra;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,02
36 Pontevedra;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;2.841
36 Pontevedra;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;2.798
36 Pontevedra;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
36 Pontevedra;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,49
36 Pontevedra;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;597
36 Pontevedra;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;588
36 Pontevedra;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
36 Pontevedra;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;98,49
36 Pontevedra;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;2.244
36 Pontevedra;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;2.210
36 Pontevedra;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
36 Pontevedra;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,48
36 Pontevedra;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;3.400
36 Pontevedra;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;3.375
36 Pontevedra;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;3.347
36 Pontevedra;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
36 Pontevedra;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,26
36 Pontevedra;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;98,44
36 Pontevedra;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;520
36 Pontevedra;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;515
36 Pontevedra;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;500
36 Pontevedra;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
36 Pontevedra;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;99,04
36 Pontevedra;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;96,15
36 Pontevedra;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;2.880
36 Pontevedra;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;2.860
36 Pontevedra;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;2.847
36 Pontevedra;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
36 Pontevedra;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,31
36 Pontevedra;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,85
36 Pontevedra;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;3.493
36 Pontevedra;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;3.440
36 Pontevedra;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
36 Pontevedra;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,48
36 Pontevedra;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;479
36 Pontevedra;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;440
36 Pontevedra;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
36 Pontevedra;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,86
36 Pontevedra;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;3.014
36 Pontevedra;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;3.000
36 Pontevedra;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
36 Pontevedra;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,54
36 Pontevedra;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;164
36 Pontevedra;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;164
36 Pontevedra;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;164
36 Pontevedra;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
36 Pontevedra;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
36 Pontevedra;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
36 Pontevedra;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;18
36 Pontevedra;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;18
36 Pontevedra;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;18
36 Pontevedra;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
36 Pontevedra;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
36 Pontevedra;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
36 Pontevedra;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;146
36 Pontevedra;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;146
36 Pontevedra;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;146
36 Pontevedra;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
36 Pontevedra;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
36 Pontevedra;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
36 Pontevedra;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;187
36 Pontevedra;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;182
36 Pontevedra;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
36 Pontevedra;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,33
36 Pontevedra;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;23
36 Pontevedra;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;18
36 Pontevedra;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
36 Pontevedra;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;78,26
36 Pontevedra;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;164
36 Pontevedra;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;164
36 Pontevedra;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
36 Pontevedra;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
36 Pontevedra;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;79
36 Pontevedra;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;79
36 Pontevedra;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;79
36 Pontevedra;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
36 Pontevedra;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
36 Pontevedra;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
36 Pontevedra;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;15
36 Pontevedra;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;15
36 Pontevedra;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;15
36 Pontevedra;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
36 Pontevedra;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
36 Pontevedra;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
36 Pontevedra;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;64
36 Pontevedra;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;64
36 Pontevedra;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;64
36 Pontevedra;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
36 Pontevedra;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
36 Pontevedra;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
36 Pontevedra;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;80
36 Pontevedra;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;79
36 Pontevedra;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
36 Pontevedra;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,75
36 Pontevedra;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;8
36 Pontevedra;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;7
36 Pontevedra;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
36 Pontevedra;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;87,5
36 Pontevedra;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;72
36 Pontevedra;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;72
36 Pontevedra;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
36 Pontevedra;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
36 Pontevedra;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;8.250
26 Rioja, La;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
26 Rioja, La;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;7.840
26 Rioja, La;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;7.537
26 Rioja, La;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
26 Rioja, La;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
26 Rioja, La;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;95,03
26 Rioja, La;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;91,36
26 Rioja, La;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;2.322
26 Rioja, La;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
26 Rioja, La;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;2.122
26 Rioja, La;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.981
26 Rioja, La;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
26 Rioja, La;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
26 Rioja, La;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,39
26 Rioja, La;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;85,31
26 Rioja, La;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;5.928
26 Rioja, La;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
26 Rioja, La;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;5.718
26 Rioja, La;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;5.556
26 Rioja, La;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
26 Rioja, La;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
26 Rioja, La;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,46
26 Rioja, La;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;93,72
26 Rioja, La;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;8.245
26 Rioja, La;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;7.858
26 Rioja, La;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
26 Rioja, La;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
26 Rioja, La;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
26 Rioja, La;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
26 Rioja, La;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,31
26 Rioja, La;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;2.157
26 Rioja, La;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.970
26 Rioja, La;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
26 Rioja, La;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
26 Rioja, La;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
26 Rioja, La;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
26 Rioja, La;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,33
26 Rioja, La;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;6.088
26 Rioja, La;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;5.888
26 Rioja, La;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
26 Rioja, La;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
26 Rioja, La;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
26 Rioja, La;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
26 Rioja, La;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,71
26 Rioja, La;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
26 Rioja, La;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
26 Rioja, La;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
26 Rioja, La;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
26 Rioja, La;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
26 Rioja, La;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
26 Rioja, La;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
26 Rioja, La;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
26 Rioja, La;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
26 Rioja, La;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
26 Rioja, La;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
26 Rioja, La;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
26 Rioja, La;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
26 Rioja, La;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
26 Rioja, La;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
26 Rioja, La;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
26 Rioja, La;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
26 Rioja, La;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
26 Rioja, La;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
26 Rioja, La;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
26 Rioja, La;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
26 Rioja, La;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
26 Rioja, La;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
26 Rioja, La;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
26 Rioja, La;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;5.957
26 Rioja, La;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;5.573
26 Rioja, La;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;5.309
26 Rioja, La;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
26 Rioja, La;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,55
26 Rioja, La;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;89,12
26 Rioja, La;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1.893
26 Rioja, La;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1.700
26 Rioja, La;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.576
26 Rioja, La;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
26 Rioja, La;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;89,8
26 Rioja, La;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;83,25
26 Rioja, La;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;4.064
26 Rioja, La;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;3.873
26 Rioja, La;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;3.733
26 Rioja, La;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
26 Rioja, La;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,3
26 Rioja, La;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;91,86
26 Rioja, La;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;5.909
26 Rioja, La;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;5.571
26 Rioja, La;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
26 Rioja, La;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,28
26 Rioja, La;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1.752
26 Rioja, La;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.589
26 Rioja, La;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
26 Rioja, La;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,7
26 Rioja, La;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;4.157
26 Rioja, La;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;3.982
26 Rioja, La;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
26 Rioja, La;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,79
26 Rioja, La;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;886
26 Rioja, La;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;871
26 Rioja, La;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;852
26 Rioja, La;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
26 Rioja, La;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,31
26 Rioja, La;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,16
26 Rioja, La;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;214
26 Rioja, La;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;210
26 Rioja, La;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;204
26 Rioja, La;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
26 Rioja, La;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,13
26 Rioja, La;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;95,33
26 Rioja, La;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;672
26 Rioja, La;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;661
26 Rioja, La;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;648
26 Rioja, La;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
26 Rioja, La;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,36
26 Rioja, La;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,43
26 Rioja, La;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;912
26 Rioja, La;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;892
26 Rioja, La;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
26 Rioja, La;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,81
26 Rioja, La;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;202
26 Rioja, La;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;196
26 Rioja, La;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
26 Rioja, La;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;97,03
26 Rioja, La;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;710
26 Rioja, La;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;696
26 Rioja, La;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
26 Rioja, La;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,03
26 Rioja, La;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.319
26 Rioja, La;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.308
26 Rioja, La;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.288
26 Rioja, La;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
26 Rioja, La;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,17
26 Rioja, La;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,65
26 Rioja, La;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;208
26 Rioja, La;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;205
26 Rioja, La;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;194
26 Rioja, La;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
26 Rioja, La;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,56
26 Rioja, La;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;93,27
26 Rioja, La;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.111
26 Rioja, La;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.103
26 Rioja, La;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.094
26 Rioja, La;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
26 Rioja, La;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,28
26 Rioja, La;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,47
26 Rioja, La;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.320
26 Rioja, La;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.293
26 Rioja, La;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
26 Rioja, La;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,95
26 Rioja, La;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;188
26 Rioja, La;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;172
26 Rioja, La;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
26 Rioja, La;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,49
26 Rioja, La;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.132
26 Rioja, La;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.121
26 Rioja, La;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
26 Rioja, La;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,03
26 Rioja, La;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;63
26 Rioja, La;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;63
26 Rioja, La;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;63
26 Rioja, La;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
26 Rioja, La;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
26 Rioja, La;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
26 Rioja, La;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;5
26 Rioja, La;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;5
26 Rioja, La;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;5
26 Rioja, La;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
26 Rioja, La;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
26 Rioja, La;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
26 Rioja, La;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;58
26 Rioja, La;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;58
26 Rioja, La;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;58
26 Rioja, La;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
26 Rioja, La;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
26 Rioja, La;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
26 Rioja, La;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;80
26 Rioja, La;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;78
26 Rioja, La;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
26 Rioja, La;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,5
26 Rioja, La;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;13
26 Rioja, La;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;11
26 Rioja, La;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
26 Rioja, La;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;84,62
26 Rioja, La;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;67
26 Rioja, La;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;67
26 Rioja, La;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
26 Rioja, La;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
26 Rioja, La;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;25
26 Rioja, La;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;25
26 Rioja, La;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;25
26 Rioja, La;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
26 Rioja, La;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
26 Rioja, La;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
26 Rioja, La;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;2
26 Rioja, La;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;2
26 Rioja, La;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;2
26 Rioja, La;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
26 Rioja, La;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
26 Rioja, La;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
26 Rioja, La;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;23
26 Rioja, La;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;23
26 Rioja, La;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;23
26 Rioja, La;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
26 Rioja, La;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
26 Rioja, La;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
26 Rioja, La;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;24
26 Rioja, La;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;24
26 Rioja, La;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
26 Rioja, La;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
26 Rioja, La;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;2
26 Rioja, La;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;2
26 Rioja, La;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
26 Rioja, La;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
26 Rioja, La;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;22
26 Rioja, La;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;22
26 Rioja, La;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
26 Rioja, La;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
26 Rioja, La;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;7.678
37 Salamanca;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
37 Salamanca;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;7.318
37 Salamanca;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;7.062
37 Salamanca;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
37 Salamanca;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
37 Salamanca;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;95,31
37 Salamanca;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;91,98
37 Salamanca;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;2.080
37 Salamanca;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
37 Salamanca;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1.914
37 Salamanca;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.800
37 Salamanca;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
37 Salamanca;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
37 Salamanca;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;92,02
37 Salamanca;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;86,54
37 Salamanca;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;5.598
37 Salamanca;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
37 Salamanca;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;5.404
37 Salamanca;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;5.262
37 Salamanca;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
37 Salamanca;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
37 Salamanca;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,53
37 Salamanca;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;94
37 Salamanca;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;7.673
37 Salamanca;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;7.348
37 Salamanca;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
37 Salamanca;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
37 Salamanca;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
37 Salamanca;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
37 Salamanca;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,76
37 Salamanca;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1.928
37 Salamanca;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.777
37 Salamanca;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
37 Salamanca;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
37 Salamanca;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
37 Salamanca;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
37 Salamanca;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;92,17
37 Salamanca;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;5.745
37 Salamanca;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;5.571
37 Salamanca;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
37 Salamanca;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
37 Salamanca;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
37 Salamanca;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
37 Salamanca;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,97
37 Salamanca;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
37 Salamanca;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
37 Salamanca;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
37 Salamanca;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
37 Salamanca;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
37 Salamanca;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
37 Salamanca;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
37 Salamanca;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
37 Salamanca;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
37 Salamanca;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
37 Salamanca;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
37 Salamanca;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
37 Salamanca;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
37 Salamanca;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
37 Salamanca;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
37 Salamanca;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
37 Salamanca;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
37 Salamanca;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
37 Salamanca;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
37 Salamanca;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
37 Salamanca;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
37 Salamanca;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
37 Salamanca;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
37 Salamanca;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
37 Salamanca;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;5.661
37 Salamanca;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;5.319
37 Salamanca;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;5.095
37 Salamanca;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
37 Salamanca;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,96
37 Salamanca;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;90
37 Salamanca;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1.721
37 Salamanca;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1.560
37 Salamanca;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.459
37 Salamanca;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
37 Salamanca;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;90,64
37 Salamanca;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;84,78
37 Salamanca;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;3.940
37 Salamanca;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;3.759
37 Salamanca;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;3.636
37 Salamanca;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
37 Salamanca;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,41
37 Salamanca;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;92,28
37 Salamanca;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;5.628
37 Salamanca;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;5.350
37 Salamanca;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
37 Salamanca;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,06
37 Salamanca;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1.607
37 Salamanca;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.482
37 Salamanca;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
37 Salamanca;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;92,22
37 Salamanca;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;4.021
37 Salamanca;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;3.868
37 Salamanca;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
37 Salamanca;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,19
37 Salamanca;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;866
37 Salamanca;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;853
37 Salamanca;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;834
37 Salamanca;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
37 Salamanca;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,5
37 Salamanca;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,3
37 Salamanca;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;182
37 Salamanca;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;178
37 Salamanca;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;171
37 Salamanca;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
37 Salamanca;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,8
37 Salamanca;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;93,96
37 Salamanca;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;684
37 Salamanca;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;675
37 Salamanca;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;663
37 Salamanca;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
37 Salamanca;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,68
37 Salamanca;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,93
37 Salamanca;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;864
37 Salamanca;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;846
37 Salamanca;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
37 Salamanca;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,92
37 Salamanca;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;156
37 Salamanca;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;152
37 Salamanca;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
37 Salamanca;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;97,44
37 Salamanca;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;708
37 Salamanca;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;694
37 Salamanca;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
37 Salamanca;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,02
37 Salamanca;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.098
37 Salamanca;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.093
37 Salamanca;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.080
37 Salamanca;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
37 Salamanca;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,54
37 Salamanca;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;98,36
37 Salamanca;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;170
37 Salamanca;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;169
37 Salamanca;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;163
37 Salamanca;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
37 Salamanca;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;99,41
37 Salamanca;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;95,88
37 Salamanca;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;928
37 Salamanca;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;924
37 Salamanca;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;917
37 Salamanca;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
37 Salamanca;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,57
37 Salamanca;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,81
37 Salamanca;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.120
37 Salamanca;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.096
37 Salamanca;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
37 Salamanca;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,86
37 Salamanca;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;154
37 Salamanca;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;137
37 Salamanca;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
37 Salamanca;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;88,96
37 Salamanca;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;966
37 Salamanca;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;959
37 Salamanca;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
37 Salamanca;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,28
37 Salamanca;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;34
37 Salamanca;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;34
37 Salamanca;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;34
37 Salamanca;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
37 Salamanca;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
37 Salamanca;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
37 Salamanca;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;6
37 Salamanca;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;6
37 Salamanca;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;6
37 Salamanca;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
37 Salamanca;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
37 Salamanca;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
37 Salamanca;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;28
37 Salamanca;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;28
37 Salamanca;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;28
37 Salamanca;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
37 Salamanca;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
37 Salamanca;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
37 Salamanca;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;42
37 Salamanca;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;38
37 Salamanca;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
37 Salamanca;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;90,48
37 Salamanca;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;10
37 Salamanca;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;6
37 Salamanca;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
37 Salamanca;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;60
37 Salamanca;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;32
37 Salamanca;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;32
37 Salamanca;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
37 Salamanca;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
37 Salamanca;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;19
37 Salamanca;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;19
37 Salamanca;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;19
37 Salamanca;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
37 Salamanca;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
37 Salamanca;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
37 Salamanca;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1
37 Salamanca;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1
37 Salamanca;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1
37 Salamanca;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
37 Salamanca;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
37 Salamanca;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
37 Salamanca;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;18
37 Salamanca;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;18
37 Salamanca;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;18
37 Salamanca;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
37 Salamanca;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
37 Salamanca;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
37 Salamanca;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;19
37 Salamanca;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;18
37 Salamanca;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
37 Salamanca;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,74
37 Salamanca;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1
37 Salamanca;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;0
37 Salamanca;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
37 Salamanca;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;0
37 Salamanca;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;18
37 Salamanca;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;18
37 Salamanca;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
37 Salamanca;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
37 Salamanca;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
37 Salamanca;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
37 Salamanca;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
37 Salamanca;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
37 Salamanca;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
37 Salamanca;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
37 Salamanca;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;27.058
38 Santa Cruz de Tenerife;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;25.514
38 Santa Cruz de Tenerife;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;24.403
38 Santa Cruz de Tenerife;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,29
38 Santa Cruz de Tenerife;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;90,19
38 Santa Cruz de Tenerife;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;9.989
38 Santa Cruz de Tenerife;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;9.129
38 Santa Cruz de Tenerife;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;8.512
38 Santa Cruz de Tenerife;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,39
38 Santa Cruz de Tenerife;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;85,21
38 Santa Cruz de Tenerife;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;17.069
38 Santa Cruz de Tenerife;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;16.385
38 Santa Cruz de Tenerife;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;15.891
38 Santa Cruz de Tenerife;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,99
38 Santa Cruz de Tenerife;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;93,1
38 Santa Cruz de Tenerife;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;26.986
38 Santa Cruz de Tenerife;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;25.609
38 Santa Cruz de Tenerife;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,9
38 Santa Cruz de Tenerife;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;9.367
38 Santa Cruz de Tenerife;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;8.582
38 Santa Cruz de Tenerife;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,62
38 Santa Cruz de Tenerife;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;17.619
38 Santa Cruz de Tenerife;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;17.027
38 Santa Cruz de Tenerife;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,64
38 Santa Cruz de Tenerife;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;19.537
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;18.117
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;17.124
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;92,73
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;87,65
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;7.981
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;7.177
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;6.620
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;89,93
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;82,95
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;11.556
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;10.940
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;10.504
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;94,67
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;90,9
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;19.505
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;18.237
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,5
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;7.550
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;6.816
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,28
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;11.955
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;11.421
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,53
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;3.223
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;3.152
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;3.089
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;97,8
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;95,84
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;973
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;939
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;906
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;96,51
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;93,11
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;2.250
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;2.213
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;2.183
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,36
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,02
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;3.207
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;3.150
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,22
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;905
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;875
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;96,69
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;2.302
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;2.275
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,83
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;4.020
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;3.967
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;3.913
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,68
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,34
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1.001
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;979
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;952
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,8
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;95,1
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;3.019
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;2.988
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;2.961
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,97
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,08
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;3.991
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;3.940
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,72
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;885
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;865
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;97,74
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;3.106
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;3.075
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;184
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;184
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;183
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;99,46
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;25
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;25
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;25
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;159
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;159
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;158
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;99,37
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;189
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;188
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;99,47
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;19
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;18
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;94,74
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;170
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;170
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;94
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;94
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;94
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;9
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;9
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;9
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;85
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;85
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;85
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;94
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;94
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;8
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;8
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;86
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;86
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;3.975
40 Segovia;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
40 Segovia;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;3.781
40 Segovia;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;3.626
40 Segovia;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
40 Segovia;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
40 Segovia;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;95,12
40 Segovia;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;91,22
40 Segovia;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1.094
40 Segovia;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
40 Segovia;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1.008
40 Segovia;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;937
40 Segovia;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
40 Segovia;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
40 Segovia;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;92,14
40 Segovia;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;85,65
40 Segovia;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;2.881
40 Segovia;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
40 Segovia;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;2.773
40 Segovia;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;2.689
40 Segovia;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
40 Segovia;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
40 Segovia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,25
40 Segovia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;93,34
40 Segovia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;3.979
40 Segovia;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;3.787
40 Segovia;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
40 Segovia;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
40 Segovia;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
40 Segovia;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
40 Segovia;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,17
40 Segovia;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
40 Segovia;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1.016
40 Segovia;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;921
40 Segovia;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
40 Segovia;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
40 Segovia;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
40 Segovia;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
40 Segovia;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,65
40 Segovia;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
40 Segovia;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;2.963
40 Segovia;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;2.866
40 Segovia;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
40 Segovia;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
40 Segovia;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
40 Segovia;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
40 Segovia;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,73
40 Segovia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
40 Segovia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
40 Segovia;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
40 Segovia;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
40 Segovia;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
40 Segovia;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
40 Segovia;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
40 Segovia;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
40 Segovia;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
40 Segovia;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
40 Segovia;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
40 Segovia;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
40 Segovia;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
40 Segovia;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
40 Segovia;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
40 Segovia;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
40 Segovia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
40 Segovia;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
40 Segovia;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
40 Segovia;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
40 Segovia;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
40 Segovia;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
40 Segovia;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
40 Segovia;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
40 Segovia;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
40 Segovia;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
40 Segovia;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
40 Segovia;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
40 Segovia;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
40 Segovia;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
40 Segovia;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
40 Segovia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;2.990
40 Segovia;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;2.814
40 Segovia;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;2.674
40 Segovia;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
40 Segovia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,11
40 Segovia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;89,43
40 Segovia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;900
40 Segovia;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;817
40 Segovia;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;751
40 Segovia;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
40 Segovia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;90,78
40 Segovia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;83,44
40 Segovia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;2.090
40 Segovia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.997
40 Segovia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.923
40 Segovia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
40 Segovia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,55
40 Segovia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;92,01
40 Segovia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;2.989
40 Segovia;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;2.820
40 Segovia;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
40 Segovia;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,35
40 Segovia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;835
40 Segovia;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;754
40 Segovia;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
40 Segovia;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,3
40 Segovia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;2.154
40 Segovia;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;2.066
40 Segovia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
40 Segovia;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,91
40 Segovia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;444
40 Segovia;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;436
40 Segovia;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;428
40 Segovia;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
40 Segovia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,2
40 Segovia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,4
40 Segovia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;107
40 Segovia;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;106
40 Segovia;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;105
40 Segovia;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
40 Segovia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;99,07
40 Segovia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;98,13
40 Segovia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;337
40 Segovia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;330
40 Segovia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;323
40 Segovia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
40 Segovia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;97,92
40 Segovia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;95,85
40 Segovia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;444
40 Segovia;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;436
40 Segovia;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
40 Segovia;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,2
40 Segovia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;98
40 Segovia;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;96
40 Segovia;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
40 Segovia;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;97,96
40 Segovia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;346
40 Segovia;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;340
40 Segovia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
40 Segovia;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,27
40 Segovia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;516
40 Segovia;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;507
40 Segovia;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;500
40 Segovia;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
40 Segovia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,26
40 Segovia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,9
40 Segovia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;86
40 Segovia;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;85
40 Segovia;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;81
40 Segovia;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
40 Segovia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,84
40 Segovia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;94,19
40 Segovia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;430
40 Segovia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;422
40 Segovia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;419
40 Segovia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
40 Segovia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,14
40 Segovia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,44
40 Segovia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;518
40 Segovia;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;507
40 Segovia;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
40 Segovia;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,88
40 Segovia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;79
40 Segovia;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;71
40 Segovia;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
40 Segovia;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;89,87
40 Segovia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;439
40 Segovia;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;436
40 Segovia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
40 Segovia;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,32
40 Segovia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;19
40 Segovia;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;18
40 Segovia;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;18
40 Segovia;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
40 Segovia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,74
40 Segovia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;94,74
40 Segovia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
40 Segovia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
40 Segovia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
40 Segovia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1
40 Segovia;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;0
40 Segovia;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;0
40 Segovia;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
40 Segovia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;0
40 Segovia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;0
40 Segovia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
40 Segovia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
40 Segovia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
40 Segovia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;18
40 Segovia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;18
40 Segovia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;18
40 Segovia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
40 Segovia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
40 Segovia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
40 Segovia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
40 Segovia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
40 Segovia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
40 Segovia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;21
40 Segovia;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;17
40 Segovia;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
40 Segovia;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;80,95
40 Segovia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
40 Segovia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
40 Segovia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
40 Segovia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
40 Segovia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;4
40 Segovia;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;0
40 Segovia;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
40 Segovia;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;0
40 Segovia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
40 Segovia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
40 Segovia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
40 Segovia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
40 Segovia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;17
40 Segovia;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;17
40 Segovia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
40 Segovia;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
40 Segovia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
40 Segovia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
40 Segovia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
40 Segovia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
40 Segovia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
40 Segovia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
40 Segovia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
40 Segovia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
40 Segovia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
40 Segovia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
40 Segovia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
40 Segovia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
40 Segovia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
40 Segovia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
40 Segovia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
40 Segovia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
40 Segovia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
40 Segovia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
40 Segovia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
40 Segovia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
40 Segovia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
40 Segovia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
40 Segovia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
40 Segovia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
40 Segovia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
40 Segovia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
40 Segovia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
40 Segovia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
40 Segovia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;6
40 Segovia;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;6
40 Segovia;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;6
40 Segovia;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
40 Segovia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
40 Segovia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
40 Segovia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;0
40 Segovia;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;0
40 Segovia;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;0
40 Segovia;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;..
40 Segovia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;..
40 Segovia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;..
40 Segovia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;6
40 Segovia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;6
40 Segovia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;6
40 Segovia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
40 Segovia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
40 Segovia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
40 Segovia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;7
40 Segovia;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;7
40 Segovia;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
40 Segovia;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
40 Segovia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;0
40 Segovia;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;0
40 Segovia;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;..
40 Segovia;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;..
40 Segovia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;7
40 Segovia;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;7
40 Segovia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
40 Segovia;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
40 Segovia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
40 Segovia;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
40 Segovia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
40 Segovia;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
40 Segovia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
40 Segovia;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
40 Segovia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;45.789
41 Sevilla;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
41 Sevilla;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;43.038
41 Sevilla;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;40.998
41 Sevilla;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
41 Sevilla;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
41 Sevilla;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,99
41 Sevilla;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;89,54
41 Sevilla;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;16.754
41 Sevilla;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
41 Sevilla;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;15.276
41 Sevilla;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;14.231
41 Sevilla;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
41 Sevilla;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
41 Sevilla;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,18
41 Sevilla;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;84,94
41 Sevilla;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;29.035
41 Sevilla;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
41 Sevilla;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;27.762
41 Sevilla;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;26.767
41 Sevilla;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
41 Sevilla;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
41 Sevilla;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,62
41 Sevilla;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;92,19
41 Sevilla;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;46.098
41 Sevilla;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;43.374
41 Sevilla;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
41 Sevilla;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
41 Sevilla;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
41 Sevilla;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
41 Sevilla;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,09
41 Sevilla;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;15.555
41 Sevilla;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;14.183
41 Sevilla;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
41 Sevilla;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
41 Sevilla;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
41 Sevilla;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
41 Sevilla;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,18
41 Sevilla;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;30.543
41 Sevilla;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;29.191
41 Sevilla;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
41 Sevilla;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
41 Sevilla;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
41 Sevilla;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
41 Sevilla;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,57
41 Sevilla;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
41 Sevilla;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
41 Sevilla;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
41 Sevilla;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
41 Sevilla;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
41 Sevilla;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
41 Sevilla;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
41 Sevilla;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
41 Sevilla;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
41 Sevilla;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
41 Sevilla;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
41 Sevilla;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
41 Sevilla;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
41 Sevilla;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
41 Sevilla;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
41 Sevilla;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
41 Sevilla;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
41 Sevilla;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
41 Sevilla;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
41 Sevilla;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
41 Sevilla;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
41 Sevilla;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
41 Sevilla;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
41 Sevilla;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
41 Sevilla;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;33.514
41 Sevilla;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;30.972
41 Sevilla;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;29.134
41 Sevilla;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
41 Sevilla;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;92,42
41 Sevilla;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;86,93
41 Sevilla;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;13.408
41 Sevilla;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;12.016
41 Sevilla;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;11.061
41 Sevilla;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
41 Sevilla;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;89,62
41 Sevilla;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;82,5
41 Sevilla;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;20.106
41 Sevilla;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;18.956
41 Sevilla;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;18.073
41 Sevilla;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
41 Sevilla;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;94,28
41 Sevilla;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;89,89
41 Sevilla;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;33.537
41 Sevilla;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;31.006
41 Sevilla;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
41 Sevilla;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;92,45
41 Sevilla;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;12.457
41 Sevilla;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;11.158
41 Sevilla;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
41 Sevilla;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;89,57
41 Sevilla;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;21.080
41 Sevilla;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;19.848
41 Sevilla;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
41 Sevilla;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;94,16
41 Sevilla;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;5.025
41 Sevilla;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;4.902
41 Sevilla;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;4.795
41 Sevilla;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
41 Sevilla;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;97,55
41 Sevilla;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;95,42
41 Sevilla;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1.558
41 Sevilla;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1.504
41 Sevilla;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.458
41 Sevilla;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
41 Sevilla;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;96,53
41 Sevilla;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;93,58
41 Sevilla;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;3.467
41 Sevilla;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;3.398
41 Sevilla;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;3.337
41 Sevilla;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
41 Sevilla;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,01
41 Sevilla;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,25
41 Sevilla;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;5.129
41 Sevilla;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;5.021
41 Sevilla;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
41 Sevilla;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,89
41 Sevilla;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1.490
41 Sevilla;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.451
41 Sevilla;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
41 Sevilla;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;97,38
41 Sevilla;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;3.639
41 Sevilla;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;3.570
41 Sevilla;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
41 Sevilla;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,1
41 Sevilla;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;6.774
41 Sevilla;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;6.690
41 Sevilla;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;6.596
41 Sevilla;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
41 Sevilla;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,76
41 Sevilla;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,37
41 Sevilla;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1.701
41 Sevilla;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1.670
41 Sevilla;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1.626
41 Sevilla;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
41 Sevilla;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,18
41 Sevilla;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;95,59
41 Sevilla;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;5.073
41 Sevilla;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;5.020
41 Sevilla;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;4.970
41 Sevilla;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
41 Sevilla;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,96
41 Sevilla;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,97
41 Sevilla;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;6.936
41 Sevilla;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;6.852
41 Sevilla;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
41 Sevilla;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,79
41 Sevilla;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1.545
41 Sevilla;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1.511
41 Sevilla;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
41 Sevilla;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;97,8
41 Sevilla;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;5.391
41 Sevilla;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;5.341
41 Sevilla;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
41 Sevilla;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,07
41 Sevilla;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;303
41 Sevilla;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;302
41 Sevilla;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;302
41 Sevilla;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
41 Sevilla;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,67
41 Sevilla;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;99,67
41 Sevilla;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;52
41 Sevilla;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;51
41 Sevilla;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;51
41 Sevilla;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
41 Sevilla;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,08
41 Sevilla;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;98,08
41 Sevilla;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;251
41 Sevilla;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;251
41 Sevilla;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;251
41 Sevilla;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
41 Sevilla;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
41 Sevilla;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
41 Sevilla;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;312
41 Sevilla;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;311
41 Sevilla;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
41 Sevilla;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;99,68
41 Sevilla;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;37
41 Sevilla;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;37
41 Sevilla;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
41 Sevilla;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
41 Sevilla;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;275
41 Sevilla;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;274
41 Sevilla;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
41 Sevilla;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,64
41 Sevilla;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;173
41 Sevilla;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;172
41 Sevilla;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;171
41 Sevilla;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
41 Sevilla;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,42
41 Sevilla;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;98,84
41 Sevilla;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;35
41 Sevilla;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;35
41 Sevilla;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;35
41 Sevilla;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
41 Sevilla;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
41 Sevilla;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
41 Sevilla;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;138
41 Sevilla;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;137
41 Sevilla;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;136
41 Sevilla;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
41 Sevilla;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,28
41 Sevilla;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,55
41 Sevilla;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;184
41 Sevilla;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;184
41 Sevilla;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
41 Sevilla;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
41 Sevilla;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;26
41 Sevilla;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;26
41 Sevilla;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
41 Sevilla;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
41 Sevilla;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;158
41 Sevilla;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;158
41 Sevilla;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
41 Sevilla;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
41 Sevilla;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
41 Sevilla;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
41 Sevilla;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
41 Sevilla;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
41 Sevilla;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
41 Sevilla;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
41 Sevilla;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;2.197
42 Soria;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
42 Soria;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;2.071
42 Soria;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.993
42 Soria;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
42 Soria;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
42 Soria;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
42 Soria;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,26
42 Soria;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;90,71
42 Soria;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
42 Soria;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
42 Soria;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
42 Soria;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;601
42 Soria;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
42 Soria;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;538
42 Soria;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;505
42 Soria;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
42 Soria;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
42 Soria;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
42 Soria;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;89,52
42 Soria;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;84,03
42 Soria;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
42 Soria;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
42 Soria;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
42 Soria;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.596
42 Soria;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
42 Soria;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.533
42 Soria;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.488
42 Soria;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
42 Soria;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
42 Soria;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
42 Soria;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,05
42 Soria;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;93,23
42 Soria;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
42 Soria;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
42 Soria;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
42 Soria;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;2.197
42 Soria;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;2.091
42 Soria;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
42 Soria;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
42 Soria;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
42 Soria;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
42 Soria;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,18
42 Soria;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
42 Soria;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
42 Soria;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
42 Soria;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
42 Soria;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
42 Soria;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;574
42 Soria;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;522
42 Soria;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
42 Soria;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
42 Soria;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
42 Soria;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
42 Soria;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,94
42 Soria;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
42 Soria;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
42 Soria;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
42 Soria;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
42 Soria;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
42 Soria;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.623
42 Soria;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.569
42 Soria;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
42 Soria;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
42 Soria;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
42 Soria;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
42 Soria;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,67
42 Soria;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
42 Soria;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
42 Soria;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
42 Soria;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
42 Soria;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
42 Soria;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
42 Soria;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
42 Soria;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
42 Soria;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
42 Soria;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
42 Soria;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
42 Soria;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
42 Soria;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
42 Soria;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
42 Soria;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
42 Soria;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
42 Soria;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
42 Soria;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
42 Soria;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
42 Soria;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
42 Soria;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
42 Soria;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
42 Soria;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
42 Soria;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
42 Soria;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
42 Soria;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
42 Soria;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
42 Soria;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
42 Soria;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
42 Soria;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
42 Soria;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
42 Soria;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
42 Soria;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
42 Soria;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
42 Soria;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
42 Soria;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
42 Soria;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
42 Soria;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
42 Soria;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
42 Soria;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
42 Soria;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
42 Soria;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
42 Soria;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
42 Soria;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
42 Soria;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
42 Soria;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
42 Soria;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
42 Soria;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
42 Soria;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
42 Soria;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
42 Soria;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
42 Soria;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
42 Soria;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
42 Soria;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
42 Soria;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
42 Soria;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
42 Soria;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
42 Soria;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
42 Soria;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
42 Soria;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
42 Soria;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
42 Soria;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
42 Soria;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
42 Soria;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
42 Soria;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
42 Soria;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.599
42 Soria;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
42 Soria;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.481
42 Soria;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.414
42 Soria;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
42 Soria;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
42 Soria;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;92,62
42 Soria;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;88,43
42 Soria;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;495
42 Soria;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
42 Soria;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;434
42 Soria;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;404
42 Soria;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
42 Soria;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
42 Soria;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;87,68
42 Soria;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;81,62
42 Soria;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.104
42 Soria;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
42 Soria;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.047
42 Soria;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.010
42 Soria;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
42 Soria;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
42 Soria;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;94,84
42 Soria;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;91,49
42 Soria;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.571
42 Soria;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.485
42 Soria;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
42 Soria;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
42 Soria;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
42 Soria;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
42 Soria;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,53
42 Soria;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;456
42 Soria;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;417
42 Soria;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
42 Soria;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
42 Soria;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
42 Soria;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
42 Soria;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,45
42 Soria;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.115
42 Soria;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.068
42 Soria;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
42 Soria;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
42 Soria;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
42 Soria;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
42 Soria;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,78
42 Soria;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
42 Soria;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
42 Soria;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
42 Soria;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
42 Soria;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
42 Soria;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
42 Soria;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
42 Soria;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
42 Soria;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
42 Soria;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
42 Soria;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
42 Soria;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
42 Soria;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
42 Soria;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
42 Soria;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
42 Soria;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
42 Soria;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
42 Soria;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
42 Soria;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
42 Soria;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
42 Soria;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
42 Soria;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
42 Soria;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
42 Soria;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
42 Soria;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;240
42 Soria;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
42 Soria;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;234
42 Soria;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;229
42 Soria;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
42 Soria;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
42 Soria;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;97,5
42 Soria;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;95,42
42 Soria;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;59
42 Soria;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
42 Soria;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;57
42 Soria;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;56
42 Soria;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
42 Soria;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
42 Soria;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;96,61
42 Soria;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;94,92
42 Soria;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;181
42 Soria;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
42 Soria;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;177
42 Soria;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;173
42 Soria;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
42 Soria;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
42 Soria;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;97,79
42 Soria;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;95,58
42 Soria;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;258
42 Soria;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;249
42 Soria;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
42 Soria;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
42 Soria;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
42 Soria;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
42 Soria;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;96,51
42 Soria;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;66
42 Soria;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;62
42 Soria;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
42 Soria;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
42 Soria;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
42 Soria;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
42 Soria;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;93,94
42 Soria;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;192
42 Soria;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;187
42 Soria;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
42 Soria;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
42 Soria;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
42 Soria;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
42 Soria;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;97,4
42 Soria;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
42 Soria;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
42 Soria;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
42 Soria;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
42 Soria;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
42 Soria;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
42 Soria;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
42 Soria;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
42 Soria;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
42 Soria;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
42 Soria;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
42 Soria;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
42 Soria;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
42 Soria;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
42 Soria;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
42 Soria;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
42 Soria;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
42 Soria;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
42 Soria;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
42 Soria;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
42 Soria;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
42 Soria;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
42 Soria;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
42 Soria;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
42 Soria;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;329
42 Soria;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
42 Soria;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;327
42 Soria;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;321
42 Soria;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
42 Soria;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
42 Soria;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,39
42 Soria;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,57
42 Soria;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;46
42 Soria;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
42 Soria;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;46
42 Soria;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;44
42 Soria;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
42 Soria;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
42 Soria;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
42 Soria;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;95,65
42 Soria;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;283
42 Soria;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
42 Soria;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;281
42 Soria;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;277
42 Soria;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
42 Soria;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
42 Soria;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,29
42 Soria;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,88
42 Soria;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;337
42 Soria;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;328
42 Soria;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
42 Soria;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
42 Soria;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
42 Soria;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
42 Soria;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,33
42 Soria;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;49
42 Soria;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;42
42 Soria;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
42 Soria;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
42 Soria;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
42 Soria;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
42 Soria;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;85,71
42 Soria;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;288
42 Soria;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;286
42 Soria;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
42 Soria;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
42 Soria;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
42 Soria;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
42 Soria;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,31
42 Soria;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
42 Soria;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
42 Soria;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
42 Soria;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
42 Soria;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
42 Soria;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
42 Soria;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
42 Soria;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
42 Soria;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
42 Soria;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
42 Soria;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
42 Soria;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
42 Soria;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
42 Soria;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
42 Soria;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
42 Soria;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
42 Soria;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
42 Soria;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
42 Soria;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
42 Soria;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
42 Soria;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
42 Soria;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
42 Soria;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
42 Soria;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
42 Soria;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;20
42 Soria;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
42 Soria;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;20
42 Soria;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;20
42 Soria;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
42 Soria;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
42 Soria;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
42 Soria;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
42 Soria;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
42 Soria;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
42 Soria;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
42 Soria;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
42 Soria;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;0
42 Soria;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
42 Soria;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;0
42 Soria;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;0
42 Soria;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
42 Soria;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;..
42 Soria;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
42 Soria;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;..
42 Soria;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;..
42 Soria;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
42 Soria;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
42 Soria;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
42 Soria;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;20
42 Soria;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
42 Soria;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;20
42 Soria;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;20
42 Soria;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
42 Soria;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
42 Soria;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
42 Soria;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
42 Soria;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
42 Soria;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
42 Soria;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
42 Soria;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
42 Soria;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;22
42 Soria;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;20
42 Soria;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
42 Soria;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
42 Soria;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
42 Soria;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
42 Soria;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;90,91
42 Soria;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
42 Soria;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
42 Soria;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
42 Soria;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
42 Soria;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
42 Soria;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;2
42 Soria;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;0
42 Soria;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
42 Soria;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
42 Soria;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
42 Soria;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
42 Soria;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;0
42 Soria;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
42 Soria;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
42 Soria;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
42 Soria;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
42 Soria;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
42 Soria;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;20
42 Soria;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;20
42 Soria;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
42 Soria;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
42 Soria;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
42 Soria;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
42 Soria;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
42 Soria;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
42 Soria;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
42 Soria;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
42 Soria;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
42 Soria;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
42 Soria;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
42 Soria;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
42 Soria;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
42 Soria;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
42 Soria;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
42 Soria;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
42 Soria;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
42 Soria;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
42 Soria;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
42 Soria;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
42 Soria;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
42 Soria;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
42 Soria;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
42 Soria;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
42 Soria;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
42 Soria;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
42 Soria;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
42 Soria;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
42 Soria;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
42 Soria;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
42 Soria;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
42 Soria;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
42 Soria;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
42 Soria;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
42 Soria;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
42 Soria;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
42 Soria;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
42 Soria;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
42 Soria;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
42 Soria;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
42 Soria;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
42 Soria;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
42 Soria;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
42 Soria;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
42 Soria;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
42 Soria;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
42 Soria;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
42 Soria;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
42 Soria;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
42 Soria;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
42 Soria;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
42 Soria;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
42 Soria;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
42 Soria;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
42 Soria;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
42 Soria;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
42 Soria;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
42 Soria;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
42 Soria;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
42 Soria;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
42 Soria;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
42 Soria;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
42 Soria;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
42 Soria;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
42 Soria;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
42 Soria;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
42 Soria;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
42 Soria;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
42 Soria;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
42 Soria;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
42 Soria;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;9
42 Soria;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
42 Soria;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;9
42 Soria;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;9
42 Soria;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
42 Soria;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
42 Soria;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
42 Soria;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
42 Soria;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1
42 Soria;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
42 Soria;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1
42 Soria;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1
42 Soria;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
42 Soria;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
42 Soria;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
42 Soria;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
42 Soria;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;8
42 Soria;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
42 Soria;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;8
42 Soria;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;8
42 Soria;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
42 Soria;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
42 Soria;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
42 Soria;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
42 Soria;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;9
42 Soria;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;9
42 Soria;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
42 Soria;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
42 Soria;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
42 Soria;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
42 Soria;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
42 Soria;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1
42 Soria;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1
42 Soria;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
42 Soria;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
42 Soria;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
42 Soria;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
42 Soria;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
42 Soria;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;8
42 Soria;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;8
42 Soria;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
42 Soria;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
42 Soria;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
42 Soria;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
42 Soria;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
42 Soria;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
42 Soria;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
42 Soria;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
42 Soria;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
42 Soria;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
42 Soria;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
42 Soria;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
42 Soria;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
42 Soria;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
42 Soria;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
42 Soria;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
42 Soria;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
42 Soria;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
42 Soria;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
42 Soria;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
42 Soria;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
42 Soria;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
42 Soria;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
42 Soria;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
42 Soria;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
42 Soria;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
42 Soria;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
42 Soria;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
42 Soria;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
42 Soria;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
42 Soria;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
42 Soria;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
42 Soria;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
42 Soria;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
42 Soria;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
42 Soria;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
42 Soria;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
42 Soria;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
42 Soria;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
42 Soria;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
42 Soria;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
42 Soria;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;19.706
43 Tarragona;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
43 Tarragona;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;18.522
43 Tarragona;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;17.639
43 Tarragona;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
43 Tarragona;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
43 Tarragona;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,99
43 Tarragona;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;89,51
43 Tarragona;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;6.673
43 Tarragona;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
43 Tarragona;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;6.045
43 Tarragona;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;5.627
43 Tarragona;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
43 Tarragona;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
43 Tarragona;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;90,59
43 Tarragona;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;84,32
43 Tarragona;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;13.033
43 Tarragona;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
43 Tarragona;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;12.477
43 Tarragona;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;12.012
43 Tarragona;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
43 Tarragona;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
43 Tarragona;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,73
43 Tarragona;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;92,17
43 Tarragona;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;20.175
43 Tarragona;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;19.077
43 Tarragona;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
43 Tarragona;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
43 Tarragona;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
43 Tarragona;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
43 Tarragona;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,56
43 Tarragona;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;6.466
43 Tarragona;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;5.941
43 Tarragona;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
43 Tarragona;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
43 Tarragona;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
43 Tarragona;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
43 Tarragona;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,88
43 Tarragona;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;13.709
43 Tarragona;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;13.136
43 Tarragona;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
43 Tarragona;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
43 Tarragona;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
43 Tarragona;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
43 Tarragona;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,82
43 Tarragona;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
43 Tarragona;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
43 Tarragona;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
43 Tarragona;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
43 Tarragona;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
43 Tarragona;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
43 Tarragona;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
43 Tarragona;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
43 Tarragona;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
43 Tarragona;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
43 Tarragona;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
43 Tarragona;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
43 Tarragona;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
43 Tarragona;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
43 Tarragona;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
43 Tarragona;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
43 Tarragona;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
43 Tarragona;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
43 Tarragona;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
43 Tarragona;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
43 Tarragona;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
43 Tarragona;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
43 Tarragona;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
43 Tarragona;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
43 Tarragona;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;14.766
43 Tarragona;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;13.653
43 Tarragona;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;12.852
43 Tarragona;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
43 Tarragona;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;92,46
43 Tarragona;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;87,04
43 Tarragona;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;5.634
43 Tarragona;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;5.030
43 Tarragona;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;4.632
43 Tarragona;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
43 Tarragona;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;89,28
43 Tarragona;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;82,22
43 Tarragona;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;9.132
43 Tarragona;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;8.623
43 Tarragona;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;8.220
43 Tarragona;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
43 Tarragona;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;94,43
43 Tarragona;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;90,01
43 Tarragona;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;14.920
43 Tarragona;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;13.909
43 Tarragona;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
43 Tarragona;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,22
43 Tarragona;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;5.461
43 Tarragona;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;4.956
43 Tarragona;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
43 Tarragona;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,75
43 Tarragona;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;9.459
43 Tarragona;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;8.953
43 Tarragona;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
43 Tarragona;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;94,65
43 Tarragona;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;2.132
43 Tarragona;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;2.087
43 Tarragona;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;2.042
43 Tarragona;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
43 Tarragona;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;97,89
43 Tarragona;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;95,78
43 Tarragona;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;553
43 Tarragona;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;536
43 Tarragona;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;526
43 Tarragona;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
43 Tarragona;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;96,93
43 Tarragona;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;95,12
43 Tarragona;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.579
43 Tarragona;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.551
43 Tarragona;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.516
43 Tarragona;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
43 Tarragona;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,23
43 Tarragona;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,01
43 Tarragona;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;2.215
43 Tarragona;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;2.169
43 Tarragona;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
43 Tarragona;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,92
43 Tarragona;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;539
43 Tarragona;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;527
43 Tarragona;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
43 Tarragona;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;97,77
43 Tarragona;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.676
43 Tarragona;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.642
43 Tarragona;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
43 Tarragona;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;97,97
43 Tarragona;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;2.589
43 Tarragona;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;2.565
43 Tarragona;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;2.528
43 Tarragona;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
43 Tarragona;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,07
43 Tarragona;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,64
43 Tarragona;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;456
43 Tarragona;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;449
43 Tarragona;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;439
43 Tarragona;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
43 Tarragona;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,46
43 Tarragona;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;96,27
43 Tarragona;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;2.133
43 Tarragona;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;2.116
43 Tarragona;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;2.089
43 Tarragona;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
43 Tarragona;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,2
43 Tarragona;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,94
43 Tarragona;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;2.806
43 Tarragona;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;2.765
43 Tarragona;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
43 Tarragona;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,54
43 Tarragona;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;444
43 Tarragona;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;436
43 Tarragona;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
43 Tarragona;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;98,2
43 Tarragona;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;2.362
43 Tarragona;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;2.329
43 Tarragona;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
43 Tarragona;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,6
43 Tarragona;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;139
43 Tarragona;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;137
43 Tarragona;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;137
43 Tarragona;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
43 Tarragona;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,56
43 Tarragona;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;98,56
43 Tarragona;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;23
43 Tarragona;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;23
43 Tarragona;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;23
43 Tarragona;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
43 Tarragona;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
43 Tarragona;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
43 Tarragona;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;116
43 Tarragona;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;114
43 Tarragona;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;114
43 Tarragona;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
43 Tarragona;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,28
43 Tarragona;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,28
43 Tarragona;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;150
43 Tarragona;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;150
43 Tarragona;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
43 Tarragona;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
43 Tarragona;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;13
43 Tarragona;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;13
43 Tarragona;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
43 Tarragona;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
43 Tarragona;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;137
43 Tarragona;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;137
43 Tarragona;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
43 Tarragona;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
43 Tarragona;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;80
43 Tarragona;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;80
43 Tarragona;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;80
43 Tarragona;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
43 Tarragona;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
43 Tarragona;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
43 Tarragona;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;7
43 Tarragona;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;7
43 Tarragona;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;7
43 Tarragona;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
43 Tarragona;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
43 Tarragona;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
43 Tarragona;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;73
43 Tarragona;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;73
43 Tarragona;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;73
43 Tarragona;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
43 Tarragona;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
43 Tarragona;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
43 Tarragona;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;84
43 Tarragona;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;84
43 Tarragona;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
43 Tarragona;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
43 Tarragona;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;9
43 Tarragona;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;9
43 Tarragona;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
43 Tarragona;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
43 Tarragona;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;75
43 Tarragona;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;75
43 Tarragona;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
43 Tarragona;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
43 Tarragona;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
43 Tarragona;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
43 Tarragona;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
43 Tarragona;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
43 Tarragona;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
43 Tarragona;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
43 Tarragona;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;3.467
44 Teruel;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
44 Teruel;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;3.294
44 Teruel;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;3.153
44 Teruel;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
44 Teruel;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
44 Teruel;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;95,01
44 Teruel;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;90,94
44 Teruel;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1.025
44 Teruel;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
44 Teruel;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;945
44 Teruel;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;878
44 Teruel;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
44 Teruel;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
44 Teruel;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;92,2
44 Teruel;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;85,66
44 Teruel;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;2.442
44 Teruel;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
44 Teruel;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;2.349
44 Teruel;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;2.275
44 Teruel;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
44 Teruel;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
44 Teruel;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,19
44 Teruel;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;93,16
44 Teruel;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;3.451
44 Teruel;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;3.271
44 Teruel;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
44 Teruel;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
44 Teruel;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
44 Teruel;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
44 Teruel;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,78
44 Teruel;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
44 Teruel;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;957
44 Teruel;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;872
44 Teruel;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
44 Teruel;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
44 Teruel;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
44 Teruel;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
44 Teruel;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,12
44 Teruel;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
44 Teruel;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;2.494
44 Teruel;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;2.399
44 Teruel;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
44 Teruel;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
44 Teruel;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
44 Teruel;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
44 Teruel;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,19
44 Teruel;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
44 Teruel;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
44 Teruel;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
44 Teruel;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
44 Teruel;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
44 Teruel;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
44 Teruel;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
44 Teruel;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
44 Teruel;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
44 Teruel;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
44 Teruel;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
44 Teruel;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
44 Teruel;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
44 Teruel;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
44 Teruel;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
44 Teruel;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
44 Teruel;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
44 Teruel;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
44 Teruel;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
44 Teruel;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
44 Teruel;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
44 Teruel;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
44 Teruel;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
44 Teruel;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
44 Teruel;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
44 Teruel;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
44 Teruel;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
44 Teruel;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
44 Teruel;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
44 Teruel;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
44 Teruel;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
44 Teruel;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;2.643
44 Teruel;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;2.476
44 Teruel;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;2.351
44 Teruel;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
44 Teruel;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,68
44 Teruel;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;88,95
44 Teruel;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;883
44 Teruel;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;804
44 Teruel;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;745
44 Teruel;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
44 Teruel;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,05
44 Teruel;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;84,37
44 Teruel;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.760
44 Teruel;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.672
44 Teruel;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.606
44 Teruel;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
44 Teruel;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95
44 Teruel;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;91,25
44 Teruel;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;2.590
44 Teruel;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;2.432
44 Teruel;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
44 Teruel;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,9
44 Teruel;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;816
44 Teruel;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;744
44 Teruel;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
44 Teruel;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,18
44 Teruel;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.774
44 Teruel;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.688
44 Teruel;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
44 Teruel;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,15
44 Teruel;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;377
44 Teruel;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;372
44 Teruel;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;364
44 Teruel;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
44 Teruel;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,67
44 Teruel;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,55
44 Teruel;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;73
44 Teruel;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;72
44 Teruel;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;69
44 Teruel;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
44 Teruel;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,63
44 Teruel;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;94,52
44 Teruel;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;304
44 Teruel;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;300
44 Teruel;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;295
44 Teruel;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
44 Teruel;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,68
44 Teruel;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,04
44 Teruel;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;396
44 Teruel;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;389
44 Teruel;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
44 Teruel;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,23
44 Teruel;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;83
44 Teruel;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;81
44 Teruel;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
44 Teruel;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;97,59
44 Teruel;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;313
44 Teruel;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;308
44 Teruel;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
44 Teruel;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,4
44 Teruel;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;423
44 Teruel;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;422
44 Teruel;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;414
44 Teruel;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
44 Teruel;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,76
44 Teruel;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,87
44 Teruel;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;68
44 Teruel;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;68
44 Teruel;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;63
44 Teruel;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
44 Teruel;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
44 Teruel;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;92,65
44 Teruel;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;355
44 Teruel;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;354
44 Teruel;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;351
44 Teruel;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
44 Teruel;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,72
44 Teruel;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,87
44 Teruel;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;439
44 Teruel;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;425
44 Teruel;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
44 Teruel;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;96,81
44 Teruel;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;55
44 Teruel;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;45
44 Teruel;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
44 Teruel;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;81,82
44 Teruel;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;384
44 Teruel;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;380
44 Teruel;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
44 Teruel;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,96
44 Teruel;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;20
44 Teruel;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;20
44 Teruel;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;20
44 Teruel;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
44 Teruel;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
44 Teruel;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
44 Teruel;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
44 Teruel;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
44 Teruel;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
44 Teruel;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1
44 Teruel;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1
44 Teruel;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1
44 Teruel;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
44 Teruel;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
44 Teruel;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
44 Teruel;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
44 Teruel;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
44 Teruel;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
44 Teruel;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;19
44 Teruel;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;19
44 Teruel;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;19
44 Teruel;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
44 Teruel;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
44 Teruel;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
44 Teruel;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
44 Teruel;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
44 Teruel;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
44 Teruel;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;23
44 Teruel;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;22
44 Teruel;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
44 Teruel;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,65
44 Teruel;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
44 Teruel;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
44 Teruel;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
44 Teruel;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
44 Teruel;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;3
44 Teruel;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;2
44 Teruel;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
44 Teruel;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;66,67
44 Teruel;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
44 Teruel;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
44 Teruel;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
44 Teruel;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
44 Teruel;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;20
44 Teruel;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;20
44 Teruel;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
44 Teruel;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
44 Teruel;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
44 Teruel;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
44 Teruel;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
44 Teruel;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
44 Teruel;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
44 Teruel;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
44 Teruel;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
44 Teruel;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
44 Teruel;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
44 Teruel;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
44 Teruel;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
44 Teruel;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
44 Teruel;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
44 Teruel;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
44 Teruel;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
44 Teruel;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
44 Teruel;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
44 Teruel;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
44 Teruel;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
44 Teruel;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
44 Teruel;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
44 Teruel;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
44 Teruel;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
44 Teruel;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
44 Teruel;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
44 Teruel;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
44 Teruel;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
44 Teruel;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
44 Teruel;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;4
44 Teruel;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;4
44 Teruel;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;4
44 Teruel;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
44 Teruel;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
44 Teruel;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
44 Teruel;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;0
44 Teruel;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;0
44 Teruel;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;0
44 Teruel;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;..
44 Teruel;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;..
44 Teruel;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;..
44 Teruel;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;4
44 Teruel;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;4
44 Teruel;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;4
44 Teruel;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
44 Teruel;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
44 Teruel;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
44 Teruel;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;3
44 Teruel;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;3
44 Teruel;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
44 Teruel;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
44 Teruel;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;0
44 Teruel;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;0
44 Teruel;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;..
44 Teruel;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;..
44 Teruel;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;3
44 Teruel;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;3
44 Teruel;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
44 Teruel;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
44 Teruel;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
44 Teruel;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
44 Teruel;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
44 Teruel;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
44 Teruel;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
44 Teruel;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
44 Teruel;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;16.036
45 Toledo;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
45 Toledo;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;15.133
45 Toledo;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;14.459
45 Toledo;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
45 Toledo;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
45 Toledo;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,37
45 Toledo;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;90,17
45 Toledo;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;5.264
45 Toledo;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
45 Toledo;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;4.767
45 Toledo;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;4.421
45 Toledo;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
45 Toledo;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
45 Toledo;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;90,56
45 Toledo;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;83,99
45 Toledo;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;10.772
45 Toledo;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
45 Toledo;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;10.366
45 Toledo;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;10.038
45 Toledo;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
45 Toledo;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
45 Toledo;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,23
45 Toledo;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;93,19
45 Toledo;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;16.138
45 Toledo;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;15.271
45 Toledo;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
45 Toledo;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
45 Toledo;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
45 Toledo;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
45 Toledo;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,63
45 Toledo;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
45 Toledo;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;5.024
45 Toledo;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;4.564
45 Toledo;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
45 Toledo;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
45 Toledo;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
45 Toledo;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
45 Toledo;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,84
45 Toledo;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
45 Toledo;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;11.114
45 Toledo;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;10.707
45 Toledo;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
45 Toledo;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
45 Toledo;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
45 Toledo;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
45 Toledo;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,34
45 Toledo;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
45 Toledo;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
45 Toledo;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
45 Toledo;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
45 Toledo;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
45 Toledo;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
45 Toledo;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
45 Toledo;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
45 Toledo;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
45 Toledo;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
45 Toledo;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
45 Toledo;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
45 Toledo;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
45 Toledo;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
45 Toledo;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
45 Toledo;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
45 Toledo;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
45 Toledo;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
45 Toledo;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
45 Toledo;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
45 Toledo;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
45 Toledo;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
45 Toledo;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
45 Toledo;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
45 Toledo;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
45 Toledo;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
45 Toledo;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
45 Toledo;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
45 Toledo;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
45 Toledo;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
45 Toledo;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
45 Toledo;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;11.929
45 Toledo;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;11.080
45 Toledo;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;10.473
45 Toledo;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
45 Toledo;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;92,88
45 Toledo;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;87,79
45 Toledo;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;4.401
45 Toledo;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;3.925
45 Toledo;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;3.607
45 Toledo;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
45 Toledo;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;89,18
45 Toledo;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;81,96
45 Toledo;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;7.528
45 Toledo;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;7.155
45 Toledo;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;6.866
45 Toledo;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
45 Toledo;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,05
45 Toledo;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;91,21
45 Toledo;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;11.927
45 Toledo;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;11.157
45 Toledo;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
45 Toledo;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,54
45 Toledo;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;4.171
45 Toledo;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;3.772
45 Toledo;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
45 Toledo;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,43
45 Toledo;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;7.756
45 Toledo;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;7.385
45 Toledo;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
45 Toledo;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,22
45 Toledo;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.724
45 Toledo;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.694
45 Toledo;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.663
45 Toledo;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
45 Toledo;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,26
45 Toledo;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,46
45 Toledo;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;430
45 Toledo;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;415
45 Toledo;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;404
45 Toledo;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
45 Toledo;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;96,51
45 Toledo;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;93,95
45 Toledo;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.294
45 Toledo;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.279
45 Toledo;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.259
45 Toledo;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
45 Toledo;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,84
45 Toledo;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,3
45 Toledo;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.751
45 Toledo;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.721
45 Toledo;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
45 Toledo;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,29
45 Toledo;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;420
45 Toledo;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;408
45 Toledo;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
45 Toledo;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;97,14
45 Toledo;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.331
45 Toledo;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.313
45 Toledo;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
45 Toledo;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,65
45 Toledo;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;2.263
45 Toledo;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;2.239
45 Toledo;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;2.204
45 Toledo;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
45 Toledo;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,94
45 Toledo;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,39
45 Toledo;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;423
45 Toledo;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;417
45 Toledo;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;400
45 Toledo;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
45 Toledo;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,58
45 Toledo;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;94,56
45 Toledo;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.840
45 Toledo;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.822
45 Toledo;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.804
45 Toledo;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
45 Toledo;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,02
45 Toledo;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,04
45 Toledo;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;2.324
45 Toledo;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;2.267
45 Toledo;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
45 Toledo;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,55
45 Toledo;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;417
45 Toledo;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;377
45 Toledo;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
45 Toledo;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,41
45 Toledo;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.907
45 Toledo;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.890
45 Toledo;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
45 Toledo;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,11
45 Toledo;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;75
45 Toledo;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;75
45 Toledo;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;74
45 Toledo;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
45 Toledo;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
45 Toledo;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;98,67
45 Toledo;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
45 Toledo;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
45 Toledo;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
45 Toledo;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;6
45 Toledo;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;6
45 Toledo;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;6
45 Toledo;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
45 Toledo;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
45 Toledo;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
45 Toledo;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
45 Toledo;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
45 Toledo;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
45 Toledo;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;69
45 Toledo;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;69
45 Toledo;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;68
45 Toledo;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
45 Toledo;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
45 Toledo;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,55
45 Toledo;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
45 Toledo;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
45 Toledo;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
45 Toledo;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;88
45 Toledo;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;80
45 Toledo;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
45 Toledo;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;90,91
45 Toledo;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
45 Toledo;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
45 Toledo;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
45 Toledo;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
45 Toledo;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;10
45 Toledo;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;3
45 Toledo;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
45 Toledo;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;30
45 Toledo;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
45 Toledo;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
45 Toledo;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
45 Toledo;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
45 Toledo;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;78
45 Toledo;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;77
45 Toledo;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
45 Toledo;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,72
45 Toledo;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
45 Toledo;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
45 Toledo;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
45 Toledo;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
45 Toledo;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
45 Toledo;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
45 Toledo;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
45 Toledo;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
45 Toledo;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
45 Toledo;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
45 Toledo;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
45 Toledo;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
45 Toledo;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
45 Toledo;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
45 Toledo;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
45 Toledo;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
45 Toledo;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
45 Toledo;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
45 Toledo;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
45 Toledo;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
45 Toledo;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
45 Toledo;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
45 Toledo;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
45 Toledo;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
45 Toledo;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
45 Toledo;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
45 Toledo;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
45 Toledo;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
45 Toledo;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;45
45 Toledo;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;45
45 Toledo;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;45
45 Toledo;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
45 Toledo;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
45 Toledo;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
45 Toledo;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;4
45 Toledo;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;4
45 Toledo;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;4
45 Toledo;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
45 Toledo;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
45 Toledo;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
45 Toledo;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;41
45 Toledo;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;41
45 Toledo;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;41
45 Toledo;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
45 Toledo;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
45 Toledo;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
45 Toledo;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;48
45 Toledo;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;46
45 Toledo;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
45 Toledo;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,83
45 Toledo;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;6
45 Toledo;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;4
45 Toledo;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
45 Toledo;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;66,67
45 Toledo;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;42
45 Toledo;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;42
45 Toledo;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
45 Toledo;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
45 Toledo;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
45 Toledo;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
45 Toledo;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
45 Toledo;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
45 Toledo;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
45 Toledo;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
45 Toledo;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;69.116
46 Valencia/València;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
46 Valencia/València;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;65.065
46 Valencia/València;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;62.196
46 Valencia/València;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
46 Valencia/València;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
46 Valencia/València;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,14
46 Valencia/València;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;89,99
46 Valencia/València;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;24.636
46 Valencia/València;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
46 Valencia/València;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;22.373
46 Valencia/València;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;20.830
46 Valencia/València;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
46 Valencia/València;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
46 Valencia/València;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;90,81
46 Valencia/València;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;84,55
46 Valencia/València;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;44.480
46 Valencia/València;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
46 Valencia/València;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;42.692
46 Valencia/València;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;41.366
46 Valencia/València;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
46 Valencia/València;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
46 Valencia/València;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,98
46 Valencia/València;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;93
46 Valencia/València;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;69.538
46 Valencia/València;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;65.893
46 Valencia/València;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
46 Valencia/València;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
46 Valencia/València;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
46 Valencia/València;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
46 Valencia/València;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,76
46 Valencia/València;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;23.251
46 Valencia/València;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;21.289
46 Valencia/València;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
46 Valencia/València;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
46 Valencia/València;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
46 Valencia/València;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
46 Valencia/València;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,56
46 Valencia/València;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;46.287
46 Valencia/València;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;44.604
46 Valencia/València;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
46 Valencia/València;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
46 Valencia/València;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
46 Valencia/València;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
46 Valencia/València;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,36
46 Valencia/València;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
46 Valencia/València;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
46 Valencia/València;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
46 Valencia/València;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
46 Valencia/València;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
46 Valencia/València;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
46 Valencia/València;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
46 Valencia/València;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
46 Valencia/València;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
46 Valencia/València;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
46 Valencia/València;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
46 Valencia/València;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
46 Valencia/València;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
46 Valencia/València;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
46 Valencia/València;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
46 Valencia/València;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
46 Valencia/València;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
46 Valencia/València;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
46 Valencia/València;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
46 Valencia/València;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
46 Valencia/València;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
46 Valencia/València;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
46 Valencia/València;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
46 Valencia/València;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
46 Valencia/València;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;49.815
46 Valencia/València;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;46.081
46 Valencia/València;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;43.532
46 Valencia/València;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
46 Valencia/València;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;92,5
46 Valencia/València;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;87,39
46 Valencia/València;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;19.949
46 Valencia/València;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;17.803
46 Valencia/València;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;16.385
46 Valencia/València;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
46 Valencia/València;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;89,24
46 Valencia/València;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;82,13
46 Valencia/València;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;29.866
46 Valencia/València;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;28.278
46 Valencia/València;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;27.147
46 Valencia/València;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
46 Valencia/València;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;94,68
46 Valencia/València;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;90,9
46 Valencia/València;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;49.933
46 Valencia/València;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;46.593
46 Valencia/València;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
46 Valencia/València;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,31
46 Valencia/València;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;18.859
46 Valencia/València;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;16.998
46 Valencia/València;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
46 Valencia/València;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,13
46 Valencia/València;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;31.074
46 Valencia/València;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;29.595
46 Valencia/València;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
46 Valencia/València;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,24
46 Valencia/València;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;7.584
46 Valencia/València;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;7.433
46 Valencia/València;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;7.248
46 Valencia/València;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
46 Valencia/València;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,01
46 Valencia/València;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;95,57
46 Valencia/València;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;2.286
46 Valencia/València;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;2.228
46 Valencia/València;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;2.147
46 Valencia/València;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
46 Valencia/València;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,46
46 Valencia/València;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;93,92
46 Valencia/València;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;5.298
46 Valencia/València;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;5.205
46 Valencia/València;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;5.101
46 Valencia/València;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
46 Valencia/València;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,24
46 Valencia/València;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,28
46 Valencia/València;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;7.659
46 Valencia/València;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;7.489
46 Valencia/València;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
46 Valencia/València;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,78
46 Valencia/València;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;2.138
46 Valencia/València;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;2.079
46 Valencia/València;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
46 Valencia/València;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;97,24
46 Valencia/València;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;5.521
46 Valencia/València;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;5.410
46 Valencia/València;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
46 Valencia/València;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;97,99
46 Valencia/València;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;10.797
46 Valencia/València;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;10.641
46 Valencia/València;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;10.511
46 Valencia/València;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
46 Valencia/València;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,56
46 Valencia/València;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,35
46 Valencia/València;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;2.250
46 Valencia/València;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;2.194
46 Valencia/València;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;2.151
46 Valencia/València;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
46 Valencia/València;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,51
46 Valencia/València;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;95,6
46 Valencia/València;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;8.547
46 Valencia/València;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;8.447
46 Valencia/València;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;8.360
46 Valencia/València;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
46 Valencia/València;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,83
46 Valencia/València;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,81
46 Valencia/València;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;10.975
46 Valencia/València;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;10.845
46 Valencia/València;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
46 Valencia/València;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,82
46 Valencia/València;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;2.101
46 Valencia/València;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;2.059
46 Valencia/València;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
46 Valencia/València;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;98
46 Valencia/València;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;8.874
46 Valencia/València;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;8.786
46 Valencia/València;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
46 Valencia/València;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,01
46 Valencia/València;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;603
46 Valencia/València;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;596
46 Valencia/València;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;594
46 Valencia/València;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
46 Valencia/València;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,84
46 Valencia/València;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;98,51
46 Valencia/València;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;96
46 Valencia/València;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;95
46 Valencia/València;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;95
46 Valencia/València;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
46 Valencia/València;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,96
46 Valencia/València;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;98,96
46 Valencia/València;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;507
46 Valencia/València;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;501
46 Valencia/València;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;499
46 Valencia/València;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
46 Valencia/València;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,82
46 Valencia/València;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,42
46 Valencia/València;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;648
46 Valencia/València;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;646
46 Valencia/València;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
46 Valencia/València;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;99,69
46 Valencia/València;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;101
46 Valencia/València;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;101
46 Valencia/València;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
46 Valencia/València;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
46 Valencia/València;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;547
46 Valencia/València;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;545
46 Valencia/València;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
46 Valencia/València;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,63
46 Valencia/València;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;317
46 Valencia/València;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;314
46 Valencia/València;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;311
46 Valencia/València;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
46 Valencia/València;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,05
46 Valencia/València;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;98,11
46 Valencia/València;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;55
46 Valencia/València;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;53
46 Valencia/València;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;52
46 Valencia/València;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
46 Valencia/València;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;96,36
46 Valencia/València;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;94,55
46 Valencia/València;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;262
46 Valencia/València;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;261
46 Valencia/València;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;259
46 Valencia/València;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
46 Valencia/València;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,62
46 Valencia/València;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,85
46 Valencia/València;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;323
46 Valencia/València;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;320
46 Valencia/València;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
46 Valencia/València;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;99,07
46 Valencia/València;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;52
46 Valencia/València;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;52
46 Valencia/València;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
46 Valencia/València;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
46 Valencia/València;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;271
46 Valencia/València;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;268
46 Valencia/València;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
46 Valencia/València;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,89
46 Valencia/València;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;11.706
47 Valladolid;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
47 Valladolid;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;11.156
47 Valladolid;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;10.712
47 Valladolid;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
47 Valladolid;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
47 Valladolid;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;95,3
47 Valladolid;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;91,51
47 Valladolid;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;3.346
47 Valladolid;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
47 Valladolid;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;3.080
47 Valladolid;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;2.881
47 Valladolid;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
47 Valladolid;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
47 Valladolid;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;92,05
47 Valladolid;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;86,1
47 Valladolid;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;8.360
47 Valladolid;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
47 Valladolid;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;8.076
47 Valladolid;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;7.831
47 Valladolid;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
47 Valladolid;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
47 Valladolid;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,6
47 Valladolid;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;93,67
47 Valladolid;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;11.701
47 Valladolid;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;11.132
47 Valladolid;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
47 Valladolid;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
47 Valladolid;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
47 Valladolid;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
47 Valladolid;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,14
47 Valladolid;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;3.110
47 Valladolid;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;2.835
47 Valladolid;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
47 Valladolid;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
47 Valladolid;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
47 Valladolid;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
47 Valladolid;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,16
47 Valladolid;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;8.591
47 Valladolid;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;8.297
47 Valladolid;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
47 Valladolid;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
47 Valladolid;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
47 Valladolid;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
47 Valladolid;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,58
47 Valladolid;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
47 Valladolid;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
47 Valladolid;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
47 Valladolid;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
47 Valladolid;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
47 Valladolid;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
47 Valladolid;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
47 Valladolid;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
47 Valladolid;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
47 Valladolid;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
47 Valladolid;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
47 Valladolid;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
47 Valladolid;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
47 Valladolid;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
47 Valladolid;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
47 Valladolid;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
47 Valladolid;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
47 Valladolid;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
47 Valladolid;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
47 Valladolid;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
47 Valladolid;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
47 Valladolid;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
47 Valladolid;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
47 Valladolid;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
47 Valladolid;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;8.405
47 Valladolid;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;7.889
47 Valladolid;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;7.495
47 Valladolid;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
47 Valladolid;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,86
47 Valladolid;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;89,17
47 Valladolid;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;2.705
47 Valladolid;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;2.447
47 Valladolid;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;2.265
47 Valladolid;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
47 Valladolid;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;90,46
47 Valladolid;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;83,73
47 Valladolid;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;5.700
47 Valladolid;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;5.442
47 Valladolid;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;5.230
47 Valladolid;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
47 Valladolid;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,47
47 Valladolid;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;91,75
47 Valladolid;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;8.341
47 Valladolid;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;7.839
47 Valladolid;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
47 Valladolid;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,98
47 Valladolid;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;2.504
47 Valladolid;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;2.262
47 Valladolid;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
47 Valladolid;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,34
47 Valladolid;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;5.837
47 Valladolid;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;5.577
47 Valladolid;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
47 Valladolid;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,55
47 Valladolid;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.304
47 Valladolid;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.282
47 Valladolid;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.258
47 Valladolid;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
47 Valladolid;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,31
47 Valladolid;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,47
47 Valladolid;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;289
47 Valladolid;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;282
47 Valladolid;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;275
47 Valladolid;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
47 Valladolid;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,58
47 Valladolid;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;95,16
47 Valladolid;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.015
47 Valladolid;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.000
47 Valladolid;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;983
47 Valladolid;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
47 Valladolid;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,52
47 Valladolid;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,85
47 Valladolid;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.312
47 Valladolid;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.289
47 Valladolid;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
47 Valladolid;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,25
47 Valladolid;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;279
47 Valladolid;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;271
47 Valladolid;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
47 Valladolid;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;97,13
47 Valladolid;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.033
47 Valladolid;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.018
47 Valladolid;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
47 Valladolid;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,55
47 Valladolid;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.838
47 Valladolid;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.826
47 Valladolid;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.800
47 Valladolid;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
47 Valladolid;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,35
47 Valladolid;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,93
47 Valladolid;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;319
47 Valladolid;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;318
47 Valladolid;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;308
47 Valladolid;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
47 Valladolid;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;99,69
47 Valladolid;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;96,55
47 Valladolid;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.519
47 Valladolid;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.508
47 Valladolid;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.492
47 Valladolid;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
47 Valladolid;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,28
47 Valladolid;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,22
47 Valladolid;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.865
47 Valladolid;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.828
47 Valladolid;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
47 Valladolid;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,02
47 Valladolid;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;292
47 Valladolid;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;274
47 Valladolid;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
47 Valladolid;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;93,84
47 Valladolid;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.573
47 Valladolid;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.554
47 Valladolid;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
47 Valladolid;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,79
47 Valladolid;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;106
47 Valladolid;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;106
47 Valladolid;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;106
47 Valladolid;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
47 Valladolid;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
47 Valladolid;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
47 Valladolid;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;23
47 Valladolid;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;23
47 Valladolid;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;23
47 Valladolid;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
47 Valladolid;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
47 Valladolid;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
47 Valladolid;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;83
47 Valladolid;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;83
47 Valladolid;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;83
47 Valladolid;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
47 Valladolid;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
47 Valladolid;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
47 Valladolid;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;125
47 Valladolid;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;118
47 Valladolid;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
47 Valladolid;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,4
47 Valladolid;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;26
47 Valladolid;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;19
47 Valladolid;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
47 Valladolid;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;73,08
47 Valladolid;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;99
47 Valladolid;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;99
47 Valladolid;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
47 Valladolid;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
47 Valladolid;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;53
47 Valladolid;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;53
47 Valladolid;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;53
47 Valladolid;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
47 Valladolid;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
47 Valladolid;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
47 Valladolid;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;10
47 Valladolid;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;10
47 Valladolid;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;10
47 Valladolid;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
47 Valladolid;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
47 Valladolid;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
47 Valladolid;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;43
47 Valladolid;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;43
47 Valladolid;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;43
47 Valladolid;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
47 Valladolid;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
47 Valladolid;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
47 Valladolid;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;58
47 Valladolid;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;58
47 Valladolid;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
47 Valladolid;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
47 Valladolid;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;9
47 Valladolid;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;9
47 Valladolid;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
47 Valladolid;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
47 Valladolid;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;49
47 Valladolid;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;49
47 Valladolid;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
47 Valladolid;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
47 Valladolid;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
47 Valladolid;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
47 Valladolid;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
47 Valladolid;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
47 Valladolid;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
47 Valladolid;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
47 Valladolid;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;3.849
49 Zamora;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
49 Zamora;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;3.678
49 Zamora;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;3.520
49 Zamora;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
49 Zamora;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
49 Zamora;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;95,56
49 Zamora;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;91,45
49 Zamora;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1.012
49 Zamora;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
49 Zamora;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;941
49 Zamora;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;882
49 Zamora;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
49 Zamora;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
49 Zamora;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;92,98
49 Zamora;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;87,15
49 Zamora;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;2.837
49 Zamora;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
49 Zamora;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;2.737
49 Zamora;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;2.638
49 Zamora;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
49 Zamora;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
49 Zamora;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,48
49 Zamora;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;92,99
49 Zamora;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;3.864
49 Zamora;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;3.673
49 Zamora;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
49 Zamora;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
49 Zamora;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
49 Zamora;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
49 Zamora;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,06
49 Zamora;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
49 Zamora;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;957
49 Zamora;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;879
49 Zamora;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
49 Zamora;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
49 Zamora;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
49 Zamora;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
49 Zamora;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,85
49 Zamora;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
49 Zamora;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;2.907
49 Zamora;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;2.794
49 Zamora;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
49 Zamora;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
49 Zamora;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
49 Zamora;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
49 Zamora;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,11
49 Zamora;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
49 Zamora;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
49 Zamora;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
49 Zamora;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
49 Zamora;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
49 Zamora;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
49 Zamora;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
49 Zamora;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
49 Zamora;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
49 Zamora;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
49 Zamora;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
49 Zamora;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
49 Zamora;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
49 Zamora;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
49 Zamora;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
49 Zamora;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
49 Zamora;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
49 Zamora;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
49 Zamora;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
49 Zamora;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
49 Zamora;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
49 Zamora;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
49 Zamora;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
49 Zamora;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
49 Zamora;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
49 Zamora;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
49 Zamora;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
49 Zamora;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
49 Zamora;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
49 Zamora;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
49 Zamora;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
49 Zamora;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;3.031
49 Zamora;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;2.868
49 Zamora;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;2.721
49 Zamora;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
49 Zamora;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;94,62
49 Zamora;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;89,77
49 Zamora;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;866
49 Zamora;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;797
49 Zamora;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;743
49 Zamora;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
49 Zamora;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;92,03
49 Zamora;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;85,8
49 Zamora;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;2.165
49 Zamora;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;2.071
49 Zamora;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.978
49 Zamora;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
49 Zamora;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,66
49 Zamora;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;91,36
49 Zamora;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;3.024
49 Zamora;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;2.853
49 Zamora;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
49 Zamora;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,35
49 Zamora;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;819
49 Zamora;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;753
49 Zamora;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
49 Zamora;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,94
49 Zamora;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;2.205
49 Zamora;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;2.100
49 Zamora;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
49 Zamora;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,24
49 Zamora;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;363
49 Zamora;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;360
49 Zamora;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;354
49 Zamora;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
49 Zamora;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,17
49 Zamora;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,52
49 Zamora;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;81
49 Zamora;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;80
49 Zamora;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;78
49 Zamora;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
49 Zamora;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,77
49 Zamora;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;96,3
49 Zamora;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;282
49 Zamora;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;280
49 Zamora;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;276
49 Zamora;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
49 Zamora;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,29
49 Zamora;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,87
49 Zamora;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;361
49 Zamora;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;353
49 Zamora;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
49 Zamora;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,78
49 Zamora;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;68
49 Zamora;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;67
49 Zamora;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
49 Zamora;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;98,53
49 Zamora;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;293
49 Zamora;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;286
49 Zamora;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
49 Zamora;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;97,61
49 Zamora;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;436
49 Zamora;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;431
49 Zamora;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;426
49 Zamora;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
49 Zamora;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,85
49 Zamora;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,71
49 Zamora;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;62
49 Zamora;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;61
49 Zamora;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;58
49 Zamora;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
49 Zamora;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,39
49 Zamora;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;93,55
49 Zamora;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;374
49 Zamora;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;370
49 Zamora;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;368
49 Zamora;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
49 Zamora;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,93
49 Zamora;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,4
49 Zamora;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;457
49 Zamora;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;446
49 Zamora;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
49 Zamora;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,59
49 Zamora;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;66
49 Zamora;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;56
49 Zamora;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
49 Zamora;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;84,85
49 Zamora;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;391
49 Zamora;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;390
49 Zamora;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
49 Zamora;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,74
49 Zamora;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;11
49 Zamora;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;11
49 Zamora;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;11
49 Zamora;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
49 Zamora;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
49 Zamora;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
49 Zamora;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
49 Zamora;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
49 Zamora;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
49 Zamora;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;2
49 Zamora;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;2
49 Zamora;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;2
49 Zamora;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
49 Zamora;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
49 Zamora;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
49 Zamora;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
49 Zamora;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
49 Zamora;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
49 Zamora;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;9
49 Zamora;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;9
49 Zamora;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;9
49 Zamora;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
49 Zamora;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
49 Zamora;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
49 Zamora;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
49 Zamora;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
49 Zamora;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
49 Zamora;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;15
49 Zamora;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;14
49 Zamora;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
49 Zamora;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,33
49 Zamora;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
49 Zamora;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
49 Zamora;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
49 Zamora;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
49 Zamora;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;3
49 Zamora;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;2
49 Zamora;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
49 Zamora;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;66,67
49 Zamora;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
49 Zamora;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
49 Zamora;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
49 Zamora;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
49 Zamora;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;12
49 Zamora;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;12
49 Zamora;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
49 Zamora;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
49 Zamora;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
49 Zamora;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
49 Zamora;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
49 Zamora;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
49 Zamora;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
49 Zamora;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
49 Zamora;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
49 Zamora;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
49 Zamora;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
49 Zamora;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
49 Zamora;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
49 Zamora;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
49 Zamora;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
49 Zamora;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
49 Zamora;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
49 Zamora;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
49 Zamora;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
49 Zamora;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
49 Zamora;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
49 Zamora;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
49 Zamora;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
49 Zamora;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
49 Zamora;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
49 Zamora;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
49 Zamora;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
49 Zamora;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
49 Zamora;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
49 Zamora;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
49 Zamora;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;8
49 Zamora;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;8
49 Zamora;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;8
49 Zamora;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
49 Zamora;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
49 Zamora;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
49 Zamora;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1
49 Zamora;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1
49 Zamora;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1
49 Zamora;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
49 Zamora;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
49 Zamora;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
49 Zamora;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;7
49 Zamora;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;7
49 Zamora;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;7
49 Zamora;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
49 Zamora;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
49 Zamora;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
49 Zamora;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;7
49 Zamora;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;7
49 Zamora;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
49 Zamora;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
49 Zamora;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1
49 Zamora;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1
49 Zamora;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
49 Zamora;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
49 Zamora;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;6
49 Zamora;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;6
49 Zamora;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
49 Zamora;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
49 Zamora;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
49 Zamora;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
49 Zamora;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
49 Zamora;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
49 Zamora;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
49 Zamora;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
49 Zamora;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;22.374
50 Zaragoza;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
50 Zaragoza;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;21.295
50 Zaragoza;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;20.425
50 Zaragoza;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
50 Zaragoza;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
50 Zaragoza;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;95,18
50 Zaragoza;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;91,29
50 Zaragoza;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;6.573
50 Zaragoza;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
50 Zaragoza;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;6.025
50 Zaragoza;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;5.628
50 Zaragoza;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
50 Zaragoza;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
50 Zaragoza;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,66
50 Zaragoza;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;85,62
50 Zaragoza;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;15.801
50 Zaragoza;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
50 Zaragoza;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;15.270
50 Zaragoza;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;14.797
50 Zaragoza;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
50 Zaragoza;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
50 Zaragoza;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,64
50 Zaragoza;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;93,65
50 Zaragoza;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;22.363
50 Zaragoza;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;21.294
50 Zaragoza;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
50 Zaragoza;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
50 Zaragoza;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
50 Zaragoza;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
50 Zaragoza;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;95,22
50 Zaragoza;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;6.087
50 Zaragoza;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;5.595
50 Zaragoza;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
50 Zaragoza;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
50 Zaragoza;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
50 Zaragoza;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
50 Zaragoza;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,92
50 Zaragoza;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;16.276
50 Zaragoza;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;15.699
50 Zaragoza;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
50 Zaragoza;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
50 Zaragoza;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
50 Zaragoza;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
50 Zaragoza;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,45
50 Zaragoza;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
50 Zaragoza;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
50 Zaragoza;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
50 Zaragoza;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
50 Zaragoza;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
50 Zaragoza;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
50 Zaragoza;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
50 Zaragoza;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
50 Zaragoza;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
50 Zaragoza;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
50 Zaragoza;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
50 Zaragoza;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
50 Zaragoza;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
50 Zaragoza;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
50 Zaragoza;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
50 Zaragoza;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
50 Zaragoza;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
50 Zaragoza;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
50 Zaragoza;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
50 Zaragoza;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
50 Zaragoza;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
50 Zaragoza;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
50 Zaragoza;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
50 Zaragoza;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
50 Zaragoza;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;15.757
50 Zaragoza;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;14.741
50 Zaragoza;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;13.984
50 Zaragoza;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
50 Zaragoza;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,55
50 Zaragoza;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;88,75
50 Zaragoza;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;5.343
50 Zaragoza;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;4.814
50 Zaragoza;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;4.464
50 Zaragoza;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
50 Zaragoza;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;90,1
50 Zaragoza;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;83,55
50 Zaragoza;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;10.414
50 Zaragoza;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;9.927
50 Zaragoza;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;9.520
50 Zaragoza;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
50 Zaragoza;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,32
50 Zaragoza;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;91,42
50 Zaragoza;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;15.665
50 Zaragoza;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;14.721
50 Zaragoza;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
50 Zaragoza;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,97
50 Zaragoza;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;4.977
50 Zaragoza;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;4.541
50 Zaragoza;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
50 Zaragoza;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,24
50 Zaragoza;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;10.688
50 Zaragoza;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;10.180
50 Zaragoza;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
50 Zaragoza;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,25
50 Zaragoza;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;2.444
50 Zaragoza;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;2.417
50 Zaragoza;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;2.353
50 Zaragoza;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
50 Zaragoza;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,9
50 Zaragoza;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,28
50 Zaragoza;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;564
50 Zaragoza;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;553
50 Zaragoza;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;527
50 Zaragoza;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
50 Zaragoza;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,05
50 Zaragoza;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;93,44
50 Zaragoza;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;1.880
50 Zaragoza;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;1.864
50 Zaragoza;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;1.826
50 Zaragoza;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
50 Zaragoza;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,15
50 Zaragoza;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,13
50 Zaragoza;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;2.509
50 Zaragoza;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;2.454
50 Zaragoza;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
50 Zaragoza;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,81
50 Zaragoza;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;530
50 Zaragoza;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;511
50 Zaragoza;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
50 Zaragoza;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;96,42
50 Zaragoza;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.979
50 Zaragoza;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;1.943
50 Zaragoza;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
50 Zaragoza;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,18
50 Zaragoza;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;3.825
50 Zaragoza;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;3.791
50 Zaragoza;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;3.742
50 Zaragoza;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
50 Zaragoza;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,11
50 Zaragoza;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,83
50 Zaragoza;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;637
50 Zaragoza;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;629
50 Zaragoza;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;608
50 Zaragoza;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
50 Zaragoza;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;98,74
50 Zaragoza;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;95,45
50 Zaragoza;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;3.188
50 Zaragoza;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;3.162
50 Zaragoza;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;3.134
50 Zaragoza;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
50 Zaragoza;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,18
50 Zaragoza;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,31
50 Zaragoza;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;3.814
50 Zaragoza;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;3.752
50 Zaragoza;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
50 Zaragoza;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;98,37
50 Zaragoza;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;544
50 Zaragoza;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;515
50 Zaragoza;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
50 Zaragoza;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;94,67
50 Zaragoza;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;3.270
50 Zaragoza;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;3.237
50 Zaragoza;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
50 Zaragoza;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,99
50 Zaragoza;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;223
50 Zaragoza;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;221
50 Zaragoza;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;221
50 Zaragoza;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
50 Zaragoza;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,1
50 Zaragoza;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;99,1
50 Zaragoza;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;22
50 Zaragoza;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;22
50 Zaragoza;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;22
50 Zaragoza;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
50 Zaragoza;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
50 Zaragoza;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
50 Zaragoza;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;201
50 Zaragoza;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;199
50 Zaragoza;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;199
50 Zaragoza;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
50 Zaragoza;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99
50 Zaragoza;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;99
50 Zaragoza;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;241
50 Zaragoza;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;233
50 Zaragoza;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
50 Zaragoza;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;96,68
50 Zaragoza;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;33
50 Zaragoza;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;25
50 Zaragoza;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
50 Zaragoza;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;75,76
50 Zaragoza;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;208
50 Zaragoza;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;208
50 Zaragoza;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
50 Zaragoza;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
50 Zaragoza;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;125
50 Zaragoza;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;125
50 Zaragoza;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;125
50 Zaragoza;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
50 Zaragoza;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
50 Zaragoza;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
50 Zaragoza;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;7
50 Zaragoza;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;7
50 Zaragoza;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;7
50 Zaragoza;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
50 Zaragoza;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
50 Zaragoza;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
50 Zaragoza;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;118
50 Zaragoza;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;118
50 Zaragoza;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;118
50 Zaragoza;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
50 Zaragoza;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
50 Zaragoza;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
50 Zaragoza;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;134
50 Zaragoza;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;134
50 Zaragoza;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
50 Zaragoza;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
50 Zaragoza;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;3
50 Zaragoza;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;3
50 Zaragoza;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
50 Zaragoza;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
50 Zaragoza;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;131
50 Zaragoza;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;131
50 Zaragoza;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
50 Zaragoza;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
50 Zaragoza;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.470
51 Ceuta;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
51 Ceuta;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.399
51 Ceuta;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.332
51 Ceuta;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
51 Ceuta;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
51 Ceuta;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;95,17
51 Ceuta;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;90,61
51 Ceuta;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;480
51 Ceuta;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
51 Ceuta;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;446
51 Ceuta;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;414
51 Ceuta;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
51 Ceuta;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
51 Ceuta;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;92,92
51 Ceuta;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;86,25
51 Ceuta;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;990
51 Ceuta;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
51 Ceuta;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;953
51 Ceuta;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;918
51 Ceuta;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
51 Ceuta;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
51 Ceuta;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;96,26
51 Ceuta;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;92,73
51 Ceuta;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.476
51 Ceuta;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.395
51 Ceuta;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
51 Ceuta;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
51 Ceuta;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
51 Ceuta;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
51 Ceuta;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;94,51
51 Ceuta;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;456
51 Ceuta;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;416
51 Ceuta;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
51 Ceuta;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
51 Ceuta;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
51 Ceuta;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
51 Ceuta;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,23
51 Ceuta;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;1.020
51 Ceuta;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;979
51 Ceuta;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
51 Ceuta;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
51 Ceuta;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
51 Ceuta;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
51 Ceuta;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,98
51 Ceuta;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
51 Ceuta;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
51 Ceuta;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
51 Ceuta;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
51 Ceuta;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
51 Ceuta;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
51 Ceuta;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
51 Ceuta;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
51 Ceuta;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
51 Ceuta;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
51 Ceuta;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
51 Ceuta;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
51 Ceuta;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
51 Ceuta;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
51 Ceuta;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
51 Ceuta;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
51 Ceuta;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
51 Ceuta;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
51 Ceuta;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
51 Ceuta;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
51 Ceuta;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
51 Ceuta;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
51 Ceuta;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
51 Ceuta;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
51 Ceuta;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.057
51 Ceuta;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;991
51 Ceuta;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;935
51 Ceuta;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
51 Ceuta;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;93,76
51 Ceuta;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;88,46
51 Ceuta;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;364
51 Ceuta;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;333
51 Ceuta;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;305
51 Ceuta;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
51 Ceuta;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;91,48
51 Ceuta;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;83,79
51 Ceuta;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;693
51 Ceuta;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;658
51 Ceuta;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;630
51 Ceuta;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
51 Ceuta;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;94,95
51 Ceuta;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;90,91
51 Ceuta;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.065
51 Ceuta;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;996
51 Ceuta;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
51 Ceuta;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,52
51 Ceuta;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;350
51 Ceuta;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;315
51 Ceuta;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
51 Ceuta;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90
51 Ceuta;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;715
51 Ceuta;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;681
51 Ceuta;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
51 Ceuta;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,24
51 Ceuta;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;171
51 Ceuta;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;168
51 Ceuta;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;163
51 Ceuta;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
51 Ceuta;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;98,25
51 Ceuta;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;95,32
51 Ceuta;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;49
51 Ceuta;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;48
51 Ceuta;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;46
51 Ceuta;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
51 Ceuta;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;97,96
51 Ceuta;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;93,88
51 Ceuta;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;122
51 Ceuta;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;120
51 Ceuta;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;117
51 Ceuta;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
51 Ceuta;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,36
51 Ceuta;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;95,9
51 Ceuta;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;155
51 Ceuta;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;150
51 Ceuta;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
51 Ceuta;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;96,77
51 Ceuta;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;36
51 Ceuta;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;33
51 Ceuta;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
51 Ceuta;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;91,67
51 Ceuta;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;119
51 Ceuta;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;117
51 Ceuta;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
51 Ceuta;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,32
51 Ceuta;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;226
51 Ceuta;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;224
51 Ceuta;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;218
51 Ceuta;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
51 Ceuta;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,12
51 Ceuta;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;96,46
51 Ceuta;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;65
51 Ceuta;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;63
51 Ceuta;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;61
51 Ceuta;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
51 Ceuta;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;96,92
51 Ceuta;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;93,85
51 Ceuta;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;161
51 Ceuta;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;161
51 Ceuta;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;157
51 Ceuta;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
51 Ceuta;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
51 Ceuta;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;97,52
51 Ceuta;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;237
51 Ceuta;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;231
51 Ceuta;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
51 Ceuta;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;97,47
51 Ceuta;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;65
51 Ceuta;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;64
51 Ceuta;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
51 Ceuta;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;98,46
51 Ceuta;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;172
51 Ceuta;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;167
51 Ceuta;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
51 Ceuta;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;97,09
51 Ceuta;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;12
51 Ceuta;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;12
51 Ceuta;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;12
51 Ceuta;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
51 Ceuta;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
51 Ceuta;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
51 Ceuta;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1
51 Ceuta;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1
51 Ceuta;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1
51 Ceuta;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
51 Ceuta;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
51 Ceuta;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
51 Ceuta;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;11
51 Ceuta;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;11
51 Ceuta;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;11
51 Ceuta;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
51 Ceuta;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
51 Ceuta;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
51 Ceuta;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;15
51 Ceuta;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;14
51 Ceuta;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
51 Ceuta;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,33
51 Ceuta;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;4
51 Ceuta;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;3
51 Ceuta;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
51 Ceuta;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;75
51 Ceuta;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;11
51 Ceuta;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;11
51 Ceuta;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
51 Ceuta;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
51 Ceuta;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;4
51 Ceuta;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;4
51 Ceuta;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;4
51 Ceuta;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
51 Ceuta;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
51 Ceuta;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
51 Ceuta;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;1
51 Ceuta;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;1
51 Ceuta;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;1
51 Ceuta;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
51 Ceuta;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
51 Ceuta;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;100
51 Ceuta;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;3
51 Ceuta;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;3
51 Ceuta;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;3
51 Ceuta;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
51 Ceuta;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
51 Ceuta;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
51 Ceuta;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;4
51 Ceuta;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;4
51 Ceuta;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
51 Ceuta;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
51 Ceuta;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;1
51 Ceuta;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;1
51 Ceuta;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
51 Ceuta;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;100
51 Ceuta;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;3
51 Ceuta;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;3
51 Ceuta;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
51 Ceuta;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
51 Ceuta;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
51 Ceuta;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
51 Ceuta;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
51 Ceuta;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
51 Ceuta;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
51 Ceuta;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
51 Ceuta;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.487
52 Melilla;Total;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
52 Melilla;Total;Cohort January 1;All ages;Survival in the first trimester;2026QI;1.376
52 Melilla;Total;Cohort January 1;All ages;Survival in the second trimester;2026QII;1.305
52 Melilla;Total;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
52 Melilla;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;Total;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;Total;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;Total;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
52 Melilla;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;Total;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;92,54
52 Melilla;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;87,76
52 Melilla;Total;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Total;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Total;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;568
52 Melilla;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
52 Melilla;Total;Cohort January 1;5 and under;Survival in the first trimester;2026QI;496
52 Melilla;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QII;451
52 Melilla;Total;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
52 Melilla;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;Total;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;Total;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
52 Melilla;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;Total;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;87,32
52 Melilla;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;79,4
52 Melilla;Total;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Total;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Total;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;919
52 Melilla;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
52 Melilla;Total;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;880
52 Melilla;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;854
52 Melilla;Total;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
52 Melilla;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;Total;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;Total;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
52 Melilla;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;Total;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;95,76
52 Melilla;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;92,93
52 Melilla;Total;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Total;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Total;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.483
52 Melilla;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;Total;Cohort April 1;All ages;Survival in the first trimester;2026QII;1.390
52 Melilla;Total;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
52 Melilla;Total;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
52 Melilla;Total;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
52 Melilla;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;Total;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;Total;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
52 Melilla;Total;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;93,73
52 Melilla;Total;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
52 Melilla;Total;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Total;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Total;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;517
52 Melilla;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QII;456
52 Melilla;Total;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
52 Melilla;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
52 Melilla;Total;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
52 Melilla;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;Total;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
52 Melilla;Total;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;88,2
52 Melilla;Total;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
52 Melilla;Total;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Total;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Total;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;966
52 Melilla;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;934
52 Melilla;Total;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
52 Melilla;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
52 Melilla;Total;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
52 Melilla;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;Total;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
52 Melilla;Total;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;96,69
52 Melilla;Total;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
52 Melilla;Total;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Total;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Total;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;Total;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
52 Melilla;Total;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
52 Melilla;Total;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
52 Melilla;Total;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
52 Melilla;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;Total;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;Total;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;Total;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;Total;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
52 Melilla;Total;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Total;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Total;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
52 Melilla;Total;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
52 Melilla;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
52 Melilla;Total;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
52 Melilla;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;Total;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;Total;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;Total;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
52 Melilla;Total;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Total;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Total;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
52 Melilla;Total;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
52 Melilla;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
52 Melilla;Total;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
52 Melilla;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;Total;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;Total;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;Total;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
52 Melilla;Total;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Total;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Total;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;Total;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
52 Melilla;Total;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
52 Melilla;Total;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
52 Melilla;Total;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
52 Melilla;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;Total;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;Total;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;Total;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;Total;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
52 Melilla;Total;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Total;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Total;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
52 Melilla;Total;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
52 Melilla;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
52 Melilla;Total;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
52 Melilla;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;Total;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;Total;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;Total;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
52 Melilla;Total;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Total;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Total;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
52 Melilla;Total;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
52 Melilla;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
52 Melilla;Total;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
52 Melilla;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;Total;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;Total;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;Total;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
52 Melilla;Total;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Total;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Total;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;1.057
52 Melilla;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort January 1;All ages;Survival in the first trimester;2026QI;952
52 Melilla;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QII;892
52 Melilla;From 1 to 5;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;From 1 to 5;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
52 Melilla;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;90,07
52 Melilla;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;84,39
52 Melilla;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 1 to 5;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;460
52 Melilla;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort January 1;5 and under;Survival in the first trimester;2026QI;391
52 Melilla;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QII;353
52 Melilla;From 1 to 5;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;From 1 to 5;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
52 Melilla;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;85
52 Melilla;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;76,74
52 Melilla;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 1 to 5;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;597
52 Melilla;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;561
52 Melilla;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;539
52 Melilla;From 1 to 5;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;From 1 to 5;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
52 Melilla;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;93,97
52 Melilla;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;90,28
52 Melilla;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 1 to 5;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;1.060
52 Melilla;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QII;976
52 Melilla;From 1 to 5;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
52 Melilla;From 1 to 5;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;92,08
52 Melilla;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 1 to 5;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;430
52 Melilla;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QII;375
52 Melilla;From 1 to 5;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
52 Melilla;From 1 to 5;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;87,21
52 Melilla;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 1 to 5;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;630
52 Melilla;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;601
52 Melilla;From 1 to 5;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
52 Melilla;From 1 to 5;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;95,4
52 Melilla;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 1 to 5;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;From 1 to 5;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 1 to 5;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;From 1 to 5;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 1 to 5;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;From 1 to 5;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 1 to 5;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;From 1 to 5;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 1 to 5;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;From 1 to 5;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 1 to 5;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;From 1 to 5;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 1 to 5;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;205
52 Melilla;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort January 1;All ages;Survival in the first trimester;2026QI;200
52 Melilla;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QII;193
52 Melilla;From 6 to 9;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;From 6 to 9;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
52 Melilla;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;97,56
52 Melilla;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;94,15
52 Melilla;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 6 to 9;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;59
52 Melilla;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort January 1;5 and under;Survival in the first trimester;2026QI;56
52 Melilla;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QII;52
52 Melilla;From 6 to 9;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;From 6 to 9;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
52 Melilla;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;94,92
52 Melilla;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;88,14
52 Melilla;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 6 to 9;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;146
52 Melilla;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;144
52 Melilla;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;141
52 Melilla;From 6 to 9;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;From 6 to 9;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
52 Melilla;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;98,63
52 Melilla;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;96,58
52 Melilla;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 6 to 9;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;211
52 Melilla;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QII;204
52 Melilla;From 6 to 9;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
52 Melilla;From 6 to 9;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;96,68
52 Melilla;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 6 to 9;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;54
52 Melilla;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QII;49
52 Melilla;From 6 to 9;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
52 Melilla;From 6 to 9;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;90,74
52 Melilla;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 6 to 9;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;157
52 Melilla;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;155
52 Melilla;From 6 to 9;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
52 Melilla;From 6 to 9;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;98,73
52 Melilla;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 6 to 9;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;From 6 to 9;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 6 to 9;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;From 6 to 9;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 6 to 9;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;From 6 to 9;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 6 to 9;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;From 6 to 9;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 6 to 9;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;From 6 to 9;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 6 to 9;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;From 6 to 9;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 6 to 9;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;219
52 Melilla;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort January 1;All ages;Survival in the first trimester;2026QI;218
52 Melilla;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QII;214
52 Melilla;From 10 to 99;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;From 10 to 99;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
52 Melilla;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;99,54
52 Melilla;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;97,72
52 Melilla;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 10 to 99;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;49
52 Melilla;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort January 1;5 and under;Survival in the first trimester;2026QI;49
52 Melilla;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QII;46
52 Melilla;From 10 to 99;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;From 10 to 99;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;100
52 Melilla;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;100
52 Melilla;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;93,88
52 Melilla;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 10 to 99;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;170
52 Melilla;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;169
52 Melilla;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;168
52 Melilla;From 10 to 99;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;From 10 to 99;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
52 Melilla;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;99,41
52 Melilla;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;98,82
52 Melilla;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 10 to 99;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;207
52 Melilla;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QII;205
52 Melilla;From 10 to 99;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
52 Melilla;From 10 to 99;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;99,03
52 Melilla;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 10 to 99;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;33
52 Melilla;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QII;32
52 Melilla;From 10 to 99;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;100
52 Melilla;From 10 to 99;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;96,97
52 Melilla;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 10 to 99;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;174
52 Melilla;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;173
52 Melilla;From 10 to 99;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
52 Melilla;From 10 to 99;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;99,43
52 Melilla;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 10 to 99;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;From 10 to 99;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 10 to 99;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;From 10 to 99;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 10 to 99;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;From 10 to 99;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 10 to 99;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;From 10 to 99;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 10 to 99;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;From 10 to 99;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 10 to 99;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;From 10 to 99;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 10 to 99;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;4
52 Melilla;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort January 1;All ages;Survival in the first trimester;2026QI;4
52 Melilla;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QII;4
52 Melilla;from 100 to 249;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;from 100 to 249;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
52 Melilla;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
52 Melilla;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
52 Melilla;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
52 Melilla;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
52 Melilla;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
52 Melilla;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;from 100 to 249;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;0
52 Melilla;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort January 1;5 and under;Survival in the first trimester;2026QI;0
52 Melilla;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QII;0
52 Melilla;from 100 to 249;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;from 100 to 249;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;..
52 Melilla;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;..
52 Melilla;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;..
52 Melilla;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
52 Melilla;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
52 Melilla;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
52 Melilla;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;from 100 to 249;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;4
52 Melilla;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;4
52 Melilla;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;4
52 Melilla;from 100 to 249;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;from 100 to 249;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
52 Melilla;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
52 Melilla;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
52 Melilla;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
52 Melilla;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
52 Melilla;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
52 Melilla;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;from 100 to 249;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;3
52 Melilla;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QII;3
52 Melilla;from 100 to 249;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
52 Melilla;from 100 to 249;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
52 Melilla;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
52 Melilla;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
52 Melilla;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
52 Melilla;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
52 Melilla;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;from 100 to 249;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;0
52 Melilla;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QII;0
52 Melilla;from 100 to 249;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;..
52 Melilla;from 100 to 249;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;..
52 Melilla;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
52 Melilla;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
52 Melilla;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
52 Melilla;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
52 Melilla;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;from 100 to 249;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;3
52 Melilla;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;3
52 Melilla;from 100 to 249;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
52 Melilla;from 100 to 249;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
52 Melilla;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
52 Melilla;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
52 Melilla;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
52 Melilla;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
52 Melilla;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;from 100 to 249;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;from 100 to 249;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
52 Melilla;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
52 Melilla;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
52 Melilla;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
52 Melilla;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;from 100 to 249;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;from 100 to 249;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
52 Melilla;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
52 Melilla;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
52 Melilla;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
52 Melilla;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;from 100 to 249;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;from 100 to 249;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
52 Melilla;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
52 Melilla;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
52 Melilla;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
52 Melilla;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;from 100 to 249;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;from 100 to 249;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
52 Melilla;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
52 Melilla;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
52 Melilla;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
52 Melilla;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;from 100 to 249;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;from 100 to 249;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
52 Melilla;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
52 Melilla;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
52 Melilla;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
52 Melilla;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;from 100 to 249;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;from 100 to 249;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
52 Melilla;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
52 Melilla;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
52 Melilla;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
52 Melilla;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;from 100 to 249;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;2
52 Melilla;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort January 1;All ages;Survival in the first trimester;2026QI;2
52 Melilla;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QII;2
52 Melilla;From 250 or more ;Cohort January 1;All ages;Survival in the second trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort January 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;From 250 or more ;Cohort January 1;All ages;Number at the start of the quarter;2026QI;100
52 Melilla;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the first trimester;2026QI;100
52 Melilla;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QII;100
52 Melilla;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 250 or more ;Cohort January 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;0
52 Melilla;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort January 1;5 and under;Survival in the first trimester;2026QI;0
52 Melilla;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QII;0
52 Melilla;From 250 or more ;Cohort January 1;5 and under;Survival in the second trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort January 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;From 250 or more ;Cohort January 1;5 and under;Number at the start of the quarter;2026QI;..
52 Melilla;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the first trimester;2026QI;..
52 Melilla;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QII;..
52 Melilla;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 250 or more ;Cohort January 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;2
52 Melilla;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort January 1;Over 5 years;Survival in the first trimester;2026QI;2
52 Melilla;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QII;2
52 Melilla;From 250 or more ;Cohort January 1;Over 5 years;Survival in the second trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort January 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;From 250 or more ;Cohort January 1;Over 5 years;Number at the start of the quarter;2026QI;100
52 Melilla;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;100
52 Melilla;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QII;100
52 Melilla;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 250 or more ;Cohort January 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;2
52 Melilla;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QII;2
52 Melilla;From 250 or more ;Cohort April 1;All ages;Survival in the first trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort April 1;All ages;Survival in the second trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort April 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QII;100
52 Melilla;From 250 or more ;Cohort April 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QII;100
52 Melilla;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 250 or more ;Cohort April 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;0
52 Melilla;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QII;0
52 Melilla;From 250 or more ;Cohort April 1;5 and under;Survival in the first trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort April 1;5 and under;Survival in the second trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort April 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QII;..
52 Melilla;From 250 or more ;Cohort April 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QII;..
52 Melilla;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 250 or more ;Cohort April 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;2
52 Melilla;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QII;2
52 Melilla;From 250 or more ;Cohort April 1;Over 5 years;Survival in the first trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort April 1;Over 5 years;Survival in the second trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort April 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QII;100
52 Melilla;From 250 or more ;Cohort April 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;100
52 Melilla;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 250 or more ;Cohort April 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort July 1;All ages;Survival in the first trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort July 1;All ages;Survival in the second trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort July 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;From 250 or more ;Cohort July 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 250 or more ;Cohort July 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort July 1;5 and under;Survival in the first trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort July 1;5 and under;Survival in the second trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort July 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;From 250 or more ;Cohort July 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 250 or more ;Cohort July 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort July 1;Over 5 years;Survival in the first trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort July 1;Over 5 years;Survival in the second trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort July 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;From 250 or more ;Cohort July 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 250 or more ;Cohort July 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort October 1;All ages;Survival in the first trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort October 1;All ages;Survival in the second trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort October 1;All ages;Survival in the third trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QII;""
52 Melilla;From 250 or more ;Cohort October 1;All ages;Number at the start of the quarter;2026QI;""
52 Melilla;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 250 or more ;Cohort October 1;All ages;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort October 1;5 and under;Survival in the first trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort October 1;5 and under;Survival in the second trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort October 1;5 and under;Survival in the third trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QII;""
52 Melilla;From 250 or more ;Cohort October 1;5 and under;Number at the start of the quarter;2026QI;""
52 Melilla;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 250 or more ;Cohort October 1;5 and under;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort October 1;Over 5 years;Survival in the first trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort October 1;Over 5 years;Survival in the second trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort October 1;Over 5 years;Survival in the third trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QII;""
52 Melilla;From 250 or more ;Cohort October 1;Over 5 years;Number at the start of the quarter;2026QI;""
52 Melilla;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 250 or more ;Cohort October 1;Over 5 years;Percentage of survivals in the fourth semester;2026QI;""